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ABSTRACT 
 
 
Chitosan, a naturally occurring polysaccharide, and its derivatives have been 
widely explored for biomedical applications due to their biocompatibility and 
biodegradability. In our studies, we developed a series of chitosan derivatives through 
chemical modifications. These chitosan derivatives not only possess better processibility 
in scaffolds fabrication, but also show excellent potentials in tissue engineering 
applications, including blood vessel and bone tissue engineering. 
The excellent antithrombogenic property is crucial for vascular engineering 
applications, especially in engineering small-diameter blood vessels. In our studies, 
chitosan was chemically modified by phthalization and the phthalized chitosan exhibited 
great antithrombogenic property. Through a wet- phase-inversion process, tubular 
constructs of varying sizes, morphology, and permeability were fabricated from 
phthalized chitosan, suggesting its potential as a scaffold for vascular engineering. 
The excellent osteoconductivity of chitosan and some of its derivatives make 
them good candicates for orthorpaedic applications. In our studies, we synthesized novel 
photocurable chitosans which possess great processibility compared to raw chitosan and 
can be fabricated into scaffolds with desired shape, pore size and topography upon light 
exposure. These photocured porous chitosan scaffolds showed great osteoconductivity in 
vivo. Moreover, the photocured chitosan scaffolds were developed into osteoinductive 
scaffolds through immobilizing heparin on the surface followed by loading BMP-2. 
Ectopic bone growth is observed when subcutaneously implanted. All of these indicated 
that the newly developed photocurable chitosan have great potential in solving some 
 iii
thorny problems in bone repair, such as non-union bone defects and long bone defects 
with irregular shapes. 
In order to mimic the structure of extracellular matrix, the hybrid scaffolds 
containing photocurable chitosan and gelatin were developed. It is very interesting to 
note that the interaction between chitosan and gelatin, and the photocuring process can 
control the morphology of the complex scaffolds. Heparin can also be effectively 
immobilized on the surface of complex scaffolds. Loaded with BMP-2, the heparinized 
complex scaffolds can be used as osteoinductive scaffolds, as indicated by the ectopic 
bone growth in vivo. Moreover, this complex scaffold shows intriguing elasticity. 
Combined with the potential ability of delivering various growth factors, this complex 
scaffolds have great potentials in tissue engineering, especially in cartilage tissue 
engineering. 
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CHAPTER ONE 
 
CHITOSAN: HISTORY, PROPERTIES AND APPLICATIONS 
 
 
1.1 Chitosan: from then to now 
Chitosan is not native to animal sources and is normally obtained by the 
deacetylation of shellfish-derived chitin using an alkaline solution.  The first explicit 
description of chitin was written in 1811 by Professor Braconnot, Director of the 
Botanical Garden and member of the Academy in Sciences of Nancy, France 1. He 
described and named the alkali-resistant fraction from isolates of some higher fungi, or 
“fungine.” In 1823, Odier found a material with the same general properties as fungine in 
the cuticle of beetles. He designated this material “chitin” after the Greek word “chiton” 
meaning “coat of mail” in reference to the cuticle. Subsequently, the chemical character 
of chitin began to be elucidated, as its chemical structure was confirmed by x-ray 
diffraction, enzymatic and deamination reactions by Meyer and others in the first half of 
the 20th Century.  
The discovery of chitosan in 1859 is attributed to Rouget after he found that 
boiling chitin in potassium hydroxide rendered it soluble in organic acids. In 1894 Hoppe 
Seyler named this material chitosan. However, it was not until 1950 that the structure of 
chitosan was finally resolved. Today, chitin and chitosan are attracting more and more 
attention and are being widely used in industrial and biomedical applications. 
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1.2 Definitions 
The ideal structure of chitin is a linear polysaccharide of β (1→4)-2-acetamido-2-
deoxy-D-glucopyranose, where all residues are comprised entirely of N-acetyl-
glucosamine residues or, in chitin jargon, are fully acetylated 2. Likewise, the ideal 
structure of chitosan, the principal derivative of chitin, is a linear polymer of β (1→4)-2-
amino-2-deoxy-D-glucopyranose, where all residues are comprised entirely of N-
glucosamine residues or are fully deacetylated (Figure 1.1). 
 
O
CH2OH
OH
NHAc
O
n
O
CH2OH
OH
NH2
O
n
Chitin Chitosan
Ac = C CH3
O
 
Figure 1.1: Ideal chemical representation of chitin and chitosan 
 
However, in reality, the traditional sources of chitin and chitosan are not 100% 
acetylated or deacetylated. Instead, they exist as a co-polymer of N-acetylglucosamine 
and glucosamine, as represented in Figure 1.2. The difference between chitin and 
chitosan is their acetyl content. Generally speaking, chitin is made up of more than 50% 
(more commonly 70-90%) acetamido groups. The other forms of these copolymers are 
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termed chitosan (commonly having 70-90% amino groups). The degree of deacetylation 
(DD) is important criteria for chitosan. 
 
O
CH2OH
OH
NH
O
R
OH
O
CH2OH
OH
NHAc
O
x
O
CH2OH
OH
NH2
O
y
O
CH2OH
OH
NH
OH
R
R = C
O
CH3
and  x > 50% Chitin
R = H and  y > 50% Chitosan  
Figure 1.2: Chemical structural representation of chitin and chitosan depicting the co-
polymer character of the biopolymers 
 
1.3 Properties 
Similar to other natural polysaccharides, chitin and chitosan has many hydroxyl 
side groups. However, chitosan also possesses amino side groups, which endows it with 
many more properties than other polysaccharides 3. For example, the amino groups on the 
chitosan might be a major reason why they display antibacterial activity and hemostatic 
or blood clotting properties. In addition, these hydroxyl and amino groups offer 
versatility for chemical modification. The chitosan derivatives from chemical 
modification have been widely exploited, and they exhibit superior physical and chemical 
properties compared to raw chitosan. 
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Chitosan is a hydrated crystal at ambient temperature4. Chitosan chains are 
bonded by hydrogen bonds to make a sheet structure. Water molecules are present 
between these sheets and stabilize this crystal structure. Due to the large amount of 
hydrogen bonds and the crystal structure, chitosan is hardly dissolvable in common 
solvents except for acidic solutions (pH< 6.5). These acidic solutions ionize chitosan 
from its amino side groups, thus making it dissolvable in aqueous solutions. This 
solubility also enables chitosan to be processed into many forms, such as films, hydrogels 
and fibers. 
 
1.4 Chemical modifications 
As discussed before, chitosan has hydroxyl and amino groups as its side groups, 
which provide chemically active sites for modification. After modification, the modified 
chitosan might have improved physical properties, such as solubility, as a result of the 
chemical groups introduced during the modification process5. 
In brief, the hydroxyl and amine groups can react with certain acyl chlorides and 
anhydrides. The amine groups can react with aldehydes or ketones to yield the 
corresponding aldimines and ketimines, which are converted to N-alkyl derivatives upon 
hydrogenation with borohydride. The amine groups can also react with carboxyl groups 
and diisocyanate and can also be used as active sites for ring-opening reactions. 
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1.4.1 Hydrophobic chitosans 
These chitosan derivatives are obtained very easily by reacting chitosan with 
long-chain acyl chlorides and anhydrides. Some of these are intended to mimic 
endotoxins6. 
 
1.4.2 Hydroxyalkyl chitosans5, 7 
In addition, these chitosan derivatives can be obtained by reacting chitosan with 
epoxides. The reaction can be adjusted by pH, solvents or temperature to predominantly 
take place at the amino or alcohol groups, yielding N-hydroxyalkyl or O-hydroxyalkyl 
chitosans or a mixture of both, as shown in Figure 1.3. 
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Figure 1.3 Reaction scheme for chitosan with epoxide 
 
1.4.3 Trimethylated, N-succinylated, Thiolated and Azidated  chitosans 
Figure 1.4 shows the scheme for synthesizing these chitosan derivatives. Tri-
methylated chitosans (TMC) have been synthesized for DNA collection and delivery in 
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vitro and in vivo8-13. By virtue of the strong basic property of the quaternary ammonium 
groups, TMC has proven to be more suitable for collecting and delivering DNA than 
plain chitosan because cationic polymers have generally lead to increased transfection 
efficiencies. The chitosan-thioglycolic acid conjugate showed a tenfold increase in 
adhesion properties as compared to unmodified chitosan. Therefore, these chitosan 
derivatives bearing thiol groups can be used as mucoadhesive drug delivery systems14, 15. 
Ishihara  et al.16-18 prepared a new photocurable chitosan by introducing azidebenzoic 
acid and lactobionic acid. This chitosan can transform to a rubber-like flexible hydrogel 
under UV exposure and has been used as biomedical glue for the acceleration of wound 
closure and healing and as a carrier for delivery system. N-succinylated chitosan has the 
potential to be crosslinked with iron (III) and investigated for drug release19. 
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Figure 1.4: Chemical modification of chitosan 
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1.4.4 Sugar-modified chitosans 
Both unmodified sugar and sugar derivatives (carboxylated or sugar-aldehyde 
derivatives) can react with chitosan to yield sugar-modified chitosans. Moreover, since 
the specific recognition of cell, virus and bacteria by sugars has been discovered, this 
modification has generally been used to introduce cell-specific sugars into chitosan. For 
example, galactosylated chitosan bearing lactobionic acid is a good candidate for a 
synthetic extracellular matrix for hepatocytes attachment20 (Figure 1.5). It can also be 
used to fabricate DNA carriers for heparocyte-targeting21, 22. 
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Figure 1.5: Synthesis of galactosylated chitosan 
 
1.4.5 Poly(ethylene glycol) (PEG) grafted chitosan derivatives 
This grafted chitosan can be obtained through the reaction between chitosan and 
PEG-aldehyde followed by the reductive alkylation of chitosan’s amino group23 (Figure 
1.6). The introduction of PEG results in hydrophilic chitosan, but the fundamental 
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skeleton remains intact. PEG grafted chitosan can be used as anionic drugs carriers and in 
blood-contacting applications. 
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Figure 1.6: Grafting of poly(ethylene glycol) onto chitosan by reductive alkylation with 
PEG-aldehyde derivatives 
 
 
1.5 Applications in industry 
Due to its physical and chemical properties, chitosan has widely been used in 
cosmetics, water treatment, plant protection, and more3.  
In cosmetics, chitosan is mainly used in hair care, skin care and oral care. 
Chitosan widely used in cosmetics because it is the only natural cationic gum that 
becomes viscous on being naturalized with acid, while its polycationic chain facilitates its 
interaction with common integuments (skin covers) and hair. Positively charged chitosan 
can form a clear, elastic film on negatively charged hair, thus increasing its softness, 
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smoothness and strength. At the same time, chitosan is fungicidal and fungistatic in 
nature. Chitosan is compatible with many biologically active components incorporated in 
cosmetic products’ composition. In addition, substances absorbing harmful UV radiation 
or different dyes can be easily covalently bounded to chitosan’s amino groups. Chitosan 
and some of its derivatives can be used in shampoos, rinses, permanent wave agents, hair 
dyes, styling lotions, hair sprays and hair tonics. In skin care, besides the positive charge 
environment, its high molecular weight prevents its penetration into the skin. And 
because of its low cost, it might compete with hyaluronic acid in this specific application. 
Chitosan and its derivatives are already used in creams, pack materials, lotion, nail 
enamel, nail lacquer, foundation, eye shadow, lipstick, cleansing materials and bath 
agents. In addition, chitosan and its derivatives can also be used in toothpaste, 
mouthwashes and chewing gum. They freshen the breath and prevent the formation of 
plaque and tooth decay. 
In water treatment, due to its positively charged chain structure, chitosan can 
effectively capture heavy metals from wastewater and can thus compete with synthetic 
resin. Chitosan can also bind many negatively charged dyes from wastewater and remove 
arsenic from contaminated drinking water24-26. 
In agriculture, chitosan-treated seeds have growth-accelerating and growth-
enhancing effects. Chitosan additions to the potting mixture/soil results in significant 
reduction in root knot worm infestations and suppression of fungal pathogens. 
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In addition, because of some chitosan derivatives’ water solubility, they are also 
used for papermaking. Microcrystalline chitin can also be used as a dietary fiber in baked 
food because it is nontoxic for warm-blooded animals 27. 
 
1.6 Biomedical applications 
Chitosan is highly biocompatible, biodegradable and bioactive; therefore, it is 
widely used in biomedical applications, such as gene delivery, wound healing, skin 
substitutes, nerve regeneration and cartilage and bone tissue regeneration.  
 
1.6.1 Gene delivery 
Gene delivery aims at genetically modifying animal cells. This transfection of 
cells is normally achieved by the uptake of DNA from a culture media. The DNA to be 
transfected is normally in the form of the recombinant plasmid or other types of DNA 
vectors containing the gene of interest. The strong electrostatic interaction between 
positively charged chitosan and DNA makes it  resistant to dissociation until it enters the 
cells28, 29. In addition, the relatively high efficiency of transfection from chitosan-DNA 
hybrids can be attributed to their superior biocompatibility in membrane adhesion30 and 
their protection from lysosomal nuclease due acidification delay31. 
Hybrid DNA-chitosan systems can be classified into two categories: complexes 
and nanospheres32. Complexes are fabricated by simply mixing solutions of DNA and 
chitosan, which creates loose rod-like and toroidal structures33. The method used for 
making nanospheres is more complicated than that for complexes. Mixing speed and 
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temperature should be adjusted, a dilute salt (Na2SO4) should be added to the DNA 
solution and a desolvating agent needs to be added to the polymer solution34. The 
nanosphere can trap a low level of small molecules, such as chloroquine, a well-known 
lysosomotropic agent, enabling a simultaneous delivery of DNA28. 
 
1.6.2 Wound healing 
Compared to common polysaccharides, chitosan and chitin-based products 
provide improved healing of surgical wounds. The application of these products results in 
faster healing process and smoother scars35. These healing effects can be attributed to the 
enhanced vascularization induced by the chitosan and chitin. In addition, the degradation 
of chitosan and chitin by lysozyme and N-acetyl-β-D-glucosaminidase provides a 
continuous supply of chitooligomers to the wound, which stimulate correct deposition, 
assembly and orientation of collagen fibrils36, 37. The chitooligomers can act as templates 
for hyaluronan synthesis38, 39. The subsequent increase of hyaluronan production can 
promote cell motility, adhesion and proliferation. At the same time, the induced 
hyaluronan play an important role in morphogenesis, inflammation and wound repair40. 
 
1.6.3 Skin substitute 
Chitosan has been widely studied for skin substitutes. One of the advantages is 
that chitosan was found to facilitate rapid wound reepithelialization and the regeneration 
of nerves within a vascular dermis41. It can also increase the production of collagen and 
regulatory factors by fibroblasts. A typical example is a skin substitute made of type I and 
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type III collagen, chitosan and chondroitin 4- and 6-sulfate (72% collagen, 20% chitosan 
and 8% glucosaminoglycan). The addition of chitosan results in good fibroblast adhesion, 
controlled vascularization and fibroblastic colonization, organized matrix yields and 
limited granulation and hypertophic scar formations. In addition, the crosslinking 
between chitosan’s primary amine and the sulfate groups can impart the insolubility and 
mechanical resistance. 
 
1.6.4 Nerve regeneration 
 For nerve regeneration applications, chitosan solutions have used to 
macroencapsulate PC12 cells in hollow fibers. The chitosan prevents extensive cell 
clumping and necrosis, which is known to take place in alginate gels and other 
encapsulation devices. The PC12 cells successfully attach to the chitosan and extend 
neurites upon exposure to nerve growth factor (NGF). Differentiation of neuronal cells 
has also been supported by the chitosan matrix42. 
In addition, chitosan can covalently bind peptides, in specific, laminin, which is a 
glycoprotein that promotes neural cell attachement, differentiation and neurite 
outgrowth43. Chitosan can be fabricated into tubes that are hydrophilic and water 
permeable and a pore size does not permit cells to pass through the tube wall. Thus after 
binding laminin on the inner surface, the tubes can support neuronal cell growth. 
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1.6.5 Cartilage and bone tissue engineering 
A promising application of chitosan is in the orthorpaedic area, including cartilage 
and bone tissue engineering. Many reports indicate that chitosan and its derivatives are 
very good candidates as scaffolding materials for cartilage and bone tissue engineering. 
The incorporation of chitosan and its derivatives into scaffold leads to the regeneration of 
cartilage and bone tissue. In specific, chitosan was proven to be osteoconductive or even 
osteoinductive.  It can promote the growth of osteogenic cells, osteoblasts and osteocytes 
without changing their phenotype,  in addition to increasing the mineral-rich extracellular 
matrix (ECM) productions by these cells. As a molecular mechanism, there are many 
presumptions about how chitosan promotes tissue regeneration. Firstly, the degradation 
products of chitosan could be involved in the synthesis of ECM components, such as 
chondroitin, chondroitin-sulfate, dermatane-sulfate, kertan-sulfate and hyaluronic acid44. 
Second, due to the positive charge on its chain, chitosan can form a stabilized complex 
with negatively charged glycosaminoglycans (GAGs), thus preventing these GAG against 
hydrolysis by their specific enzymes and immobilizing GAG in situ to mimic the GAG-
rich ECM 45. And third, since growth factors can physically interact with GAG, this 
binding can retain growth factors in the matrix, thus further promoting the growth of new 
tissues46. Moreover, if the chitosan is derived to possess a negative charge, such as N,N-
dicarboxymethyl chitosan, it can directly associate with positively charged growth factors 
and then accelerate the tissue formation47. In addition, chitosan solutions  are commonly 
combined with bioactive ceramics, such as hydroxyapatite and β-TCP48-52. The mixing of 
a chitosan solution and bioactive ceramics results in a paste that has a rapid setting time, 
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which is very convenient for surgeons. And both of the components are osteoconductive, 
which is suitable for bone regeneration. 
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CHAPTER TWO 
 
FABRICATION OF PERMEABLE TUBULAR CONSTRUCTS FROM 
CHEMICALLY MODIFIED CHITOSAN WITH ENHANCED 
ANTITHROMBOGENIC PROPERTY 
 
 
2.1 Introduction 
An increasing number of incidences of cardiovascular diseases or other life-
threatening conditions involving blood vessel damages drive the clinicians to seek 
advanced grafts or new technologies for the therapy. Although minimally invasive 
approaches with stents have attracted attentions, the difficulty in delivering them across 
tight bends in blood vessels, particularly when there are massive calcium deposits in the 
wall, and to the very small blood vessels, and the resultant stent thrombosis, limit their 
applications. Therefore, there is still a compelling need of vascular grafts. Due to donor 
site shortage and morbidity, new technologies are required to engineer artificial vascular 
grafts with structural and functional similarity to native blood vessels. Although the 
synthetic vascular grafts, such as Dacron (polyethylene terephthalate fibre) and ePTFE 
(expanded polytetrafluoroethylene), perform adequately in clinic high-flow, medium- and 
large-diameter vessel settings, they usually lead to failure of replacements in low-flow 
and small-diameter vessels. This is mainly due to the early formation of thrombosis. And 
in clinic, small diameter grafts are critical and necessary in coronary artery bypass graft 
(CABG) surgery, lower extremity bypasses, and tissue transfer 3. To overcome this 
difficulty, many efforts have been focused on developing an anti-thrombogenic coating of 
synthetic vascular prostheses and fabricating artificial conduits with great anti-
thrombogenic property. Conventional approaches to enhance the anti-thrombogenic 
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property of vascular grafts or conduits generally involve surface and bulk modifications. 
In surface modifications, hemocompatible molecular structures such as poly(ethylene 
oxide) 5, heparin 6, 2-methacryloyloxyethyl phosphorylcholine (MPC) 7, and zwitterionic 
structure 8,9 are introduced onto the material surfaces either chemically via branching or 
grafting or physically via adsorption 10-26. Since surface coatings may not be stable for 
long-term applications, a bulk material with anti-thrombogenic property is desirable for 
the fabrication of vascular grafts or conduits. In bulk modifications, novel materials with 
structural similarity to hemocompatible molecules such as heparin are synthesized. 
Extended time to induce blood clotting, prothrombin formation, and activate partial 
thromboplastin was observed on the surfaces of the synthesized materials 27. One option 
with bulk modification is the chemical alteration of natural materials which have a 
molecular structure similar to that of heparin. In particular, chitosan, a polysaccharide 
derived from the highly abundant natural polymer chitin by alkaline deacetylation, has a 
molecular structure similar to that of heparin 28, which may suggest its excellent anti-
thrombogenic potential if appropriate structures are obtained through bulk chemical 
modification. There are two major obstacles to the use of chitosan for vascular grafts. 
One is its highly thrombogenic characteristic which has led to FDA approval for use as a 
hemostatic dressing for reducing hemorrhage 29. The other is poor 
processibility/solubility in organic solvents, which greatly affects the methods which may 
be used to fabricate vascular scaffolds with well controlled morphology and permeability. 
These characteristics of chitosan may be due to the abundant amino groups in the side 
chain. Chitosan requires chemical modification before it can be fashioned into anti-
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thrombogenic tubular structures for small-diameter blood vessel repair. Previous reports 
on chemically modified chitosans including N-sulfofurfuryl chitosan 30, N-acylated 
chitosan 31, N-hexanoyl chitosan 32, N-acetyl chitosan 33, and chitosan with 
phosphorylcholine (PC) groups 34 demonstrated improved solubility in organic solvents 
and/or improved anti-thrombogenic property. In the present study, phthalized chitosan 
was obtained through chemical modification. It can be dissolved in many organic 
solvents, including dimethylacetamide (DMAC), dimethylformamide (DMF) and 
methylsulfoxide (DMSO), but not in water. The modified chitosan was characterized 
with regard to chemical composition using Fourier-transform infrared spectroscopy 
(ATR-FTIR), hydrophilicity by water-air contact angle, fibrinogen adsorption, and 
platelet adhesion. The phthalized chitosan displayed enhanced anti-thrombogenic 
property and improved solubility, which enabled us to fabricate it into permeable tubular 
structures ranging from several hundred microns to several millimeters in diameter for 
the fabrication of small-diameter vascular grafts. 
 
2.2 Materials and Methods  
2.2.1 Materials 
2.2.1.1 Chemicals available from the shelf 
Chitosan with high molecular weight and more than 85% deacetylation was 
obtained from Sigma-Aldrich Inc. (St. Louis, MO, USA). Phthalic anhydride, extra dry 
N, N-dimethylformamide (DMF) and NaOH were obtained through Fisher Scientific Inc. 
(Waltham, MA, USA) and used directly. Fibrinogen, bovine serum albumin (BSA), 
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lysozyme, fluorescein diacetate, and ethidium bromide were purchased from Fisher 
Scientific Inc. FITC labeled dextrans ranging in size from 4 kDa to 20,000 kDa were 
obtained from Sigma-Aldrich Inc. 
 
2.2.1.2 Chemical modification of the chitosan 
Chitosan was heated to 80 °C in 50% NaOH aqueous solution under nitrogen flux 
for 8 hours, then washed with deionized (DI) water until pH value returned to 7 and dried 
under vacuum for three days. The chemical modification of the chitosan was carried out 
using a previously published method and the scheme of synthesis is shown in Figure 2.1 
35. Briefly, a mixture of chitosan (5.0 g, 31.0 mmol) and phthalic anhydride (13.8 g, 93.1 
mmol) in extra dry DMF (100ml) was heated with stirring at 130 °C under a nitrogen 
atmosphere for 12 hours. The mixture became a clear and viscous solution with only a 
little solid chitosan left which was filtered out and discarded. The polymer was then 
precipitated by pouring the solution into ice water, washed by Soxhlet’s extraction with 
ethanol and dried under vacuum for future use. 
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Figure 2.1: The scheme of chemical modification of chitosan 
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2.2.1.3 Hollow fiber membrane fabrication 
Phthalized chitosan HFMs were fabricated using a phase inversion process largely 
employed to prepare membranes used in cell encapsulation, microfiltration, dialysis, 
reverse-osmosis and gas separation. The polymer solution was prepared by mixing 
phthalized chitosan with N,N-dimethylformamide (DMF) with constant stirring. Figure 
2.2 shows the HFM fabrication system used in this study. Semipermeable, phase-
inversion membranes were formed from the polymer solution using an annular spinneret 
with a bore liquid precipitant of deionized water. The spinneret was set by precipitating 
from the inner annulus. This process created a continuous length of semi-permeable 
hollow fiber that was collected in bath of DI water to remove residual solvent. HFM 
structure and performance were controlled by varying a number of fabrication 
parameters, such as polymer solution concentration, temperature, presence of additives, 
flow rates of polymer solution or inner precipitant, and the drop height that the fiber 
travels before entering the collection bath. HFMs of different gross sizes were achieved 
by using different size spinnerets. Following fabrication, the membranes were submersed 
in deionized water for future use. 
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Figure 2.2: (A) HFM fabrication system (not to scale); (B) HFM extrusion. 
 
2.2.2 Physico-chemical characterization 
2.2.2.1 Scanning electron microscopy-HFM structure analysis 
Morphological analysis of the hollow fiber membranes was conducted using 
scanning electron microscopy (SEM, Hitachi, Japan). Samples exhibiting the outer 
surface, inner surface, and cross-section of the membranes were carefully fixed on SEM 
sample holders and sputter coated with gold. The HFMs were analyzed by SEM with an 
acceleration voltage of 5-15 kV. Representative images of the cross-sections and the 
outer and inner surfaces of the membranes were obtained. 
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2.2.2.2 Permeability Evaluation of HFM 
Diffusive permeability was determined using a range of FITC-labeled dextrans of 
varying molecular weights at 37 °C as previously described 36. This measurement also 
served as a means to assess the homogeneity of the membranes. To better mimic the 
membranes to be used for implantation, all of the sterilization procedures performed prior 
to the implantation were reproduced with the membranes used for the permeability 
evaluation. The analysis was performed using the same module described previously 37. 
The HFMs were inserted into the module and the two ends on were mounted on the 
module with UV curable LCM-23 glue (Luxtrak, Ablestik Electronic Materials & 
Adhesives, Wilmington, MA, USA). The space in the module was therefore separated 
into inner chamber (i.e., inside the HFMs) and outer chamber (i.e., outside the HFMs). 
Before the test, the testing modules were immersed into PBS for 24 hours. Probe 
solutions of FITC-labeled dextrans of different molecular weights were injected into the 
inner chamber and PBS was injected into the outer chamber. The testing modules were 
placed inside a CO2 incubator at 37 °C. After 1 hour and 8 hours, the amount of the probe 
that had diffused to the outer chamber was measured using a fluorescent plate reader. The 
diffusive permeability of the HFMs was calculated with the same method described 
previously 38: 
K0=Js/ C×A (cm/s)                                                                      (1) 
Js =Vext×Cext/ T           (2) 
where Js is the transmembrane solute flux in mass/sec, Vext is the volume of the 
outer part, Cext is the concentration of the solute in the outer part,  T is the time for the 
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incubation, and A is the log mean membrane surface area in cm2 A=2π(R2-R1) 
×Z/ln(R2/R1) , where R2 and R1 are the outer and inner radii of HFMs which can be 
determined using a microscope, Z is the length of the HFM, and ΔC is the difference in 
concentration from the inside to the outside of the HFM in mg/mL. Since the probe 
concentration inside the hollow fiber membrane was changing during the test using this 
static measurement approach, the probe concentration of the inner chamber was measured 
as well. The permeability coefficient was determined for FITC labeled dextrans ranging 
in size from 4 kDa to 20,000 kDa (Sigma-Aldrich). The average permeability coefficients 
for the various probes through the different HFMs were reported with the standard error 
of mean (n=6 samples per type of hollow fiber). The amount of the probes in the outer 
chamber was measured and the solute rejection was determined using the following 
equation based on 8-hour time point data: 
R0=(1-Cp/Cf)              (3) 
where Cp is the permeated probe concentration in the outer chamber and Cf is the initial 
probe concentration in the inner chamber. 
The mean pore size (µp) on the skin layer was determined according to the 
geometric mean diameter of the probe at solute rejection rate at 50% 39. The probe 
diameter (FITC labeled dextran) can be calculated by the following equation 40: 
Rd=0.305 × MW 0.47                (4) 
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2.2.2.3 Contact angle measurement 
Smooth raw and phthalized chitosan films were fabricated by film casting on a 
Teflon Petri dish. After the solvent had been evaporated in a vacuum oven at room 
temperature for 24 hours, membranes were washed 5 times with 75% ethanol then peeled 
off and air-dried. Contact angle measurements were performed with a contact angle 
measuring system. Measurements were carried out using the sessile drop method with 0.5 
μl DI water drops. Photographs were taken and the contact angle was measured. Reported 
results were averages of measurements on ten samples. 
 
2.2.2.4 Fourier-Transform Infrared Spectroscopy (FTIR) 
Chemical composition of raw chitosan and phthalized chitosan was analyzed 
using attenuated total internal reflective-Fourier transform infrared spectroscopy (ATR-
FTIR, Research series 100, Madison Instrument Inc., Madison, WI, USA). Polymer films 
were dehydrated in vacuum oven under 60 °C for 36 hours and then settled on the sample 
holder in the nitrogen protected chamber for FTIR characterization under room 
temperature. 
 
2.2.2.5 Gel Permeation Chromatography (GPC):  
The molecular weight was measured using a Thermo P2000 GPC/HPLC/IC triple 
system (Thermo Electron Inc., Waltham, MA, USA). Gel permeation chromatography 
(GPC) was performed in DMF with respect to polystyrene standards. Data was acquired 
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with ChromQuest 4 (Thermo Electron Inc) using refractive index (RI) detector and 
analyzed with Cirrus™ (Polymer Labs, Amherst, MA, USA). 
 
2.2.3 Biological characteristics 
2.2.3.1 Protein adsorption assay 
Raw and phthalized chitosan samples were subjected to protein adsorption assays. 
Protein solutions were freshly prepared by dissolving fibrinogen, bovine serum albumin 
(BSA), or lysozyme in PBS at pH 7.4 to give a final concentration of 0.1 mg/mL. 
Samples were immersed in PBS solution at pH 7.4 overnight prior to protein adsorption 
assays. Samples were incubated for 3 hours in 12-well cell culture plates with low 
adsorption surface filled with 3 mL protein solution per well. Samples were then removed 
and rinsed 5 times with PBS followed by sonication in 3 mL of 1 wt% sodium 
dodecylsulfate (SDS) to remove adsorbed proteins. The amount of protein adsorbed on 
the substrates was determined by the micro-BCA protein assay (Fisher Scientific Inc.). 
The absorbance of the solution was measured at 562 nm by UV–vis spectroscopy. Three 
repetitions were performed for all samples. 
 
2.2.3.2 Hemolysis assay 
The protocol used is adopted from the “American Society for Testing Materials 
(ASTM) Test F 756-00 Standard Practice for Assessment of Hemolytic Properties of 
Materials”. Two positive controls, copper and DI water, and two negative controls, glass 
cover slip and Poly-lactic acid (PLA), were used in this study. Raw chitosan, phthalized 
chitosan, and PLA samples were prepared by spinning coating onto the cover slips and 
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drying in a vacuum oven for 3 days. After drying, samples were washed three times with 
saline, sterilized by soaking in 75% alcohol for 15 minutes, then washed 5 times in PBS 
and immersed in 1.4 ml PBS for 12 hr. 0.2 ml freshly collected rabbit blood with 
anticoagulant was added to each sample well. The samples were incubated at 37 °C, with 
gentle shaking twice every 30 minutes. After 3 hours, the contents of each well were 
transferred to a 1.5 mL centrifuge tube and centrifuged at 740 ×g for 10 min at room 
temperature. 1 mL of supernatant was removed and centrifuged at 3000 ×g for 15 
minutes at room temperature. 200 μl of this supernatant was used to measure the optical 
density (OD) of the samples with a spectrophotometer at 540 nm. 
 
2.2.3.3 Platelet adhesion assay 
Platelets play a critical role in the initiation and propagation of the coagulation 
cascade when blood comes into contact with a foreign surface. When the platelets attach 
to the surfaces of the materials, they may change their morphology, influenced by the 
surface properties or the protein absorbed on the surface. The change in their morphology 
may lead to further activation 41,42. A platelet adhesion assay was performed to examine 
the blood compatibility. Several 10 mL whole blood samples from New Zealand White 
female rabbits were collected in 15 mL centrifuge tubes with 1.5 mL anticoagulant 
solution. The blood samples were centrifuged at 500 ×g for 10 minutes; the supernatants 
were collected, transferred to another centrifuge tubes, and centrifuged at 800 ×g for 10 
minutes. Supernatants were collected again and centrifuged at 3000 ×g for a further 15 
minutes. The supernatants were collected as platelet poor plasma (PPP) and the 
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remainder was platelet rich plasma (PRP). The platelet numbers in both PPP and PRP 
solutions were counted before making the final platelet testing solutions. The platelet 
testing solutions were adjusted to 1x105 platelets/μl by mixing PPP with PRP in 
appropriate ratios and incubated in a water bath at 37 °C before being seeded onto the 
samples. The raw chitosan and phthalized chitosan coated glass cover slips were 
sterilized with 75% ethanol solution, air dried, equilibrated with 1 mL PBS for 1 hr and 
then incubated in 0.7 mL prepared platelet testing solution at 37 °C for 2 h and 5 h. The 
films were washed three times in PBS with mild shaking to remove non-adherent 
platelets. Then the samples were fixed with freshly prepared 2.5% glutaraldehyde for 20 
min. After washing with PBS again, the samples were dehydrated in a graded–ethanol 
series (50, 60, 70, 80, 95 and 100%) for 10 min each and allowed to dry at room 
temperature. The platelet-attached surfaces were gold coated in a sputter coater and 
visualized using a scanning electron microscope (Hitachi, Japan). 
 
2.2.3.4 Cytotoxicity and proliferation assay 
Both qualitative and quantitative evaluations were carried out to compare the 
cytocompatibility and proliferation behavior of fibroblasts on raw chitosan and modified 
chitosan. Raw chitosan, phthalized chitosan, and PLA were spin-coated on 18 mm 
diameter coverglasses (n = 6 for each time point and each material). After being dried at 
room temperature in a vacuum oven for 48 h, samples were sterilized in 75% ethanol for 
15 min, washed with sterile PBS five times, and then put into 12-well tissue culture 
plates. Two types of assay were carried out. A proliferation assay was used to examine 
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the effect of the materials on cell adhesion and proliferation, and a cytotoxicity assay was 
used to examine the dead/live cell ratio after exposure to the materials. NIH 3T3 
Fibroblasts (CRL-1658, ATCC, Manassas, VA, USA) were used as a model cell type. 1.5 
x 104/ml cells were seeded on each sample. After five hours attachment to the polymer 
surfaces, samples were rinsed once with PBS and transferred into new 12-well tissue 
culture plates to continue culture in DMEM/F-12 with 10% FBS. On days 1, 3, 4 and 5, 
six samples were removed to determine the numbers of live and dead cells. Fluorescein 
diacetate was used to stain live cells and ethidium bromide (EtBr) was used for 
identification of dead cells. Fluorescein diacetate and EtBr were applied to cultured cells 
at a concentration of 1 μg/ml for 10 minutes. Photographs of cells were taken using 
fluorescent microscope utilizing the green channel for visualizing live cells and the red 
channel for visualizing dead cells. Cell proliferation and viability were examined at 1, 3, 
4, and 5 days using proliferation and cytotoxicity assays. Briefly, a stable cytosolic 
lactate dehydrogenase (LDH) released from dead cells (cytotoxicity assay) or lysed cells 
(proliferation assay) was coupled to a tetrazolium salt (2-p-iodophenyl-3-p-nitrophenyl-5-
phenyl tetrazolium chloride, INT) resulting in the conversion of INT into a red formazan 
product. The concentration of red formazan product was obtained by measuring the 
absorbance at 490 nm using plate reader. The amount of color present was proportional to 
the number of dead or lysed cells. Poly(lactic acid) (PLA) coated slides were used as 
negative controls and latex was used as a positive control to verify the effectiveness of 
the assay. 
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2.2.4 Statistics 
Data were represented as the mean +/- the standard error of the mean for each 
group. One-way analysis of variance (ANOVA) was performed to determine the effect of 
material type on cell response and hemocompatibility using SPSSTM 9.0 software (SPSS 
Inc., Chicago, IL). Statistical significance was accepted at p<0.05. 
 
2.3 Results 
2.3.1 Phthalization of the chitosan 
2.3.1.1 Chemical modifications and characterization 
2.3.1.1.1 Hydrophobicity 
Compared to raw chitosan, phthalized chitosan showed increased hydrophilicity 
as indicated by air–water contact angle measurements. The water contact angle for the 
raw chitosan samples was 92±8°, and the contact angle for the phthalized chitosan was 
47±6°. The increase in hydrophilicity may result from the formation of polar amide bonds 
when contact with water. 
 
2.3.1.1.2 Chemical composition 
FTIR was used to verify the phthalization of chitosan (Figure 2.3). The existence 
of phthalimido signals of the carbonyl stretching vibration at 1711 and 1775 cm−1 
demonstrated the success of phthalization of chitosan. The peaks at 724 cm-1 belonging to 
the aromatic ring also showed the successful addition of phthalimido functional group. 
These peaks were not found on raw chitosan, verifying that the substitution took place at 
the amino groups of chitosan, thus forming amide linkages. 
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Figure 2.3: FTIR spectra of raw chitosan and phthalized chitosan. The presence of 
phthalimido signals of the carbonyl stretching vibration at 1711 and 1775 cm−1 
demonstrated the success of phthalization of chitosan. The peaks at 724 cm-1 belonging to 
the aromatic ring also showed the successful addition of phthalimido functional group. 
 
2.3.1.1.3 Molecular weight distribution 
The molecular weight of phthalized-chitosan was measured using GPC with 
polystyrene as standard. The molecular weight distribution was analyzed using Cirrus™ 
(PolymerLabs). From the analysis, 90% of phthalized chitosan was found to have a 
molecular weight in the range from 300 K Da to 700 K Da. 
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2.3.1.2 Biological characterization 
2.3.1.2.1 Protein adsorption assay 
Three proteins, i.e., human fibrinogen, bovine serum albumin (BSA) and 
lysozyme, were selected for the protein adsorption assay. The amount of protein adsorbed 
was determined by bicinchoninic acid (BCA) assay. At pH 7.4, the amount of human 
fibrinogen and bovine serum albumin adsorption is significantly less (p<0.05) on the 
surfaces of phthalized chitosan than that on the surfaces of raw chitosan, as shown by the 
low pI values for human fibrinogen (pI = 5.8) and bovine serum albumin (pI = 4.0). At 
pH 7.4, the carboxylic acid was converted to a negatively charged carboxylate ion in 
human fibrinogen and BSA, so human fibrinogen and BSA were less adsorbed on the 
phthalized chitosan surface due to negative charge-charge repulsion.  On the other hand, 
the amount of lysozyme adsorption is higher (p<0.05) on phthalized chitosan than on raw 
chitosan due to the high pI value for lysozyme (pI=11), which is positively charged at 
pH7.4. Therefore, lysozyme could be better adsorbed on the phthalized chitosan due to 
the hydrogen-bonding and charge attraction with the hydrophilic surface. 
 
2.3.1.2.2 Hemolysis assay 
Hemolysis of red blood cells was used to evaluate the membrane damaging 
potential of the materials. The release of hemoglobin can be quantified by measuring the 
absorbance at 540 nm. In this assay, we used two positive controls, DI water and copper, 
and two negative controls, glass and PLGA. DI water resulted in 100% hemolysis. 
Copper with known hemolysis potential led to about 5% hemolysis. Raw chitosan, 
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modified chitosan, PLA and glass caused less than 0.1% hemolysis indicating extremely 
low membrane damaging properties of the materials. Therefore, phthalized chitosan can 
be considered as hemocompatible (Figure 2.4). 
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Figure 2.4: Hemolysis of red blood cells after 3-hour exposure to materials. Raw 
chitosan, phthalized chitosan, PLA and glass caused less than 0.1% hemolysis and 
indicating extremely low membrane damaging properties of the materials. 
 
2.3.1.2.3 Platelet adhesion assay 
Activated platelets will release their granule contents, thereby attracting further 
platelets, and show a typical shape change with flattening, formation of pseudopodia, and 
increasing area of contact. Previous studies have categorized the morphological change 
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into five stages: (I) round or discoid; (II) dendritic or early pseudopodial; (III) spread 
dendritic or intermediate pseudopodial; (IV) spreading or late pseudopodial; and (V) fully 
spread 43,44. We used a platelet adhesion assay to evaluate the materials’ blood 
compatibility. The SEM images of platelet attachment at 2 h and 5 h contact time are 
shown in Figures 5 and 6. The number of attached platelets on phthalized chitosan is 
significantly lower (p<0.001) than on raw chitosan. Moreover, from the images with 
magnification of ×5,000 (Figure 5 C and D and Figure 6 C and D), the morphological 
state of platelets on the raw chitosan surface can be classified as spread dendritic or 
intermediate pseudopodial (Stage III). However, the platelets on phthalized chitosan were 
less reactive and can be classified as early dendritic or early pseudopodial (Stage I or II). 
The phthalized chitosan shows greatly improved anti-thrombogenicity. 
A. B.
C. D.
 
Figure 2.5: Platelet adhesion assay. SEM pictures of the platelet attachment for 2 hours. 
Raw chitosan (A & C), phthalized chitosan (B&D). 
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Figure 2.6: Platelet adhesion assay. SEM pictures of the platelet attachment for 5 hours. 
Raw chitosan (A & C), phthalized chitosan (B&D). 
 
2.3.1.2.4 Cytotoxicity and proliferation assay 
We found that fibroblasts attached, extended and proliferated very well on 
phthalized chitosan. Cells were more spread out on phthalized chitosan than on raw 
chitosan films. The merged images from the red and green channels suggest that both 
materials are cytocompatible as only few dead cells (stained red) were found during the 
5-day culture period (Figure 7).  
As shown in Figure 8 (A), the total number of cells on raw chitosan, phthalized 
chitosan, and PLA increased with the time in culture. The total number of cells on latex 
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did not increase significantly, indicating that latex slowed proliferation of cells. The 
proliferation assay showed that the fibroblast proliferation in on raw chitosan, modified  
 
Figure 2.7: Bright field and fluorescence microscope images of NIH 3T3 fibroblasts 
grown on raw chitosan and phthalized chitosan for four different time points.  Scale bar = 
100 μm. 
 
chitosan and PLA are quite similar, while latex was found to inhibit fibroblast 
proliferation. Figure 8 (B) shows the percentage of dead cells in culture at different time 
points. The number of dead cells cultured with latex (positive control), was significantly 
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higher (p<0.05) than that in other groups. The data obtained from the latex group 
demonstrated that both the qualitative assay and quantitative assay work well in this 
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Figure 2.8: Quantitative assays on the proliferation and cytotoxicity of NIH 3T3 
fibroblasts on raw chitosan, phthalized chitosan, PLA control and latex control. (A). 
Proliferation assay. (B). Cytotoxicity assay. 
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study. Raw chitosan, phthalized chitosan and PLA have similar cytotoxicity as shown by 
the similar amount of dead cells. The lack of significant differences in the percentage of 
dead cells among raw chitosan, phthalized chitosan, and PLA groups indicates good 
cytocompatibility of phthalized chitosan. 
 
2.3.2 HFM fabrication and characterization 
When allowing the polymer precipitation initiate from the lumenal surface of the 
tube, HFMs with a smooth inner surface were obtained (Figure 9 A, B, and C). The 
membrane gradually formed from the inner surface skin, below which an assembly of 
finger-like macroviods was present. The finger-like porous structure provides mechanical 
support for the HFMs. By adjusting the spinneret size, and controlling the concentration 
of polymer, drop height, flow rate, and fabrication temperature, HFMs with an outer 
diameter anywhere from 200 μm to 6 mm could be fabricated for the engineering of 
different diameter blood vessels. In this study, we dissolved phthalized chitosan in DMF 
and obtain 25% (w/w) solution. Particularly, for the HFM with a diameter of around 1.2 
mm, the flow rate of polymer solution and inner coagulant were set to 0.8 ml/min and 2 
ml/min, respectively. And for those HFMs with a diameter less than 3 mm, the drop 
height was set at 10 cm, while for more than 3 mm, it was set at 0 cm. These HFMs made 
from DMF solution has smooth inner surface, however, when DMSO was used, the 
HFMs have waved inner surface with aligned grove channels. 
By controlling the fabrication parameters, such as fabrication temperature, the 
permeability and pore size of the fabricated HFMs can be adjusted. The permeability and 
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pore size of the fabricated HFMs were calculated from equation 3 and 4. For example, for 
those HFMs with a diameter around 1.2 mm, when fabricated in 0 °C, 20 °C and 50 °C, 
the permeabilities of the HFMs were 75 ± 12 KDa, 135 ± 17 KDa, and 175 ± 23 KDa, 
and the pore sizes on the skin layers were 60 ± 8.5, 75 ± 11.3, and 90 ± 13.2 nm. 
 
A. B. C.
 
Figure 2.9: Morphologies of HFMs of phthalized chitosan fabricated using a wet phase-
inversion technique. (A ) outer surface, (B) cross-section, and (C) inner surface. 
 
2.4 Discussion 
Chitosan is a natural linear polysaccharide comprising copolymers of 
glucosamine and N-acetylglucosamine and it can be derived by partial deacetylateion of 
chitin, a substance found naturally in the exoskeletons of insects, shells of crustaceans, 
and fungal cell walls 45,46. The repeating units of chitosan are β-(1→4)-linked 
glucosamines. Chitosan contains a large number of hydroxy and amino groups. These 
two functional groups provide many possibilities for derivatization or grafting of 
desirable bioactive groups 45,46. Chitosan is extensively investigated for many biomedical 
applications due to its non-toxicity, biocompatibility, and unique physical and chemical 
properties. It has been investigated for use as wound healing scaffolds, for drug delivery 
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in the form of tablets, microspheres, microcapsules, and gels, for growth factor and gene 
delivery, as a coating for liposomes and microparticles, for permeation enhancement of 
perioral administrated drugs, for mucoadhesion, for inhibition of pancreatic serine-
proteases or metallo-peptidases to protect protein/peptide drugs, etc. However, in blood-
contacting scenarios, raw chitosan presents high thrombogenicity. Chitin, its origin, is 
anti-thrombogenic. The difference of chemical structure between these two 
polysaccharides is only the degree of N-acetylation. Chitin has high degree of N-
acetylation and there are no amine groups on the backbone, while chitosan have a lot of 
amine groups on the backbone due to the low degree of N-acetylation. Some previous 
studies have proved that N-substituted chitosan derivatives could have improved anti-
thrombogenicity 31,55. With this understanding of the relationship of chemical structure 
and anti-thrombogenicity, we modified chitosan for the application as vascular grafts. 
Another of goals is to fabricate tubular structure with well controlled morphology and 
permeability with the modified chitosan. To this end, good solubility in organic solvent 
undoubtedly will contribute to the processibility. Therefore, one criteria of this study on 
the modification of chitosan is the solubility in common organic solvents. Although many 
studies have been carried out to chemically modify chitosan 48, most modified chitosans 
are not soluble in organic solvents, and provide little possibility for fabricating chitosan 
based scaffolds with desired properties, such as tubular structures with controlled 
microstructure and permeability, which are very important for engineering blood vessels 
49 and to guide nerve regeneration 50-53. To this end, chitosan was modified by 
phthalization and characterized with respect to solubility in organic solvents, chemical 
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composition, hydrophobicity, cytotoxicity and proliferation, hemocompatibility, and anti-
thrombogenic property. Phthalized chitosan was confirmed to be soluble in many 
solvents, including DMAC, DMSO, and DMF, which offers many opportunities in design 
and fabrication of scaffolds with well controlled microstructure and permeability. Based 
on this property, tubular scaffolds with rough outer surfaces and smooth inner surfaces 
were fabricated in this study using a wet-phase inversion technique. This tubular scaffold 
was demonstrated to be permeable to molecules and oxygen. The smooth inner surface 
(with nanopores 50-100 nm) of this permeable tubular scaffold may provide significant 
advantages in forming a complete endothelial monolayer 54. 
This study also clearly demonstrated that the permeability of the tubular scaffolds 
can be adjusted during the fabrication process by adjusting the fabrication parameters, 
such as fabrication temperature. Other parameters, such as solvent and non-solvent pair, 
polymer concentration, flow rate, precipitation method, drop height, and small molecular 
pore-forming agents, etc, may also be controlled to obtain appropriate permeability for 
certain applications, such as encapsulation or dialysis 37. Permeability of the tubular 
scaffold is very important, because low permeability may greatly hamper the free 
transport of nutrients, oxygen, and metabolic waste products to or from the cells seeded 
on the inner surface of the tubular scaffolds during the in vitro tissue engineering process. 
Higher permeability may cause undesirable leakage of the engineering blood vessels in 
vivo. In addition, if the tubular scaffolds are too permeable, macropores may form on the 
inner surfaces of the tubular scaffolds, which may delay the formation of the protective 
endothelial monolayer. 
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The modified chitosan with enhanced solubility and processiblity, anti-
thrombogenic property, and hemocompatibility may have remarkable potential for many 
blood-contacting applications, such as small-diameter vascular engineering and dialysis. 
This biocompatible conduit can also be used in vascular tissue engineering. For example, 
the permeable tubular structure may induce the endothelia cells to cover the inner surface 
and develop to a cellular tubular structure. 
 
2.5 Conclusions 
Chemically modification of chitosan by phthalization produced a chitosan-based 
material with good cytocompatibility, enhanced solubility and processibility, and anti-
thrombogenic property. Through a wet phase-inversion process, this chitosan derivative 
can be readily fabricated into selective permeable tubular constructs of varying sizes, 
morphology, and properties. All of these suggest its potential as a novel biomaterial for 
small-diameter vascular engineering, such as the coating material for commercially 
available conduits, fabrication and application as anti-thrombogenic conduits, and tubular 
scaffolds for vascular tissue engineering.  
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CHAPTER THREE 
 
LIGHT CURABLE BIODEGRADABLE POLYMERS FOR BIOMEDICAL 
APPLICATIONS 
 
 
3.1. Introduction 
Light curable biodegradable polymers (LCBPs) are a class of biodegradable 
prepolymers that can undergo photopolymerization upon light exposure. They combine 
photocurability with biocompatibility and biodegradability, thus finding many uses in 
biomedical applications. Briefly, from chemical structure, LCBPs are linear or low 
molecular weight prepolymer with light curable groups. And the curable groups may 
photo-polymerize to form network upon light exposure. In macroscopic view, they are 
usually liquid or paste, or they are easily dissolved into water or some solvents. They 
transform to either solid or hydrogel upon light exposure. The photopolymerization has a 
lot of advantages over normal chemical polymerization, such as great temporal and 
spatial control, ambient temperature operation, low energy consumption, and high 
polymerization rate that overcomes the oxygen inhibition. Therefore, LCBPs can be used 
to print out scaffolds with light assistance or in situ form scaffolds for tissue engineering, 
and fabricate carriers for localized drug/DNA delivery and bioadhesive. 
A LCBP consists of two basic chemical components: biodegradable segments and 
curable groups that include photosensitive groups and/or photo-initiator depended curable 
groups (listed in Table 3.1). The difference between these two types of curable groups is 
their light stability. Photosensitive groups are much more light-active and they can 
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undergo polymerization directly with light exposure. Photo-initiator depended curable 
groups are more light stable and their polymerization is slow at room temperature under  
Table 3.1: Curable groups of LCBPs 
 
light exposure if used alone. Although the addition of photo-initiators accelerate 
photopolymerization rate, some photo-initiators may influence cytocompatibility of the 
system. Therefore, the appropriate selection of photo-initiator is very important. Both the 
biodegradable segments and curable groups affect the final properties of the crosslinked 
network. For examples, the type of curable groups determines the photocuring rate and 
the mechanism of photocuring (addition polymerization or cycloaddition). And higher 
ratio of light curable groups to biodegradable segments results in higher crosslinking 
density. Biodegradable segments represent the major chemical structure of the 
photocurable polymers and they play an essential role in determining the degradation 
profile, thermodynamic and mechanical properties of the cured network. 
Types Structures References 
acrylate/methacrylate 8-10, 39, 43-46 
Fumaric acid derived 11-13, 22-26 
Maleic anhydride derived 14,15 
Photo-initiators 
depended curable 
groups 
Allyl isocyanate 27 
coumarin 7,16, 47-56 
Cinnamate 17-20, 28, 40 Photosensitive groups 
Azide 21, 59-62 
 51
The advantages of LCBPs make them more suitable in many biomedical 
applications. Major applications may include cell/drug/gene delivery, rapid prototyping 
(RP), tissue engineering, biological adhesives, etc. Specifically, LCBPs can be injected 
into the expected site and photocured by a localized light beam. This in situ scaffold 
formation makes minimally invasive surgery possible. At the same time, the conversion 
process effectively connects the scaffold to the surrounding tissue. Therefore, LCBPs 
show great potential in bone and cartilage tissue engineering. The difference is that for 
bone tissue engineering, the photocured scaffold should support force load in most cases, 
while in cartilage tissue engineering, comparatively looser network with higher 
hydrophilicity might be needed for nutrition and waste transportation. Therefore, in 
designing LCBPs for these two applications, chemical structures with higher mechanical 
properties are usually applied for bone tissue engineering, such as PLA, PCL, PPF, and 
polyanhydrides. As for scaffolds in cartilage tissue engineering, more hydrophilic 
components, such as PEG and polysaccharide are preferred. And how to design the 
network components and to control the crosslinking density that influences the nutrition 
transportation through the hydrogel and the pore size for appropriate chondrocyte growth 
and extracellular matrix (ECM) distribution are the major challenges in this specific 
application. This linear to network conversion can also facilitate the entrapment of 
drug/DNA into the polymer network for controlled delivery 2. The delivery mechanism 
and rate greatly depend on the degradation rate of the network and the affinity between 
drug/DNA and the network. In addition, the liquid to gel conversion of some LCBPs also 
offers the potential for use as biological adhesives. However, the adhesion strength is a 
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major challenge for their application in clinical settings. LCBPs also permit fabricating 
scaffolds with complex structures through computer controlled fabrication technologies, 
eliminating the high temperature problem and the solvent effect in currently used RP 
technologies. 
In this review, the principle of LCBPs designing, the efforts in developing 
different types of LCBPs and biomedical applications involved with LCBPs are 
summarized. 
 
3.2. Synthesis of light curable biodegradable polymers 
All LCBPs consist of two basic chemical components: curable groups and 
biodegradable segments. Curable groups provide photocurability, while the 
biodegradable segments provide biodegradability. The critical step in the synthesis of 
LCBPs is the incorporation of the photocurable groups and degradable groups. These two 
parts can be combined via chemical reaction. In most cases, the curable groups can be 
derived to anhydride, acyl chloride or other reactive structures and then reacted with the 
hydroxyl groups in the biodegradable segment. Since in most LCBP systems, photo-
initiators are needed, they will be first discussed, followed by curable groups and 
biodegradable segments. 
 
3.2.1 Photoinitiators 
Photoinitiators are a class of photosensitive chemicals which, upon light exposure, 
can undergo photolysis, and generate radicals that will induce addition polymerization of 
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photocurable polymers. According to the mechanism of photolysis, the photoinitiation 
can be classified into photocleavage induced radical photo polymerization, hydrogen 
abstraction, or cationic photocleavage 3. However, cationic photoinitiators are not 
suitable for cell encapsulation applications due to the protonic acid byproduct. The 
schemes of photocleavage and hydrogen abstraction are shown in Figure 3.1.  
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Figure 3.1: Photo-initiators that promote radical photopolymerization. (A) Radical 
photopolymerization by photocleavage. Upon exposure to light, these photo-initiators 
undergo cleavage to form radicals that promote the photopolymerization reaction. (B) 
Radical photopolymerization by hydrogen abstraction. Upon UV irradiation, these photo-
initiators undergo hydrogen abstraction from the H-donor (DH) to generate radicals. 
 
In photocleavage, the C-C, C-Cl, C-O, or C-S bonds cleave to form radicals when 
exposed to light (Fig. 3.1A). These photoinitiators include aromatic carbonyl compounds 
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such as benzoin derivatives, benziketals, acetophenone derivatives, and 
hydroxyalkylphenones. In contrast, aromatic ketones (i.e., benzophenone and 
thioxanthone) undergo hydrogen abstraction from an H-donor molecule to generate a 
ketyl radical and a donor radical as shown in Fig. 3.1B. 
Different photoinitiators are sensitive to light of different wavelengths, thus they 
can be also classified as ultraviolet (UV) or visible light initiators according to the 
wavelength of initiating light. Commonly used UV photo initiators include 2,2-
dimethoxy-2-phenylacetophenone (Irgacure 651), 1-hydroxycyclohexyl phenyl ketone 
(Irgacure 184), 2-methyl-1-[4-(methylthio) phenyl]-2-(4-morpholinyl)-1-propanone 
(Irgacure 907), 2-hydroxy-1-[4-(hydroxyethoxy)phenyl]-2-methyl-1-propanone (Darocur 
2959), and so on. Visible light initiating systems include camphorquinone (CQ) with 
either ethyl 4-N,N-dimethylaminobenzoate (4EDMAB) or triethanolamine (TEA), and 
the photosensitizer isopropyl thioxanthone.  
Although there are many types of photoinitiators, choosing the appropriate 
photoinitiators is still an important issue for biomedical applications, because it may 
affect the biocompatibility and cytocompatibility of the LCBP systems. Higher 
concentration of photoinitiators results in a faster reaction rate, and longer light exposure 
results in higher photocuring yield (the percentage of reacted unsaturated or 
photosensitive groups) 4. When LCBPs are used as injectable, in situ forming materials, 
the concentration of photoinitiator should be kept minimal. Unreacted photoinitiator may 
leach out of the materials and be toxic to surrounding tissues. When LCBPs are used in 
cell encapsulation systems, the concentration of photoinitiator directly affects 
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cytocompatibility. Previous studies have clearly indicated that photoinitiators at low 
concentration showed good cytocompatibility 5. For example, Darocur 2959, at 
concentration ≤ 0.05% (w/w), and CQ, at concentration ≤ 0.01% (w/w), were 
cytocompatible UV and visible light initiating systems, respectively. However, when they 
were used above those concentrations, the toxicity of the initiators was demonstrated 5,6. 
 
3.2.2 Curable groups 
The most commonly used photo-initiator depended curable groups are 
acrylate/methacrylate 8-10, fumarate 11-13 and maleic acid 14, 15 groups, while the 
commonly used photosensitive groups include coumarin 7, 16, cinnamate 17-20, and azide 
groups 21. These curable groups provide photocurability. Photo-initiator depended curable 
groups, such as methacrylate groups, undergo polymerization after being initiated by the 
photo-initiator. Due to the manner of polymerization, each LCBP molecule containing at 
least two of these groups allows the formation of a crosslinked network. If more groups 
are involved in each LCBP molecule, higher crosslinking density may be achieved. Since 
photosensitive groups, coumarin and cinnamate, undergo photodimerization that is 
different from addition polymerization, at least three of these groups are needed in each 
LCBP molecule to facilitate the network formation. Therefore, these two photosensitive 
groups are normally introduced to the end of multiarms (star shape) or side groups of a 
long prepolymer chain 7. 
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3.2.2.1 Photo-initiator depended curable groups 
3.2.2.1.1 Acrylate / methacrylate groups 
Acrylate/ methacrylate groups can be introduced to the backbone through reacting 
acryloyl/methacryloyl chloride, acrylic/methacrylic anhydride, glycidyl methacrylate or 
2-hydroxyl methacrylate with the degradable segment. For example, Matsuda et al. used 
acryloyl chloride to esterify the hydroxyl groups at the terminal ends of poly(ε-
caprolactone-co-trimethylene carbonate) copolymer 9. The common chemical structures 
for these types of light-curable oligomers are shown in Figure 3.2. The acrylate or 
methacrylate groups can be added as end-capping or pendant groups 8 depending on the 
chemical structure of the oligomer backbone. The introduced acrylate or methacrylate 
groups will undergo polymerization when initiated by the photoinitiator upon light 
exposure. The polymerization rate is rapid and the reaction is completed in a couple of 
seconds 10.  
C C
O O
C C CH2CH2
R R
C
CR CH2
O
A B
R= H, CH3  
Figure 3.2: The chemical structure of LCBPs containing acrylate/methacrylate groups. 
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3.2.2.1.2 Fumaric acid 
Fumaric acid is the trans isomer of butenedioic acid and is a diacid with a C=C 
double bond. Its structure is shown in Fig. 3.3. It is normally introduced to the backbone 
by reacting with propylene glycol through polycondensation to form poly (propylene 
fumarate) (PPF) prepolymers 21. Hydrolysis of the ester bonds degrades PPF, producing 
fumaric acid and propylene glycol 22. In addition, fumaric acid may be chemically 
converted to acyl chloride which can be used as extender in reactions with PCL diols or 
poly-ethylene-glycol (PEG) 23,24. Thus the C=C bond structure is introduced into the 
LCBP backbone. Bis(2,4,6-trimethylbenzoyl)-phenylphosphine oxide (BAPO) is a 
common used photoinitiator for PPF photocrosslinking. Upon light exposure and 
initiation, the unsaturated backbone structure will undergo a polyaddition reaction 25. 
However, due to its low reactivity, photocuring this PPF may take from 30 min to 1 hour 
to obtain more than 90% completion of the cross-linking reaction. 
HO
OH
O
O  
Figure 3.3: Structure of fumaric acid 
 
3.2.2.1.3 Other groups 
Maleic anhydride is derived from cis isomer of butenedioic acid that has a similar 
structure to fumaric acid. It can easily react with the hydroxyl groups in degradable 
segments 15, 14. The scheme is shown in Figure 3.4. Lang and Chu used maleic anhydride 
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to end-cap hydroxyl terminated four-arm poly-ε-caprolactones. The functionalized four 
arm poly-ε-caprolactones were irradiated with 365 nm wavelength UV lamp for 5h to 
obtain a photocured film 15. 
OH
O OO O C
O
CH CH COOH
 
Figure 3.4: Scheme for using maleic anhydride to incorporate unsaturated group in 
LCBPs 
 
Allyl isocyanate is another reactive molecule. Allyl group is photocurable, while 
cyanate groups can react with the hydroxyl or amine groups in degradable segments to 
incorporate allyl groups (shown in Fig 3.5). Zhang et al. synthesized a dextran derivative 
of allyl isocyanate (dextran-AI) by reacting dextran with allyl isocyanate in the presence 
of dibutyltin dilaurate as catalyst. After reaction, C=C bonds were introduced to the 
backbone of LCBPs 27. 
OH
O C
O
NH CH2 CH CH2O C N CH2 CH CH2  
Figure 3.5: Scheme for using AI to incorporate unsaturated group in LCPBs 
 
3.2.2.2 Photosensitive groups 
3.2.2.2.1 Coumarin groups 
Coumarin is sensitive to UV light. Under light irradiation, adjacent coumarin 
groups in the LCBPs undergo 2+2 cycloaddition reactions to form a crosslinking network 
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(Fig. 3.6). Since photoinitiators are not needed in the LCBP systems with these groups, 
the negative effects of the photoinitiators can be eliminated. However, the reaction rate is 
slower compared to acrylate/methacrylate groups. Moreover, due to the 2+2 
cycloaddition reactions, more than two coumarin groups have to be introduced into one 
LCBP molecule for network formation. And the higher content of coumarin groups in 
each molecule may complement the comparatively low curing rate of coumarin groups. If 
one LCBP linear molecule is endcapped with only two coumarin groups, only a linear 
structure will be formed upon light exposure. Coumarin groups can be introduced to the 
biodegradable polymers via esterification of hydroxyl groups with an acid chloride 
derivative of coumarin 7,15. For example, Matsuda et al. synthesized 7-
chlorocarbonylmethoxycoumarin that reacts with the hydroxyl groups at the terminal 
ends of copolymer, obtaining coumarin end-capped photocurable prepolymers.  
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Figure 3.6: Light-induced formation of crosslinks through cycloaddition reactions 
between adjacent coumarin groups in the precursor molecules. 
 
3.2.2.2.2 Cinnamate groups 
Cinnamate is another photosensitive group that can undergo a 2+2 cycloaddition 
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reaction 16,27 (shown in Fig. 3.7). Thus, it has the same advantages and disadvantages as 
coumarin groups. Nagata and Hizakae synthesized a photocurable biodegradable polymer 
from 4-hydroxyxcinnamic acid. When exposed to ultraviolet light irradiation (280 nm), 
the photocurable polymer undergoes a photocrosslinking reaction through an 
intermolecular dimerization. Nagata and Hizakae found only 90% of cinnamate moieties 
react within 16 min of irradiation. This reaction rate is relatively low compared to  
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Figure 3.7: Biodegradable polymers containing cinnamic groups and their 
photocrosslinking 
 
acrylate or methacrylate groups. Cinnamoyl groups can be metabolized in the body and 
has been proven to be nontoxic, so these groups are suitable for using as a constituent of 
biodegradable polymers 17. 
 
3.2.2.2.3 Azide groups 
 Azide (-N3) is another photosensitive group, which is known to release N2 upon 
UV irradiation and to be converted into highly reactive nitrene groups. Nitrene groups 
interact quickly with each other or with amino groups to generate azo groups (-N=N-), 
thus making crosslinking.  In the previous studies, azide groups are only introduced onto 
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the backbone of chitosan by reacting p-azidebenzoic acid with the amino groups on 
chitosan 21. This chitosan derivative can dissolve into water and become a hydrogel very 
fast upon light exposure. However, since the intermediate nitrene groups are highly 
reactive, they are not suitable for cell encapsulation. 
In summary, although there are many types of curable groups, they possess 
different curing properties, such as different curing rate and reaction mechanism. The 
different biomedical applications are dependent on the appropriate selection of curable 
groups. For example, the curing time should be reasonable for minimally invasive 
surgery. Too long waiting time may result in failure of surgical procedures. In addition, 
the content of curable groups in each LCBP molecule influences the crosslinking density 
(network structure) of the final cured network. And the mechanical properties and 
degradation profiles are related to the crosslinking density. 
In addition, the limitation of LCBPs for biomedical applications should be 
addressed. One concern is the availability of light from all possible directions will limit 
the maximum thickness of the photocurable polymer. This difficulty may be overcome 
using systems such as photobleaching initiators. In this system, the initiator radicals 
absorb energy at wider wavelength spectrum than the initiator molecules do, thus 
decreasing the attenuation of the light. Moreover, dual initiators may be applied. Or the 
intensity of the light source can be increased. Another concern is the interference by body 
fluids, which may be overcome by increasing the viscosity of LCBPs if the surgery 
procedure is so difficult to manipulate. 
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3.2.3 Degradable domains and synthesis of different types of LCBPs 
Chemical structure of the degradable segments plays an important role in 
determining the properties of final crosslinked network, such as mechanical properties 
and degradation profiles. One can design the chemical structure of the degradable 
segments to meet the requirements in biomedical applications. Two or more chemical 
structures can be incorporated into a degradable segment when individual structure is not 
sufficient in obtain the desired properties. In that case, the ratio of these components can 
be tuned to control the final properties of the crosslinked network. In this section, the 
chemical structures of degradable segments, the synthesis of LCBPs and the structure-
property relationship are discussed in detail. The types of degradation segments are listed 
in Table 3.2. 
 
3.2.3.1 Polyester 
There are two common approaches in synthesizing polyester, ring-opening and 
polycondensation. Initiators are used in ring-opening and they become a part of the 
chemical structure of polyester, thus they play an important role in influencing the 
properties of the final crosslinked network. Polyester is also synthesized by 
polycondensation from diacids and diols, or from small molecules with carboxyl groups 
in one-end and hydroxyl groups at the other. Therefore, polycondensation can introduce 
the unsaturated groups into the polyester backbone. In this section, polyesters are 
classified into several sub-types according to their chemical structures. 
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Table 3.2: Degradable segments of LCBPs 
Types Structures References 
Poly(α-hydroxy esters) 7, 10, 15, 16, 30-36, 69-71, 85-86, 89-91
Polycarbonate 4, 37-38, 78, 79 
phophoester 39 
Cinnamate based 17-20, 28, 40 
Polyester 
PPF oligmers 11-13, 22-26, 72-74 
Polyanhydride  43-45, 75-76 
Protein-like Peptide bonding 46-48 
dextran 49-50, 91 
Hyaluronic acid 51-57, 87 Polysaccharides 
chitosan 21, 59-62 
 
3.2.3.1.1 Poly(α-hydroxy esters) 
Poly-lactic acid (PLA), poly-glycolic acid (PGA), poly-ε-caprolactone (PCL), and 
their co-polymers are commonly used in biomedical applications, due to their excellent 
biocompatibility and nontoxic degradation products 28.  PLA and PGA have faster 
degradation rate, higher crystallization and higher Tg (glass transition temperature) than 
PCL. Therefore, materials made from PLA and PGA have relatively higher mechanical 
strength than PCL, while the materials made from PCL may have kind of elasticity. And 
the degradation rate can be tuned by copolymerizing PLA/PGA with PCL under well-
designed ratio. This type of LCBPs can be synthesized from ring-opening polymerization 
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followed by end-capping with curable groups 10, 15, 30, 31. And as mentioned before, the 
ring-opening initiators will retain in the chemical structure of the biodegradable segments 
and influences the final properties of the crosslinked network. In this part, we will mainly 
focus on the effects of initiators.  
Ring-opening initiators are the substances with hydroxyl groups. They could be 
diols, triols and polyols. Diols make a linear LCBP. If diols have high molecular weight, 
the LCBPs will have a three-block structure (A-B-A). While the triols will produces a 
three-arm LCBP and the polyols will result in a multi-arm LCBP 7, 16. For example, when 
a triol structure, such as glycerol, is used, an internal branching LCBP can be obtained. 
The internal branching or three-arm structure facilitates water penetration which 
accelerates the degradation rate 32.  It is important to note that the hydrophilicity of 
initiators influences the degradation rate of the polymer network. For example, the 
crosslinked LCBPs made from PEG, poly(propylene glycol) (PPG) and 
poly(tetramethylene glycol) (PTMG) initiators have a decreasing degradation rate 
because of their different hydrophilicity (PEG>PPG>PTMG) 30.  
The most commonly used diols are PEG or low molecular weight ethylene glycols 
(EGs). PEG has many advantages when used in the synthesis of biomedical polymers: a) 
good biocompatibility, b) availability in a very wide range of molecular weights, and c) 
hydrophilic properties which allow high rate of water retention, accelerated hydrolytic 
degradation, and controlled interaction with cell and tissues in vitro and in vivo 32. Due to 
its extreme hydrophilicity, the hydrogel made from PEG based LCBPs have decreased 
protein adsorption and cell attachment on the surface of the polymer network. Reduced 
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protein or cell adhesion allows the limiting of unwanted protein and cell adhesion and 
therefore provides great opportunities for functionalizing these materials with specific 
biomolecules to promote the attachment of desirable cell types, and the same time, wards 
off unwanted cell types. This unique characteristic allows fine tuning of the bioactivity of 
the hydrogel by selectively immobilizing specific functional biomolecules on the surface 
of the hydrogel or throughout the bulk of the gel through instant polymerization, such as 
UV light-induced polymerization 33,34, 35.  
Low molecular weight ethylene glycol (EG) is another commonly used initiator in 
ring-opening process. Burdick et al. synthesized LCBPs with varying ethylene glycol 
(EG) to lactide (LA) ratios: 2EG6LA, 2EG10LA and 8EG10LA. The digits indicate the 
number of repeat units. The ratio of EG to LA influences the contact angle and Tg (glass 
transition temperature) of the final polymer network 30. The polymers with a higher 
proportion of EG show higher contact angle indicating greater hydrophilicity. When a 
prepolymer with a higher molecular weight EG or a higher ratio of EG to LA was used, 
the final polymer network showed lower Tg. The mechanical properties of the polymer 
network can also be tuned by the oligomer chemistry and crosslinking density. For 
instance, when the same molecular weight EG was used, higher crosslinking density 
resulting from the lower molecular weight oligomer resulted in higher tensile strength 
(2EG6LA>2EG10LA) and lower strain (2EG6LA<2EG10LA). But when higher 
molecular weight EG was used, the tensile strength and strain were both decreased 
(8EG6LA has lowest tensile strength and strain among these three networks). The tensile 
modulus decreases in this order: 2EG6LA>8EG6LA>2EG10LA 30.  
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3.2.3.1.2 Polycarbonate 
Similar to PLA, PGA and PCL based photocurable polyester, photocurable 
polycarbonate was synthesized via ring-opening of trimethylene carbonate (TMC) with 
an initiator, such as pentaerythritol, four-branched poly(ethylene glycol), b-PEG, or even 
oligo(2-hydroxylethyl methacrylate), then end-capped with curable groups. The oligomer 
made from TMC has a comparatively low Tg and is amorphous, and thus it is possible to 
get a liquid prepolymer with TMC. However, poly(trimethylene carbonate) (PTMC) 
exhibits an extremely slow degradation rate in water compared with PLA, PGA and PCL, 
so in general, in the ring-opening step, caprolactone or lactide was mixed with TMC to 
produce LCBPs with accelerated degradation rate for the final networks 36. The synthesis 
scheme is shown in Fig. 3.8. And prepolymers with variable viscosities can be 
synthesized7.  
O
O
OO
O
+ + R(OH)n R CH2O C(CH2)5O CO(CH2)3O H
O O
x y n
CL TMC initiator P(CL/TMC)  
Figure 3.8: The synthesis scheme of poly(ester-carbonate) 
 
Both the initiators and the ratio of LA or CL to TMC influence the degradation 
behavior of the final polymer network. Mizutani et al. used a multifunctional hydroxyl 
group-bearing substance (di-, tri-, and tetra-functional alcohol and PEG and its four-
branched derivative) as an initiator to ring-open a mixture of ε-caprolactone (CL) and 
TMC and the hydroxyl ends were terminated with curable groups. The resultant network 
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with PEG segment undergoes surface and bulk degradation. However, only surface 
degradation was observed in the network formed from trimethylolpropane and 
pentaerythritol 4. This is because the hydrophilicity of PEG assists water to penetrate into 
the network. In addition, the ratio of TMC and CL can influence the degradation behavior 
of the network. The degradation contains two phases, the early and later phases, which 
are determined by the segment of amorphous TMC and crystal CL, respectively. Higher 
TMC content results in faster degradation in the early phase because amorphous PTMC 
facilitate water penetration. However, once the PCL becomes amorphous in the later 
phase, the degradation rate is controlled by the degradation of PCL because PCL 
degrades faster than PTMC. Therefore, higher PCL content leads to faster degradation in 
the later phases 37. They also used oligo(2-hydroxyl methacrylate) (n=6,9) as an initiator 
to ring-open CL and TMC. The resulting LCBP is solid at room temperature except when 
CL is used at low graft ratio, which is probably due to the crystallinity of the PCL 
segment 15. 
 
3.2.3.1.3 Phosphoester 
The ester bonds in this type of polyester are phosphoester, which is different from 
other types of ester bonds. Wang et al. synthesized light curable polyphosphate, 
“PhosPEG-dMA”, using ethyl dichlorophosphate (EOP) as chain extender to connect the 
PEG (Mw=3400 Da). The prepolymer is terminated with 2-hydroxylethyl methacrylate. 
Since the structure has a large PEG ratio, the resultant network is a hydrogel. The 
degradation occurs at phosphoester bonds and the degradation rate is determined by the 
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crosslinking density. Solutions containing 15 and 20% (w/v) PhosPEG were 
photopolymerized and studied. The results showed that with fixed PEG-segment size, the 
higher the concentration of PhosPEG-dMA, the higher the strength but the lower the 
water content the hydrogel possesses 38. 
 
3.2.3.1.4 Cinnamate based light curable biodegradable polyester 
As discussed earlier, the cinnamic groups are usually used as a photosensitive 
group in the LCBPs. The cinnamic groups can be introduced to the backbone of LCBPs 
by polycondensation or grafted onto the end of the oligomers.  In the polycondensation, 
the starting molecules could be 4-hydroxycinnamic acid (4HCA). It can be 
polycondensed with D,L-lactic acid (DLLA) and therefore cinnamic groups can be 
incorporated into the backbone. Since 4HCA is more hydrophobic than DLLA, the 
incorporation of 4HCA results in a decreased degradation rate compared to pure poly-
DLLA. In addition, 4HCA can be modified to 4,4’-(adipoyldioxy)dicinnamic acid (CAC) 
diacryl chloride, which can be used as chain extender and react with diols, such as PCL 
diols  19, alkane and PEG diols17.  
The type and molecular weight of the diol segments and the photocuring time 
greatly influence the properties of the final network. For example, when PCL is used, the 
final network has good elastic properties as an elastomer, and if PEG is incorporated, the 
final network has the properties of hydrogels. Nagata et al. synthesized a series of 
photocurable polyesters (CAC/PCL) from CAC diacryl chloride and PCL diols with 
varying molecular weight (Mw: 1250, 2000, 3000), shown in Fig. 3.9 19. The molecular 
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weight of the PCL diols affects the crosslinking density and degradation behavior of the 
final LCBPs. PCL diols with higher molecular weight increase the weight ratio of the 
degradable segment which in turn decreases the concentration of curable groups in the 
prepolymer, thus decreasing the crosslinking rate when exposed to the light. At the same 
time, the use of higher molecular weight PCL diols in the prepolymer lowers the Tg, 
making the Tg closer to the Tg of pure PCL. Moreover, higher molecular weight PCL 
diols result in higher crystallinity, and in turn lower the degree of elastic recovery. 
Photocuring time can influence the crosslinking density and mechanical properties of the 
final polymer. Longer photocuring time normally leads to higher crosslinking density, 
thus decreasing elongation. But longer curing time results in higher elastic recovery. In 
particular, the CAC/PCL1250 films photocured for 10-60 min exhibited a strength-at-
break of 3.1-4.7 MPa and an elongation-at-break of 640-1500%, and recovered very 
rapidly to the original size from 90 to 300% extension. The photocuring time also 
influences the degradation time scale. The degradation assay showed that the weight loss 
of the photocured films decreased markedly with increasing photocuring time due to the 
increased cross-linking density, while it increased with increasing MW of PCL diols 
(loose network).  
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Figure 3.9: Preparation of polyesters derived from adipic acid, 4-hydroxycinnamic acid 
and poly(ε-caprolactone) diols 
 
Nagata and Hizakae used alkane and PEG diols reacted with CAC diacryl 
chloride to obtain CACn and CACEm (n is the number of methylene groups in the alkane 
diol, E is PEG diol and m is the molecular weight of PEG) 17. The diol type and 
irradiation time also influence Tm (melting temperature), degree of swelling, tensile 
strength and elongation. Differential scanning calorimertry (DSC) showed that Tm of 
CACn is much higher than that of CACEm, as the PEG has a more flexible chain than the 
alkane diol. Longer PEG chains resulted in a faster and greater degree of swelling due to 
their greater hydrophilicity. The CACE8300 gel irradiated for 20 min showed the largest 
degree of swelling at 10.5 (number = the weight after swelling/ the dry weight). In 
addition, the incorporation of the PEG component decreased the tensile strength and 
initial modulus, but greatly increased the elongation 18.   
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Cinnamic groups were also used to endcap the copolymer PLLA-PEG to form 
poly(L-lactide)-block-poly(oxyethylene)-monocinnamate (PLLAPEG-C). This block 
copolymer can self-organize to a shell-core structure in aqueous solution, and the 
cinnamic group can crosslink to stabilize the shell and finally obtain the stabilized 
nanostructures 39. 
 
3.2.3.1.5 Poly(propylene fumarate) (PPF) oligomers 
PPF is a type of polyester which can be synthesized from fumaric acid and 
propylene glycol. PPF contains a repeating fumarate unit in its backbone that is 
comprised of one carbon-carbon double bond and two ester groups. The carbon-carbon 
double bond allows the viscous PPF polymer to be crosslinked into a solid, while the 
ester groups allow PPF to degrade into biocompatible fragments via ester hydrolysis 22,12.  
PPF has been also photocured with PPF-diacrylate (PPF-DA), which has acrylate 
groups in both ends of PPF. The addition of PPF-DA changes the double bond content of 
this system which in turn influences the cross-linking density 22. Timmer et al. found that 
the cross-linking density and the mechanical properties increased when more PPF-DA 
was incorporated into the network due to higher double bond concentration. And higher 
cross-linking density will result in slower degradation 25. Fisher et al. used its precursor, 
diethyl fumarate (DEF), to dissolve PPF and thus adjust its viscosity, which facilitates the 
photocuring process 12. They found that the optimal DEF content needed to produce the 
highest elastic modulus and fracture strength is approximately 25%, while the sol fraction 
increased when DEF content is increased beyond 25%. The reason is that DEF is used as 
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a crosslinking bridge and a small amount of the DEF can improve the crosslinking, but 
the crosslinking is hindered when DEF concentration is over 25%. PPF can also be used 
to synthesize several block copolymers such as poly(propylene fumarate-co-ethylene 
glycol)[P(PF-co-EG)], poly(propylene fumarate-co-sebacate)-co-poly(ethylene glycol) 
(PPFS-co-PEG), poly(2-methyl-1,4-phenylene fumarate)-co-(propylene fumarate) 
[P(MPF-co-PF)] and poly(caprolactone fumarate) which possess various physical 
properties that their parent polymers do not exhibit. For example, when PEG was used, 
the water content and degradation rate of the scaffold changed according to the 
proportion of PEG in the copolymer. Because of the flexibility of PCL, when 
polycaprolactone was used, the copolymer could self-cross-link without the use of an 
additional cross-linker 24, 23. 
 
3.2.3.2 Polyanhydride 
This system is based on dimethacrylated anhydride monomer which 
photopolymerizes quickly to form densely crosslinked polymer networks 40,41. The 
common used anhydride monomers and their photocuring scheme are shown in Fig. 3.10.  
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Figure 3.10: Dimethacrylated anhydride monomers, methacrylated sebacic acid (MSA), 
methacrylated 1,3-bis(p-carboxyphenoxy) propane (MCPP) and methacrylated 1,6-bis(p-
carboxyphenoxy) hexane (MCPH), as well as a general polymerization and degradation 
scheme 
 
The networks formed from this type of LCBPs have two important properties: they have 
high mechanical strength and degrade in a surface-eroding manner 43, 44. This can be 
distributed to their chemical structure. These LCBPs have comparatively low molecular 
weight and can form densely crosslinked polymer networks. The hydrophobicity of the 
chemical structures and densely crosslinking prevent water penetrating into the network. 
Therefore, the mass loss appears linear when plot against degradation time.  
Since this type of LCBPs contains several chemical structures that have different 
hydrophobicity, they can be co-photocured into network and the ratio of the components 
can be tuned to adjust the degradation rate. For example, by varying the ratio of 
methacrylated anhydride monomers of sebacic acid (MSA) and hydrophobic anhydride 
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monomer, methacrylated 1,6-bis(carboxyphenoxy) hexane (MCPH), the final products 
will have a degradation time scale ranging from 3 days to 1 year. The results showed that 
the 50:50 (MSA:MCPH) copolymer degrades in ~10 days, the 40:60 copolymer in ~79 
days, and the 25:75 copolymer in ~195 days 45.  
Bulk modifications can also adjust the degradation rate. Addition of hydrophobic 
linear polymer decreases the degradation time. Burkoth et al. incorporated 10 wt% 
hydrophobic linear polymer, poly[(methyl methacrylate)], into a poly(MSA) network. 
The modified network degraded only 23% in 50 hours, while pure poly(MSA) network 
degrades completely at that time. The linear polyanhydrides, poly(CPH) and 
poly(CPP:CPH) (CPP is 1,3-bis(p-carboxyphenoxy) propane and CPH is 1,6-bis(p-
carboxyphenoxy) hexane), were also incorporated into a poly(MSA) network to slow 
down the degradation. Surface modification can not only control the degradation rate of 
the crosslinked network but also the cell-material interaction 43. For example, 
hydrophobic cholesterol and stearic acid-based polymer were photo-grafted onto the 
network surface and they lower down the degradation because the grafting changes the 
degradation front. Methacrylated stearic acid (MStA) photografted polyanhydride was 
implanted subcutaneously in rat. After 7 days implantation, the presence of only a few 
macrophages and many vascular structures indicated that MStA modified surface could 
modulate acute cell responses, which may due to that stearic acid is a major component 
of various hydrophobic lipids. 
Due to the surface-eroding degradation process and the highly dense network 
structure, the structure integrity and the mechanical properties are maintained for longer 
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degradation periods than that in bulk degradation. Because they prevent water 
penetration, thus avoiding the homogeneous chain cleavage throughout the whole 
network and the sudden loss of mechanical properties of the implants. Muggli et al. found 
that these surface eroding networks maintained >70% of their tensile modulus with 50% 
mass degradation 45, which offers great potential in orthopedic applications. 
 
3.2.3.3 Protein-like LCBPs 
Protein-like LCBPs can be photocured to form hydrogels and degraded into 
amino acids. This type of material shows great potential in tissue repair due to its exellent 
biocompatibility. . Giammona et al. introduced double bonds and ester groups into K,L-
Poly(N-2-hydroxyethyl)-DL-aspartamide (PHEA), a synthetic water-soluble 
biocompatible polymer, using glycidyl methacrylate (GMA), which is shown in Fig. 3.11. 
The resulting copolymer (PHG) contained 29mol% of GMA residues. The copolymer 
forms a hydrogel on UV exposure with or without the crosslinker, N,N’-
methylenebisacrylamide (BIS). ). Both types of hydrogels exhibit a high affinity for 
aqueous media, which grants its potential to release entrapped solutes, such as drug or 
enzyme molecules, in physiological conditions 43.  The hydrogels also have different 
swelling ratio at pH = 1 (simulated gastric fluid), 6.8 (simulated intestinal fluid) and 7.4 
(simulated extracellular fluid). This property grants its potential in drug or enzyme 
delivery controlled by the pH values. Yamamoto et al synthesized polypeptides using L-
lysine or L-ornithine and grafted coumarin moieties at the sides via the N-
carboxyanhydride method. These LCBPs can undergo photo-crosslinking via 
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cycloaddition between adjacent two coumarin moieties The LCBP solution becomes a 
transparent hydrogel after 6-24 h UV exposure. Both of these two types exhibit solvent-
induced reversible expansion and contraction behavior in water and in ethanol 
(expanding in water and shrinking in ethanol). However, these two hydrogels show 
different degradation profiles. The photo-crosslinked copoly[Lys90-95Lys(Cou)10-5] 
gels are degradable by trypsin and protease type XXIII as well as by two 
microorganisms, Aspergillus oryzae and Penicillium citrinum 47. The 
copoly[Orn89/Orn(Cou)11] gel is degradable by protease type XXIII, but not by trypsin 
48, which may be due to differences in its chemical structure. 
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Figure 3.11: Chemical structure of PHG copolymer 
 
3.2.3.4 Polysaccharides 
The most commonly used polysaccharides for LCBP synthesis include dextran, 
hyaluronic acid and chitosan. These polysaccharides have hydroxyl groups in their 
backbone, providing a reactive point for introducing curable groups. And because of their 
saccharide structure, the final networks are normally hydrogels. In the synthesis, the 
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degree of substitution is very important, because it determines the crosslinking density of 
final network, and in turn the degree of swelling and the water content.  
 
3.2.3.4.1 Dextran 
Dextran is a bacterial polysaccharide composed of (1→6) linked α-D-
glucopyranosyl residues, and it has three hydroxyl groups per anhydroglucose unit 8. The 
hydroxyl group can react with acryloyl chloride 46, methacrylic anhydride 8, allyl 
isocyanate 26 and glycidyl methacrylate 47, providing the dextran with photocurability. 
Upon light exposure, a higher degree of substitution results in higher crosslinking density 
which in turn decreases the degree of swelling and the water content 8. In addition, 
different substitutive groups lead to different degradation rates and behavior. For 
instance, dextran-acrylate (Dex-AC) has a faster degradation rate than dextran-
allylisocyanate (Dex-AI), as the ester bonds in Dex-AC are easier to hydrolyze than the 
urethane bonds in Dex-AI. The properties of hydrogel can also be adjusted by 
incorporating a hydrophobic segment. The hydrophobic poly(D,L)lactic acid (PDLLA)-
diacrylate is co-photocrosslinked with Dex-AC 46. The co-photocrosslinking step 
combines the hydrophilicity and hydrophobicity. The hydrophilic, segment, dextran, 
offers open aqueous channels thus ensuring swelling of the system, while the 
hydrophobic segment regulates the swelling property and mechanical strength of the 
system as well as the proper dispersion of hydrophobic drugs if used for drug delivery. 
This co-photopolymerization is another advantage of photopolymerization. It provides a 
convenient way to combine a hydrophilic segment with a hydrophobic segment, other 
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than using either polymer synthesis to create a block chain or physical blending. Dextran-
glycidyl methacrylate was also co-photopolymerized with α,β-poly(N-2-hydroxyethyl)-
DL-aspartamide-glycidyl methacrylate (PHEA-GMA or PHG) 47, to give a resulting 
polymer which has greater swelling ability compared to photocured dextran-glycidyl 
methacrylate gels, probably due to the presence of PHG which reduces the network 
compactness.  
 
3.2.3.4.2 Hyaluronic acid (HA) 
Hyaluronic acid (HA) is a naturally derived, nonimmunogenic, nonadhesive 
glycosaminoglycan, composed of repeating disaccharide units of D-glucuronic acid 
(GlcUA) and N-acetyl-D-glucosamine (GlcNAc). It has hydroxyl, carboxyl and 
acetamido groups in its backbone which lend it versatility for modification with 
chemically active or bioactive groups 48. Like dextran, the hydroxyl groups can react with 
methacrylate anhydride 49,50, glycidyl methacrylate 6,50-52 and so on. Moreover, the 
carboxyl group in the backbone can be used to react with N-3-aminopropyl 
methacrylamide to introduce photocurable groups 53. In addition, a higher degree of 
substitution results in higher crosslinking density and lower degradation rate 6. The 
degradation rate is sensitive to the amount of hyaluronidase. The higher the proportion of 
degradation enzyme, the greater the degradation rate is. Cytocompatibility studies using 
glycidyl methacrylated HA (GMHA) and human aortic endothelial cells (HAECs) 
showed that as the photoinitiator content increased, the cytotoxicicity of the cured HA gel 
also increased. The cured HA gel was cytocompatible only when 0.01% Iragacure 2959 
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was used 6. When this hydrogel was subcutaneously implanted into rats, a small 
inflammatory response was induced and endothial cells infiltrated the GMHA gels 6. 
However, since HA gel alone does not provide a good matrix for cell adhesion 54, some 
researchers are incorporating peptides into HA gels. Two methods have been used for this 
aim 51. One is the EDC (N-(3-dimethyl-aminopropyl)-N’-ethylcarbodiimide) mediated 
method. The other is using PEG as a spacer.  In the former method, the peptide was 
coupled with photocurable HA at the carboxyl group using EDC as a catalyst. In the latter 
one, the peptide was covalently bound to photocurable PEG or its derivatives that can co-
photocured with photocurable HA 51. Park et al. found that human dermal fibroblasts 
adhered and proliferated only on the surface of HA hydrogel which incorporated with 
Arg-Gly-Asp (RGD) using PEG as a spacer 53.  
 
3.2.3.4.3 Chitosan 
Chitosan is a naturally derived macromolecule, which can be easily obtained from 
shrimp and crab shell. It shows excellent biocompatibility and in vivo biodegradability. It 
is a promising material for biomedical use. However, chitosan has very poor solubility. It 
can only be dissolved in acidic solutions, which limits its application. Several methods 
have been employed to modify chitosan to obtain better physical and chemical properties 
55. The hydroxyl and amino groups on the backbone offer possible sites for chemical 
modification. Two methods have been used in preparing photocrosslinkable chitosan. The 
first uses 4-O-β-D-galactopyranosyl-(1,4)-D-gluconic acid and p-azidebenzoic acid to 
react with the amino groups in chitosan backbone via the EDC-mediated method 20 
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(Figure 3.12). The incorporation of lactose groups improved solubility. Chitosan with 2% 
substitution of lactobionate exhibited a good aqueous solubility at neutral pH and lower.  
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Figure 3.12: Chemical structure of photocrosslinkable Az-CH-LA 
 
Incorporation with p-azidebenzoic acid introduces the photocurability without changing 
its water solubility. The modified chitosan can form an rubber-like hydrogel within 60 s 
upon UV exposure 20,56-58. The second method is N-phthaloylation followed by 
acryloylation via hydroxyl groups. N-phthaloylation improved the solubility of chitosan, 
facilitating the following reaction with acryloyl chloride in organic solvent 59. 
 
3.3. Biomedical applications of LCBPs  
The most striking advantages of LCBPs are their temporal and spatial control and 
their controllable linear to network structure conversion or liquid/paste to solid/hydrogel 
phase conversion upon light exposure. These advantages make them suitable in many 
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biomedical applications, such as bone repair, cartilage repair, therapeutic agents delivery 
and biological glue. 
 
3.3.1 Bone repair 
Every year in the United States, there are approximately 900,000 hospitalizations 
due to fracture. Many synthetic materials have been studied for bone repair. They should 
have very good biocompatibility, appropriate pore topography and size and suitable 
mechanical properties. However, currently used synthetic materials cannot solve some 
problems in bone repair, such as repairing defects with irregular shapes or irregular 
closed defects (closed fractures with bone loss, bone non-unions, and cysts) 63-67. LCBPs 
impart photocurability to biodegradable polymers, which makes it possible to overcome 
these obstacles to irregular shape bone repair. LCBPs can be injected into the defect site, 
forming a matrix in situ which not only repairs the irregular shaped defects but also 
provides good attachment of the scaffold to the surrounding tissue.  Moreover, since 
LCBPs are in liquid or paste form before polymerization and use light as initiation source 
1, using light facilitated rapid prototyping (RP), scaffolds with desire pore topography and 
size may be fabricated with high spatial resolution. In addition, some LCBPs allow for 
directly loading cells into the scaffolds during the fabrication 65. 
Currently used LCBPs for bone repair include poly(α-hydroxy esters) with low 
molecular weight EG, polycarbonate, PPF and polyanhydride. The chemical structure of 
these LCBPs determines the properties of the scaffold and in turn the outcome in bone 
repair.  Poly(α-hydroxy esters), such as poly(lactic acid) (PLA), show favorable 
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osteoblast adhesion and growth.  Burdick et al. investigated the function of osteoblasts on 
polymers formed from multifunctional lactic acid and EG based oligomers (2EG6LA, 
2EG10LA and 8EG6LA) 66. They found that after 7 to 14 days in culture, osteoblast 
viability, the adsorption of proteins, and various markers of bone formation (ALP activity 
and mineralization) were highest on the surface of the most hydrophobic samples, i.e., 
poly(2EG10LA), with the greatest fraction of lactic acid among the tested materials. 
Primary rat calvarial osteoblasts were also seeded into 3-D porous scaffolds of 
poly(2EG10LA) and attached very well on both the surface and the deep core of the 
scaffolds 66.  Burdick et al. then investigated the biocompatibility of poly(2EG10LA) in 
vivo using a rat subcutaneous implantation model. The host response is relatively mild 
when compared to PLGA and poly(8EG6LA). A thin loosely organized fibrous capsule 
was formed after 14 days of implantation; the fibrous capsule was thickened after 28 
days; and a well-developed, dense fibrous capsule with minimal chronic inflammation 
was observed after 56 days 67. Burdick et al. 68 further studied the role of poly(2EG10LA) 
scaffold with or without TGF-ß1 on in vivo bone regeneration in a rat critical-sized 
cranial defect model. They implanted 2EG10LA scaffold with or without TGF-ß1 and 
compared the regenerated bone area through radiographs. After 9 weeks implantation, the 
group without TGF-ß1 showed only 47.7 ± 1.9% radiopacity while TGF-ß1-loaded 
scaffolds showed a substantial increase to 65.8 ± 9.4%. The inflammatory response to the 
implanted scaffolds was very mild with few foreign body giant cells and macrophages 
seen within the porous scaffolds and in the adjacent tissues 68.  
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PPF was also tested for bone repair. In one study, PPF was crosslinked via 
chemical crosslinking with monomer N-vinyl pyrrolidone (NVP), the radical initiator 
benzoyl peroxide (BP), and the accelerator N,N dimethyl-p-toluidine (DMT). The 
disadvantage of this system is the potential cytotoxicity of NVP and DMT 69. When 
BAPO is used to photoinitiate the polymerization of PPF, the use of NVP and DMT can 
be effectively avoided. Moreover, the photocured network has higher double bond 
conversion and crosslinking density compared to chemical crosslinking 25. PPF was used 
to make 3-D scaffolds. Cooke et al employed stereolithography (SLA) and manufactured 
3D scaffolds with highly accurate control of the external surface and internal geometry 
using a mixture of diethyl fumarate (DEF), poly(propylene fumarate) (PPF), and a 
photoinitiator, bisacylphosphine oxide (BAPO) 70. Fisher et al fabricated porous PPF 
scaffold using salt leaching and photocuring. Fabricated porous scaffolds were implanted 
both subcutaneously and in a rabbit cranial defect model for biocompatibility and bone 
regeneration evaluation. The implanted scaffolds elicited a mild tissue response in both 
soft and hard tissues: evidence of direct bone tissue-scaffold contact was observed in 8 
out of 20 scaffolds 12. However, histological evaluation and histomorphometric analysis 
showed very poor bone growth into the pores of the scaffolds. To further improve bone 
ingrowth into the scaffolds, PPF scaffold was first treated with radio frequency glow 
discharge to enhance wettability and then coated with TGF-ß1 solution followed by 
lyophilization 69. Bone tissue integration, pore fill percentage, and total amount of bone 
tissue formation were significantly improved in TGF-ß1 coated scaffold than in the 
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noncoated control. The newly formed bone has a trabecular appearance filled with bone 
marrow-like tissue.  
Polyanhydride materials (PA) has comparatively high mechanical properties due 
to their chemical structure and dense crosslinking structure. More importantly, they 
undergo surface erosion during the degradation process and therefore can maintain high 
mechanical strength during degradation, which makes them particularly attractive for 
bone repair applications. Anseth at el investigated the osteocompatibility of the 
photocured anhydride network. A moldable putty consisting of 25 wt% methacrylated 
SA, 25 wt% methacrylated CPP, and 50 wt% of a powder of linear polyanhydride 
CPP/SA 80/20 with 1 wt% I651 photoinitiator was pressed into a 2 mm circular bone 
defect in the rat anteromedical tibial diaphysis and then photocured. The lack of 
inflammatory cells in the region between the polymer network and the cortical bone after 
4 days in situ formation indicates good osteocompatibility of the photocured PA network 
71. Poshusta et al also evaluated the osteocompatibility of the anhydride network 
photocured from a co-monomer of 22/78 MC/MSA in a proximal rat tibia defect model. 
Histological examination after 7 days of implantation revealed spicules of newly formed 
bone inside the polymer network which suggests that in situ photo-polymerization 
reaction and the implant formed are compatible with remodeling and healing of bone 
tissue 72. 
The degradation rate of the implant can greatly impact the outcome of bone 
repair. If the degradation is too fast, the resultant diacid degradation product cannot be 
clean out of the local tissue fast enough, thus decreasing the local pH, in turn inducing 
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bone resorption 72. Due to the possible copolymer structure of PA materials, the 
degradation rate of the material can be finely adjusted by co-photocuring hydrophobic 
and hydrophilic anhydrides together or photocuring with linear hydrophobic 
polyanhydride chain to get a semi-interpenetrating polymer network (semi-IPN) structure 
73. Therefore, the degradation behavior of the material can be tuned to the time scale that 
is compatible with the metabolic rate of a specific tissue and the side effects caused by 
acidic degradation products can be minimized 72. 
TMC based LCBPs also show promise in bone repair.  Mizutani et al. developed 
photocured films based on poly(CL/TMC)s, which were ring-opened with pentaerythritol 
and had CL/TMC ratio of 76/24, 49/51, 27/73 and 0/100.  They examined the host 
response using a subcutaneous implantation model in rats for up to 5 months. The mildest 
inflammation response was found in materials with the lowest PCL content (27% and 
0%) 74. Declercq et al test the osteoblast behavior on 3-D scaffolds made of 1,6-
hexanediols ring-opened and methacrylate end-capped poly(CL/TMC)s (50/50), 
poly(LA/CL)s (50/50), and poly (LA/TMC)s (50/50) (the number indicates the ratio of 
two part) in vitro with rat bone marrow mesenchymal cells. They observed higher ALP 
activity and osteocalcin secretion in scaffolds of poly(CL-TMC)s and poly(LA-TMC)s, 
when compared to poly(LA-CL)s  65,75.  
In summary, currently used LCBPs in bone repair can be used as in situ forming 
materials to repair the irregular shaped defects and using RP technique, they can be 
printed into scaffolds with desirable shape and topography. However, for practical 
application, the chemical structure should be carefully designed to possess good viscosity 
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and appropriate cure time, which will facilitate the operation for surgeons. And the good 
viscosity can be controlled by limiting the molecular weight of the LCBP and changing 
appropriate chemical structures that have lower Tg.  Moreover, although the currently 
used LCBPs were approved to have osteoconductivity to some extend, which can also be 
enhanced through incorporating bone forming growth factors. Since an ideal scaffolds 
should have osteoinductivity as well, the great challenge in developing LCBPs for bone 
repair is to fabricate osteoinductive scaffolds through the design of bone promoting 
chemical structures or modification of scaffolds. And these bioactive LCBPs will greatly 
enhance their potential in bone repair. 
 
3.3.2 Cartilage repair 
Cartilage is a highly specialized, connective tissue consisting of chondrocytes 
embedded in an extracellular matrix composed primarily of proteoglycans, collagen type 
II, and water. It is one of the few tissues found in the body that has a limited capability to 
regenerate following injury, congenital abnormalities, or arthritis 76,77. In order to repair 
damaged cartilage, a biomaterial should allow retention of native phenotype of the 
chondrocytes, promote the production of extracellular matrices, as well as mimic the 
highly aqueous environment of native cartilage, which facilitates nutrition transport for 
the growth of chondrocytes and the diffusion of cell waste product. Native cartilage is a 
durable elastic tissue and is a hydrogel in nature 78. Due to exudable water held within the 
tissue, cartilage is able to withstand large loads by virtue of the matrix’s strength and the 
water retention. Thus, hydrogels are especially attractive for cartilage tissue regeneration 
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due to their excellent diffusive permeability, minimal irritation to surrounding tissues, 
low surface friction and wear that related to the strong water retention of the hydrophilic 
network 79. Since most cartilage defects are irregular in shape and size, instant 
polymerization causing the gel to assume the shape of the defect offers a great advantage 
for in situ scaffold formation and also provides a minimally invasive strategy for cell 
transplantation. To this end, a photo-polymerization feature was incorporated into 
hydrogels to use as an injectable, in situ forming hydrogel for cartilage repair.  
Poly(ethylene oxide) dimethacrylate, which was first used to photo-encapsulate 
chondrocytes 78,80, demonstrated significant production of both collagen II and 
glycosaminoglycan (GAG) over a 2-week culture period 78. However, the network based 
on PEO-dimethacrylate is not degradable. PLA was incorporated to introduce 
biodegradability. The PLA-PEO-PLA dimethacrylate was also used to photo-encapsulate 
chondrocytes. Fast degradation of lactide segments resulted in the deposition of high 
amounts of inter-territorial matrix and the degradation rate influence of the distribution of 
secreted type II collagen. For example, type II collagen was found localized in the 
pericellular region in 50% degradable gel. However, type II collagen was found 
throughout the neo-tissue when the gel has increased degradation 81. In addition, Bryant 
et al. found that the degradation rate of the scaffold influences the ratio of collagen to 
glycosaminoglycan. For instance, when the ratio of EG to LA changed from 19 to 7, the 
total collagen synthesis increased 2.5-fold after 6 weeks in vitro. Furthermore, the ratio of 
collagen to glycosaminoglycan varied from glycosaminoglycan-rich, 0.33±0.13, to 
collagen-rich, 4.58±1.21 82.  
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Photocurable hyaluronic acid was also used in cartilage repair. HA is well known 
to promote chondrogenesis of many cell types, including bone marrow-derived 
mesenchymal cells 83. Moreover, hyaluronic acid is an important GAG in cartilage 
matrix. The large hyaluronate-proteoglycan aggregates are bound to the thin collagen 
fibrils by electrostatic interactions and by cross-linking glycoproteins. HA-methacrylate 
solution was injected to a rabbit osteochondral defect and photocured in situ. Cells 
migrated from the underlying bone tissue, and penetrated into the crosslinked hydrogels. 
Some cells differentiated into chondrogenetic cells having a rounded morphology and 
depositing collagen II and GAGs 50.  
One major challenge in employing hydrogels for load-bearing cartilage repair is 
insufficient mechanical strength. For instance, articular cartilage contains ~70% water 
and bears loads up to 100 MPa 84, but most hydrogels, either synthetic or derived from 
natural sources, can be easily broken by pressing with a finger or pulling with the hand, 
indicating that they are much weaker than native cartilage tissue. Wang et al. developed a 
photo-curable polyester containing phosphate (PhosPEG) 38. The rheological properties 
of PhosPEG gels were tested by torsional mechanical analysis. The elastic modulus (1-2 
× 106 dyn/cm2) of the PhosPEG Gel cured from 20% (W/V) solution is close to the 
complex modulus of cartilage tissue (2 × 106 to 2.5 × 107) under minimal testing torsional 
frequency. Human mesenchymal stem cells were encapsulated in the PhosPEG hydrogel. 
Good cell encapsulation efficiency and high cell viability were achieved 38.  To further 
develop in this direction, our lab recently developed a series of elastic polyurethane-
based degradable hydrogels with great potential for cartilage repair. The soft segments, 
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PEG and PCL, were endcapped with lysine diisocyanate (LDI) followed by 2-
hydroxyethyl methacrylate (HEMA). The photocured materials show great mechanical 
properties with elastic moduli ranging from 16.8±3.3 MPa to 26.6±3.9 MPa, which are 
very close to the properties of native cartilage. Moreover, RGD can be incorporated into 
the matrix during photocuring, thus improving cell growth 35.  
 
3.3.3 Carriers for therapeutic agents 
Photo-polymerized polymers show great promise for use as carriers for 
therapeutic agents. The linear to network structure conversion facilitates the entrapment 
of drugs, proteins, peptides and oligonucleotides. The liquid to solid and hydrogel phase 
conversion enables in situ formation and effective localization, which allows the use of 
smaller doses of drug and in turn minimizes side effects of certain drugs 85. However, 
there are still some issues should be considered. The hydrophilicity of the photo-
polymerized matrix will greatly influence the dispersion and release of the entrapped 
substances 85. So during the design of LCBPs, the hydrophilicity of LCBPs and entrapped 
agents should be considered. In addition, the release rate is a big issue. Both the 
degradation rate of the matrix and the molecular affinity between matrix and entrapped 
substances regulate their release rate. 
One popular material used to deliver proteins, peptides and oligonucleotides is 
acrylated PLA-PEG-PLA. The presence of a large ratio of PEG results in the formation 
of a hydrogel. When the repeat unit of LA remained constant, the length of the PEG 
segment controls the pore size of the photocured hydrogel. Once LA segments degrade, 
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the pore size of the matrix increases, thus enabling or accelerating the release 86. In 
addition, the PLA segment can be changed to PGA or PCL to increase or decrease 
degradation rate 85. 
Besides PEG, dextran can also be used as a hydrophilic component. Zhang et al. 
photo-cured dextran-AI and PDLLA to obtain a delivery carrier for indomethacin 87. 
When the concentration of PDLLA in the hydrogel increased, both the diffusion 
coefficient (D) and the release constant (k) decreased, which may be due to the 
interaction between hydrophobic PDLLA and indomethacin. Pitarresi et al. photo-cured 
DEX-MA and PHG together and investigated the drug delivery profile using theophylline 
as a model drug 47. The drug, e.g., theophylline, was entrapped into the network via either 
a soaking procedure after curing and incorporation during crosslinking. The drug released 
faster from the hydrogel prepared by the soaking procedure than from that prepared by 
the incorporation during crosslinking. DEX-MA/PHG has a faster drug delivery rate due 
to its greater swelling ability. 
Photocurable chitosan is also used as a carrier for growth factor delivery. Due to  
positively charged nature of chitosan, negatively charged molecules, such as fibroblast 
growth factor-1 (FGF-1), FGF-2 and heparin, can interact electrostatically with chitosan 
hydrogel. This electrostatic charge retains growth factor in the hydrogel and permits 
release from the hydrogel during chitosan degradation 57. In vivo studies showed that 
chitosan hydrogel degraded in 10-14 days and the growth factors released with preserved 
bioactivity from hydrogel during degradation and took effect in the local implantation 
area. 
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3.3.4 Biological adhesive 
Biological adhesives are used for tissue adhesion, hemostasis and sealing of the 
leakage of air and body fluid during surgical procedures. The current clinically used 
biological adhesive is fibrin glue containing fibrinogen, thrombin, factor XIII, and 
protease inhibitor. However, the fibrin glue has drawbacks in its industrial production and 
its difficulty in preventing infectious contaminations. Research is ongoing for an 
alternative biological adhesive. One good candidate, Az-Ch-LA, has developed from 
chitosan by Ishihara et al. This material exhibits a liquid to hydrogel conversion and has 
great potential in biological adhesive applications. It firmly adhered two slices of ham 
together, because the azide groups can link with amino groups on protein upon UV 
exposure, thus covalently linking Az-Ch-LA with tissue protein 20. Compared to fibrin 
glue, the chitosan hydrogel has similar binding strength and can more effectively seal air 
leakage from pinholes on isolated small intestine and aorta. Furthermore, Az-CH-LA and 
its hydrogel showed no cytotoxicity in cell culture and no harm to mice in in vivo studies. 
 
3.4. Conclusions and Future Perspective 
In summary, LCBPs present many advantages for biomedical applications, 
including ease of handling, temporally and spatially controlled polymerization, which 
provides great opportunities for in situ scaffold formation, and scaffold fabrication using 
rapid prototyping. From the structure point of view, a LCBP system contains curable 
groups and biodegradable domains. Photoinitiator is needed when the unsaturated group 
in the system is not sufficiently photo-active for photopolymerization. Like other polymer 
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systems, the structure determines properties. Chemical structure and crosslinking density 
(network structure) influence the properties of LCBPs and photocured networks, 
including mechanical properties, thermo-properties (Tg, Tm), degradation profile, 
swelling degree, bioactivity, etc. The chemical structure of LCBPs can be tailored by 
choosing different degradable components. For example, adjusting the hydrophilicity of 
the degradable segments or the ratio of the hydrophilic domain can influence the 
degradation rate and release profile of loaded therapeutic agents. The crosslinking density 
of the final product can be adjusted by light density, exposure time, the concentration of 
curable groups and chain length of degradable segments between two curable groups.  
The design of the LCBPs must to be customized for specific biomedical 
applications. For instance, the chemical structure, mechanical properties and the 
degradation mechanism have to be finely tuned to have a favorable loading support for 
bone repair. For cartilage repair, the chemical structure, swelling ratio and degradation 
profile have to be controlled to facilitate chondrocytes behavior. For the therapeutic agent 
delivery system, the affinity between the specific agent and the carrier has to be well 
controlled to achieve a desirable release profile.   
Although many efforts have been focused on the designing of favorable chemical 
structures for different biomedical applications, there are still many challenges in these 
fields. And these challenges are related to the requirements in different biomedical 
applications. In the future of developments, one important area is to develop strong load 
bearing LCBPs. For example, cured scaffolds should have good mechanical properties 
for loading support. The balance between porous and strength is crucial consideration. 
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From the point view of tissue engineering scaffold, a highly porous structure may 
facilitate cells penetration and growth inside the scaffolds. But the porous structure will 
obviously decrease strength of the scaffold.  In another case, photocured hydrogels that 
have great elasticity and higher strength will benefit the application in cartilage repair. 
This can be obtained by developing water-soluble polyurethane based LCBPs. 
Incorporation of biospecific active agent, such as functional peptide, is also an active 
research area, which can regulate cell attachment and proliferation. 
The other important area is to develop more functional LCBPs. By tailoring the 
chemical structures, LCBPs may possess both mechanical strength and bioactivity, such 
as osteoconductivity and osteoinductivity in bone regeneration. However, few reports 
proved that the currently used LCBPs have these bioactivities. One way to improve the 
bioactivity is load biological molecules into or on the surface of LCBPs. Long term 
delivery may allows targeted spatial and temporal delivery to tissues of multiple 
modulators of tissue response with predetermined kinetics.  
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CHAPTER FOUR 
 
CHEMICALLY MODIFIED LIGHT-CURABLE CHITOSANS WITH ENHANCED 
POTENTIAL FOR BONE TISSUE REPAIR 
 
 
4.1 Introduction 
Every year in the United States, there are ~900,000 hospitalizations due to bone 
defect and trauma 1. Bone tissue engineering provides a clinically applicable strategy for 
bone repair, among which biocompatible materials and implants play an important role in 
supporting bone regeneration. For these materials, biocompatibility, chemical structure, 
pore topography and size, surface topography and mechanical properties are all important 
factors influencing the final success in bone repair. Studies on currently used synthetic 
materials both in vitro and in vivo indicate that synthetic materials show great potential as 
scaffolding materials in bone repair 2–6. However, currently used biomaterials have 
limitations in some bone repair scenarios, such as repairing irregularly shaped defects in 
either open or closed forms. Light curable polymers are good candidates for these repairs. 
Light-curable polymers can undergo photopolymerization upon light exposure, which 
shows many advantages compared with chemical polymerization, including a high 
polymerization rate that overcomes the oxygen inhibition and solvent effects in normal 
polymerization, good temporal and spatial control and resolution, ambient temperature 
operation and low energy consumption 7. Light-curable polymers may be used for in situ 
scaffold forming, which makes minimally invasive surgery possible. Moreover, the light-
curable materials may be used for computer-aided fabrication through rapid prototyping 
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which allows fabricating scaffolds with customized shape and reproducible 
microarchitecture on a large scale. 
Chitosan is a natural biopolymer that has been widely used in medical 
applications because of its biocompatibility and biodegradability 8–10. Many studies have 
indicated that chitosan is a good candidate for orthopedic applications 1,6,11–14. In cartilage 
tissue engineering, chitosan was shown to promote chondrocyte attachment and 
proliferation and maintain chondrogenic phenotype, which may be due to its structural 
similarity to various glycosaminoglycans (GAGs) found in articular cartilage 8,11,15,16. 
Chitosan has also been extensively used in bone tissue engineering as it has been shown 
to facilitate growth and biomineralization by osteoblasts 14. Modified light curable 
chitosans may have great potential for use in fabricating scaffolds with desired shape and 
pore topography for bone tissue engineering and in overcoming some obstacles in current 
bone repair. Many types of chemical modifications of chitosan have been employed to 
broaden its applications, however, there has been little endeavor in developing 
photocurable chitosans. 
In this study, we improved a synthesis method used by Badawy et al.17 and 
synthesized a series of photocurable chitosans. These chitosan derivatives possess very 
good solubility in organic solvents and light curability as well. Moreover, the light 
curability is controllable through adjusting the feeding ratio of raw components during 
synthesis. The chemical structures of these photocurable chitosans were confirmed by 
FTIR–ATR and 1H NMR. The cytocompatibility of these light-cured chitosans was tested 
in vitro. To further explore the potential for bone repair, these photocurable chitosans 
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were photocured into scaffolds with interconnected pores, seeded with osteoblasts, and 
the bone formation was evaluated in vivo. 
 
4.2 Materials and methods 
4.2.1 Materials 
Chitosan with high molecular weight and more than 85% deacetylation and 
dimethyl sulfoxide (DMSO) were both obtained from Sigma–Aldrich. (St. Louis, MO). 
Methane sulfonic acid was purchased from Acros Organics (Geel, Belgium). Benzoyl 
chloride, methacryloyl chloride and Ammonium hydroxide water solution (5N) were 
obtained from Fisher Scientific. Iragure 2959 was kindly donated by Ciba Specialty 
Chemicals.  
 
4.2.2 Synthesis of light-curable chitosans  
The light-curable chitosans were synthesized via a method similar to that 
described by Badawy et al.17  (Fig. 4.1). Briefly, 1 g chitosan powder was dissolved in 15 
mL methane sulfonic acid, and the mixture was stirred until the chitosan was completely 
dissolved. Acyl chloride at five times the M ratio of the glucosidic unit was added 
dropwise into the solution over a 30-min period. The reaction was continued for another 
3 h and the solution was stored at –20oC overnight. After thawing, the solution was added 
dropwise into excess water to obtain a precipitate that was then filtered and stirred in 4% 
amine water solution overnight. The final product was obtained after repeated filtering, 
rinsing, and vacuum drying until constant weight was achieved. For the modifications of 
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chitosan, two acyl chloride compounds, benzoyl chloride and methacryloyl chloride, 
were used. The modified chitosans with benzoyl chloride and methacryloyl chloride were 
named benzoyled chitosan (BC) and methacrylated chitosan (MC), respectively. We also 
mixed benzoyl and methacryl chloride together to react with chitosan. The amounts of 
benzoyl and methacryloyl chloride were varied to give final ratios of 1:3, 1:1, and 3:1. 
The final products were named BMC13, BMC11, and BMC31, respectively. (B stands 
for benzoyl groups, M for methacrylate groups, C for chitosan and the numbers for the 
feeding ratio of benzoyl and methacryloyl chlorides). 
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Figure 4.1: Synthesis scheme of photocurable chitosans 
 
4.2.3 Characterizations 
The chemical structure of the photocurable chitosans was characterized using the 
FTIR–ATR (Research Series 100, Madison Instrument, Madison, WI) and 1H NMR 
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(Varian INOVA-400 (9.4 T), Varian, Walnut Creek, CA) operated at 400 MHz proton 
with d-DMSO as solvent. 
 
4.2.4 Fabrication of light-cured film and 3D porous scaffolds 
An ultraviolet light generator (American Ultraviolet Company, Santa Ana, CA) 
was used to generate the UV light to initiate polymerization. The light intensity was 800 
mW/cm2 at a wavelength of 365 nm. Irradiation from the generator was transmitted 
through a quartz optical guide fiber (diameter: 5 mm; length: 1 m) to the pre-polymers. 
All of the pre-polymers before light cured were dissolved in DMSO at 15 wt % except for 
MC, which was dissolved at 10 wt % owing to its lower solubility in DMSO. 0.05 wt % 
of the photoinitiator, Irgacure 2959, was added to the solution and mixed 
homogeneously. For the photocured films, the solution was cast on a glass slide and 
exposed to UV light. The UV cured films were stored in DI water for further use. Salt 
leaching with photocuring were employed to fabricate the porous scaffolds. First, the 
mold (4 mm in diameter and 2.5 mm in height) was filled with salt crystals (NaCl) and 
then the polymer solution was added dropwise on the top of the salt. The chitosan 
solution infiltrated downwards to the bottom and filled the interspaces between salt 
crystals then the filled mold was exposed to UV for the appropriate time period (the 
distance between UV source and the top of mold is about 1.5 cm). After curing, the discs 
were taken out and immersed in DI water to eliminate the remaining solvent and salt. DI 
water was changed frequently to ensure that all of the solvent and salt was driven out 
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from the porous scaffolds. Scanning electron microscopy (SEM, Hitachi, Japan) was used 
to visualize the morphology of he scaffolds. 
 
4.2.5 In vitro cytocompatibility test  
The photocured chitosan films were removed from DI water and sterilized with 
70% ethanol for 30 minutes, then air-dried in the cell culture hood. NIH 3T3 fibroblasts 
were used for cytocompatibility testing. After counting, 5000 NIH 3T3 fibroblasts were 
seeded in each well of a 6-well cell culture plate. The sterilized chitosan films were put 
into the wells and co-cultured with cells. Every other day, alamar blue solution was used 
to test cytocompatibility. Briefly, after the culture media was removed, 10% v/v alamar 
blue in fresh culture medium was added and incubated for 4 h. Then the alamar blue 
solution was removed and the absorbance was measured at 570 nm and 600 nm. The 
difference between treated and control cells was calculated and expressed as percentage 
reduction. 
 
4.2.6 In vivo osteoconductivity test 
The porous scaffolds were freeze-dried and sterilized with ethylene oxide. 
Primary fetal bovine osteoblasts were propagated in monolayer culture until confluence. 
The harvested cells were then loaded onto porous disc scaffolds at a concentration of 5 X 
106 cells/scaffold. PLGA discs were used as control. Under general anesthesia and sterile 
conditions, the scaffolds were subcutaneously implanted into the backs of 4–6-week old 
male, athymic (nu/nu) rat. Six rats were used for each sample type. After 6 weeks, the 
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rats were sacrificed and the implants were harvested. Each implant was processed for 
histology and stained with H&E and Anderson’s rapid bone stain counterstained with 
acid fuchsin. 
 
4.3 Results 
4.3.1 Synthesis, fabrication and characterizations 
4.3.1.1 Solvent solubility 
Because of its semicrystalline structure, raw chitosan has very poor solubility in 
organic solvents and can only be dissolved in some acids, such as acetic acid. After 
modification, MC has low solvent solubility, becoming cloudy when the concentration 
reaches 10% in DMSO. However, BMC13, BMC11, and BMC31 have very good 
solubility in many organic solvents (up to 50%), including dimethylformamide (DMF), 
DMSO, dimethylacetamide (DMAC), acetone, methane chloride, and so forth, which 
facilitates the fabrication of scaffolds with desired structures. 
 
4.3.1.2 FTIR–ATR 
From the IR spectra of each sample (Fig. 4.2), characteristic peaks at around 1720 
cm-1 show the existence of ester carbonyl groups, indicating that the acyl chloride groups 
have reacted with the hydroxyl groups in the chitosan. The presence of amino group 
peaks at around 1600 cm-1, with no peaks at 1670 cm-1 (amide I) and 1536 cm-1 (amide 
II), indicates that the amino groups were protected during the reaction due to the 
protonation of the amino groups when reacting with methanesulfonic acid17, 18.  
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Figure 4.2: FTIR-ATR characterization of Photocurable Chitosans 
Moreover, the peak at 710 cm-1 indicates the existence of the aromatic ring belonging to 
the benzoyl group. The intensity of this peak decreased when more methacryloyl chloride 
was used during synthesis. Conversely, the intensity increased for the peaks belonging to 
methacrylate groups at about 950 cm-1 and 1300 cm-1. Thus, during synthesis, by 
adjusting the feed ratio of benzoyl and methacryloyl chloride, we can control the ratio of 
curable groups in the final products. 
 
4.3.1.3 1H NMR 
In 1H NMR (Fig. 4.3), the chemical shift δ = 2.8–5.2 ppm is assigned to the 
protons in the pyranose ring. The signals for the protons on the benzoyl group appear at δ 
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= 7.5–8.2 ppm, and for the protons on the methylene in the olefin, the signal appears at δ 
= 5.7–6.3 ppm. To determine the practical ratio of grafted benzoyl and methacryloyl 
groups, the peak area of benzoyl and methacryloyl groups was integrated and the ratio 
was calculated according to Eq. (1). 
Practical ratio = (Peak areabenzolyl groups/5) : (Peak areamethacryloyl groups/2)                (1) 
The practical ratio of benzoyl and methacryloyl groups after integration of the 
peak area is shown in Table 4.1. The results show that the reactivity of benzoyl chloride  
 
12 10 8 6 4 2 0
BC 
ppm
 
12 10 8 6 4 2 0 
MC 
ppm 
 
(A)                (B) 
 
12 10 8 6 4 2 0 
BMC31 
ppm 
 
12 10 8 6 4 2 0
BMC11
ppm
 
12 10 8 6 4 2 0
BMC13 
ppm
 
(C)                (D)                (E) 
Figure 4.3: 1H-NMR characterization of Photocurable Chitosans (a) BC (b) MC (c) 
BMC31 (d) BMC11 (e) BMC13 
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is much higher than methacryloyl chloride as the practical ratio of benzoyl groups is 
always higher than its feeding ratio. So the content of methacryloyl groups is influenced 
not only by the feeding ratio but also by the reactivity of these two acyl chlorides.  
 
Table 4.1: The theoretic and practical ratio of benzoyl and methacrylate groups 
 BMC31 BMC11 BMC13 
Theoretical ratio 3:1 1:1 1:3 
Practical ratio 4.5:1 1.5:1 1:2 
 
Fabrication of light cured chitosan films and porous scaffolds and structure study using 
SEM.  
As expected, the time scale for light curing is determined by the content 
ofmethacryloyl groups in the backbone. More methacryloyl groups result in a faster 
curing rate. For example, BMC13 (30 s) is light curedmuch faster than BMC31 (120 s), 
and BMC11 has an intermediate rate.  
In fabrication of scaffolds, we used salt crystals ranging from 125 to 210 μm as 
the porogen. SEM images (Fig. 4.4) show that the size of the pores is the same as the 
porogen, and there is no marked difference in morphology between different photocured 
chitosans. Furthermore, SEM images show that these pores are interconnected.  
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(A)        (B)      (C) 
Figure 4.4: SEM of photocured chitosans (A) BMC13 (B) BMC11 (C) BMC31 
 
4.3.2 In vitro cytocompatibility tests  
In this in vitro test, photocured chitosan was co-cultured with NIH 3T3 fibroblasts 
to determine whether photocured chitosans release toxic substances which influence cell 
growth. Latex was used as a positive control and PLGA as a negative control. Alamar 
blue was used to test cytocompatibility of photocured chitosans by measuring the 
proliferation of the co-cultured cells. Specifically, alamar blue incorporates an oxidation-
reduction (REDOX) indicator that both fluoresces and changes color in response to 
chemical reduction of growth medium resulting from cell growth. The percent difference 
in reduction between cells on experimental groups and control groups was calculated and 
plotted in Figure 4.5. 
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Figure 4.5: Cytocompatibility test of photocured chitosans in 7 days culture 
 
From the plot, it can be seen that photocured chitosans and PLGA showed no toxicity 
during the 7-day culture period. However, latex showed strong toxicity, with the number 
of fibroblasts in the wells cultured with latex being less than 20% of the control (PLGA) 
and the photocured chitosans. This test indicated that photocured chitosans are 
cytocompatible. 
 
4.3.3 In vivo osteoconductivity test 
Osteoconductivity of photocured chitosans was studied over a 6-week period. 
Porous discs seeded with fetal bovine osteoblasts were implanted subcutaneously in the 
backs of athymic rats. Implants were harvested and processed for paraffin embedding. 
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Specimens in paraffin blocks were cut into 5 um sections and stained with H&E and 
Anderson’s rapid bone stain counterstained with acid fuchsin (Fig. 4.6). Anderson’s rapid 
bone stain stained bone matrix to red and soft tissue to blue. In the PLGA control, 
extensive amount of fibrotic tissues were found even though some bone matrixes were 
also observed. The fragmentary bone matrixes in PLGA scaffolds were surrounded by 
connective tissue. However, low amount of fibrotic tissues were found in the pores of 
photocured chitosans scaffolds. Instead, extensive amount of bone matrixes were found 
in the scaffolds (stained into red after applied with Anderson’s rapid bone stain; [Fig. 
4.6.(E,I,L)]. At the same time, many cartilaginous cells with rounded shape were also 
observed in the pores, which can be seen in H&E staining [Fig. 4.6(D,E,G,H,J,K)]. The 
ECM of these cartilaginous cells is surrounded by or connected with bone matrix [Fig. 
4.6(E,I,L)], which indicates that the endochondral ossification was taking place in the 
scaffolds. These findings indicate the photocured chitosans have better osteoconductivity 
than PLGA. In addition, from the pictures, we also can notice that there is less BMC31 
remained in the explants than BMC11 and BMC13. This might be due to lower 
crosslinking density and faster degradation of BMC31. 
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Figure 4.6: Histological pictures of scaffolds with H&E staining and Anderson’s rapid 
bone stain counterstained with acid fushcin (A) PLGA ×10, H&E; (B) PLGA ×20, H&E; 
(C) PLGA ×20, Anderson’s (D) BMC31 ×10, H&E; (E) BMC31 ×20, H&E; (F) BMC31 
×20, Anderson’s; (G) BMC11 ×10, H&E; (H) BMC11 ×20, H&E; (I) BMC11 ×20, 
Anderson’s; (J) BMC13 ×10, H&E; (K) BMC13 ×20, H&E; (L) BMC13 ×20, 
Anderson’s 
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4.4 Discussion 
Chitosan is a partially de-acetylated derivative of chitin, the second most 
abundant natural polymer found in shells of marine crustaceans and cell walls of fungi 
13,19,20. It is a linear polysaccharide composed of α-(1→4)-linked-2-amino-2-deoxy-β-D-
glucopyranose with hydroxyl and amino side groups. Because of its chemical structure, 
chitosan shows high biocompatibility leading to its being extensively applied in 
biomedical areas, for such uses as surgical sutures, dental implants, artificial skin, and so 
forth.9 In recent research, chitosan has been widely used as a scaffolding material for 
tissue engineering15,21–27. Many studies indicate that chitosan is suitable for orthopedic 
applications1,6,11–14. Chitosan’s amino side groups endow it with a cationic environment 
that makes it electrostatically interact with anionic molecules, such as 
glycosaminoglycans (GAGs), proteoglycans and other negatively charged molecules. 
Because a large number of cytokines/growth factors could be linked to GAGs, the 
interaction between chitosan and GAGs may retain and concentrate both the endogenous 
tropic factors secreted by colonizing cells, as well as the exogenous factors that may be 
loaded inside the scaffold8. This might be one reason that chitosan shows favorable 
results in cartilage tissue engineering. Another reason maybe due to its structural 
similarity to various GAGs found in articular cartilage10. Moreover, chitosan has also 
been extensively used in bone tissue engineering because it has been shown to facilitate 
growth and mineral rich matrix deposition by osteoblasts in culture14.  
However, chitosan has very poor solubility because of the intramolecular or 
intermolecular hydrogen bond formed between amino and acyl groups, which makes it 
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soluble only in aqueous acid solutions, thus greatly limiting its application19. For 
example, chitosan can be only dissolved into aqueous solution of acetic acid at a low 
concentration, around 2 wt %. The modified chitosans with good solubility in many 
common organic solvents are believed to possess the abilities not only in further 
modification by introducing active groups and chemically combining with other polymers 
to improve mechanical properties but also for processing into scaffolds with desired 
microstructure or gross shape. Various efforts have been made to prepare functional 
chitosan derivatives via chemical modification, but few increased the solubility of 
chitosan in organic solvents17,18,28–31. Nishimura et al. modified chitosan with phthalic 
anhydride, producing a final product that can be easily dissolved into general organic 
solvents, such as DMSO, DMF, and DMAC17,18,28–31. Badawy et al. developed a method 
to improve the solubility of chitosan via the grafting of benzoyl groups onto the 
backbone17,18,28–31. 
In this study, we modified chitosan with photocurable groups (methacrylate 
groups) and benzoyl groups. The modified chitosan shows great solubility in many 
common organic solvents. The method we used is similar to that employed by Badawy17. 
We mixed methacryloyl chloride with benzoyl chloride, and we postulate that 
methacrylate groups can compete with benzoyl groups in grafting on the chitosan 
backbone. As expected, both groups are grafted onto the backbone. Benzoyl groups 
provide great solubility in general organic solvents, and methacrylate groups provide 
photocurability. However, too much methacrylate group will result in decreased 
solubility. For example, a solution of 10% MC in DMSO is cloudy. The mixtures 
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BMC31, BMC11, and BMC13 can reach a concentration as high as 50% in DMSO, 
which may be due to the aromatic rings in the backbone. Moreover, the content of 
methacrylate groups in modified chitosan, which provide light curability, can be adjusted 
by changing the feeding ratio of methacryloyl and benzoyl chlorides, meaning that we 
can adjust the crosslinking density of the final cured network. In addition, we found that 
more methacryloyl groups in chitosan backbone resulted in a faster curing rate.  
The main purpose of this study is to obtain functional scaffold materials for bone 
tissue engineering. From the point of view in bone tissue engineering, a good scaffolding 
material should have osteocompatibility and osteoconductivity. For example, it can 
induce bone repair in the wound that cannot heal if left untreated and facilitate the bone 
cells growth in the scaffold to form bone. And it will be perfect if the materials have 
osteoinductivity32. To some extent, these bioactivities are determined by the chemical 
structure or components. Chitosan is a linear polysaccharide and has been proven to be a 
candidate of scaffolding material for bone tissue engineering. Borah et al.33 found that N-
acetyl-chitosan induced calcification better than the control. And many other chitosan 
derivatives have been indicated to have good osteoconductivity, such as N-carboxylbutyl-
chitosan34, imidazole-chitosan35, and 6-oxylchitin36. In addition, osteoinductivity was also 
observed with a chitosan coated hydroxyapatite nail37. These results suggested that raw 
chitosan or modified chitosan could be a series of good scaffolding materials for bone 
tissue engineering. To this end, we developed the photocurable chitosans for repairing 
bone defects. Owing to the advantages of photopolymerization, the photocurable 
chitosans can be fabricated into scaffolds with desired shape and pore topography. In this 
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study, we used salt leaching coupled with photocuring to fabricate scaffolds with 
interconnected pores as a model tested the feasibility. For bone tissue engineering, the 
pore size of the scaffold is a major factor affecting the regeneration of bone. Small pore 
size prevents cells from penetrating into the scaffold. However, pores which are too large 
cannot be effectively occupied by cells. The optimal pore size of scaffolds for bone tissue 
engineering is around 100–300 μm. The salt crystals used in this study range in size from 
125 to 210 μm. From the SEM images, it can be seen that after salt leaching, the pores in 
the scaffolds are in the optimal size range and they are interconnected. The 6-week 
osteoconductivity test in which we implanted cellseeded photocured modified chitosan 
scaffolds into the backs of athymic rats showed very good osteoconductivity of the 
photocured chitosans. This further verified that photocurable chitosans are suitable for 
use as scaffolding materials for bone tissue engineering.However, the control, PLGA 
porous scaffolds, contains large amount of fibrotic tissues and few bone tissues, which 
may be due to its faster degradation rate (loss of porous structure after 6 weeks from [Fig. 
4.6(A–C)] and the acidic degraded products induce inflammation reaction and reduce the 
bone formation. Because the photocurable chitosans have the potential to be fabricated 
into desired shapes, fabricating larger scaffolds with irregular shapes and pore 
topography through stereolithography is the future target. In addition, the photocurable 
chitosans can be coupled with other synthetic materials through chemical reactions, 
which might result in improved mechanical properties. 
 
 118
4.5 Conclusions 
A series of photocurable chitosans with great solubility in organic solvents have been 
synthesized. The content of the photocurable groups (methacryloyl groups) in the 
backbone can be controlled by adjusting the feeding ratio of the acyl chloride. The 
structures of these photocurable chitosans were confirmed by FTIR–ATR and 1H NMR 
measurements. Moreover, from 1H NMR, we found that the benzoyl chloride has much 
higher reactivity than methacryloyl chloride in this reaction. The modified chitosans can 
be fabricated into porous scaffolds with desired pore size by salt leaching and 
photocrosslinking, which means that the modified chitosans can be more easily fabricated 
into scaffolds than raw chitosan. In vitro cytocompatibility testing showed that the 
photocured chitosans are cytocompatible. Porous photocured discs were also 
subcutaneously implanted into the backs of athymic rats. After 6 weeks of implantation 
of osteoblasts seeded scaffolds, histological analysis indicated that photocured chitosans 
have good osteoconductivity. 
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CHAPTER FIVE 
 
NOVEL LIGHT CURABLE CHITOSANS WITH IMPROVED PROPERTIES FOR 
BONE TISSUE ENGINEERING 
 
 
5.1 Introduction 
In chapter 4, we synthesized a series of novel photocurable chitosans which have 
very good solubility and photocurability. These improved properties result from the 
introduction of benzoic and methacrylate groups onto chitosan. From the molecular 
structure, chitosan is a linear polysaccharide composed of α-(1→4)-linked 2-amino-2-
deoxy-β-D-glucopyranose with hydroxyl and amino side groups. These hydroxyl and 
amino side groups provide the reactive sites for our chemical modification.  
Although in our previous chapter, the modified chitosan derivatives have good 
solubility and photocurability, we found that the photocured chitosans don’t possess 
desired mechanical properties, for example, it is easily broken and hardly bear bending. 
This not only makes the fabrication of scaffolds difficult, but also hampers the 
application of the photocurable chitosans as bone grafts. The poor mechanical properties 
may be due to the use of methanesulfonic acid as solvent in the synthesis. It is a strong 
acid and tends to cleave the chitosan chain if the reaction lasts too long. And too high 
substitutions of benzoic and methacrylate groups on chitosan can also influence the 
chain’s flexibility. 
The goal of our study was to develop novel chemically modified chitosans with 
better mechanical properties compared to those we synthesized in Chapter 4 1.The 
improved properties were achieved by adjusting the reaction time and amount of acyl 
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chlorides. These resultant chitosan derivatives still had good solubility and 
photocurability. The chemical structure and photocuring properties of these light curable 
chitosans were characterized. And physical properties of the hydrated photocured 
chitosans, such as swelling ratio and viscoelasticity, and biocompatibility were also 
studied. One of these light curable chitosans was screened to fabricated into 3-D porous 
scaffold using photocuring and salt leaching. And its osteoconductivity was confirmed by 
ectopic bone formation on rats’ back. 
 
5.2 Materials and Methods 
5.2.1 Materials  
Chitosans with high molecular weight and 85% deacetylation and dimethyl 
sulfoxide (DMSO) were both obtained from Sigma-Aldrich Inc. (St. Louis, MO, USA). 
Methane sulfonic acid was purchased from Acros Organics (Geel, Belgium). Benzoyl 
chloride and methacryloyl chloride were obtained from Fisher Scientific, Inc. 
Ammonium hydroxide water solution (5N) was purchased from VWR, Inc. Iragure 2959 
was kindly donated by Ciba Specialty Chemicals. 
 
5.2.2 Synthesis of light curable chitosans 
In this study, we modified the synthesis method used in our previous study 1. The 
reaction time and amount of acyl chlorides were adjusted. Briefly, 1 g chitosan was 
dissolved into 15 ml methanesulfonic acid with stirring for 25 minutes, followed by 
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adding dropwise mixtures of benzoyl chloride and methacryloyl chloride under stirring. 
The content of the acyl chlorides mixtures were listed in Table 5.1. 
Table 5.1: Content of acyl chloride for synthesis 
 
 
 
 
 
 
 
 
 
Then, the solution was kept at room temperature with stirring for another 30 
minutes. After that, the solution was dropped into ammonium hydroxide aqueous solution 
(100 ml 5N ammonium hydroxide solution + 600 ml DI water) to precipitate the light 
curable chitosans. This precipitate was filtered and washed with DI water 10 times to 
clean the remained reagents and solvent. Finally, the product was dried in vacuum over 
P2O5 for two days. FTIR (Nicolet Impact 410 FTIR spectrometer, Inspiratech 2000 Ltd., 
UK) was taken to qualitatively measure the chemical structure of these three products by 
proving the existence of benzoic and methacrylate groups. 1H NMR (Varian 
UNITYINOVA- 400 (9.4 T), operating at 400MHz proton, d-DMSO as solvent) was also 
measured to confirm the chemical structure of the resulting light curable chitosans. A: δ 
0.95-1.2 (0.45H, -OC-CH3), 1.5-2 (2.73H, -CH3), 3-5.2 (7H, -CH- and –CH2- from 
pyranose ring), 5.5-6.2 (1.82H, =CH2), 7.2-8.2 (1.55H, -CH- in benzene ring); B: δ 0.95-
1.2 (0.45H, -OC-CH3), 1.5-2 (1.80H, -CH3), 3-5.2 (7H, -CH- and –CH2- from pyranose 
ring), 5.5-6.2 (1.20H, =CH2), 7.2-8.2 (1.9H, -CH- in benzene ring); C: δ 0.95-1.2 (0.45H, 
 Chitosan (g) Benzoyl chloride (g) Methacryloyl chloride (g) 
A 1.000 0.880 1.227 
B 1.000 1.100 0.820 
C 1.000 1.100 1.227 
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-OC-CH3), 1.5-2 (2.79H, -CH3), 3-5.2 (7H, -CH- and –CH2- from pyranose ring), 5.5-6.2 
(1.86H, =CH2), 7.2-8.2 (2H, -CH- in benzene ring). 
 
5.2.3 Photocuring of light curable chitosans. 
Conversion of methacrylate groups (intensity of ‘H2C=’ IR peak at 950 cm-1) was 
used to evaluate the effect of the curing time and concentration of photo-initiator for the 
photocrosslinking. Photocurable chitosan C was dissolved in DMSO to 20% solution 
with different amount of photo-initiator, Iragure 2959 (0.1%, 0.2%, 0.3%, 0.4% and 0.5% 
(w/w)). 0.1g solution was dropped onto slide surface and put under UV exposure for 180s 
to obtain photocured chitosan films. To obtain photocured chitosan films with different 
curing time, 0.1g solution with 0.5% photo-initiator was also exposed under UV 
(10w/cm2) for 30 s, 60s, 120s and 180s, respectively. All of these films were immersed 
into DI water and washed for several times to eliminate solvent, DMSO. After freeze-
drying, the structure of all these films was analyzed via FTIR. 
 
5.2.4 Fabrication of cured films and porous scaffolds. 
Photocured chitosan films from A, B and C for further study were made with 
similar method. The concentration of photo-initiator was 0.5%  (w/w) and the 
photocuring time was 180s. For the porous scaffolds, salt crystals were filled into a hight-
adjustable mold of 8 mm in diameter and 2 mm in height. The chitosan solution was then 
dropped onto the top, after that, the solution penetrated to the bottom very fast and filled 
the inter-space between salt crystals. After exposed under UV for 5 minutes, the disc was 
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immersed into DI water to wash off the solvent and salt. The porous scaffolds were 
further freeze-dried and SEM was taken for morphology study. 
 
5.2.5 Swelling ratio test 
The photocured chitosan films made from A, B and C were carefully blot dried 
with filter paper and then weighted. The films were dried in vacuum over P2O5 for two 
days and weighted again. The swelling ratio was calculated by equation 1.  
Swelling ratio = (Weight wet – Weight dry)/Weight dry                        (1) 
The swelling ratio of 3-D porous scaffolds was analyzed with the same method. 
 
5.2.6 Rheological study of light cured chitosans 
In order to test the viscoelasticity of light cured chitosans, the discs of 8 mm in 
diameter and 5 mm in height were made using the same mold as that used for porous 
discs. The mold was filled with 20% chitosan-DMSO solution and then exposed to UV 
for 5 minutes. Then the disc was immersed into DI water. Before measurement, these 
discs were washed for 10 time and eliminate solvent DMSO. Dynamic oscillatory 
experiments were performed on an AR-G2 model stress controlled rheometor (T.A. 
Instuments, U.K.) with a 8 mm parallel plate geometry at 25 0C. By adjusting the upper 
plate, a 10% compressive stain was applied to all the discs. Frequency sweep experiments 
were carried out at 0.1% strain between 0.1 and 100 Hz (i.e., 0.0628 and 62.8 rad/s) on 
these discs. Photocured PEG-dimethacrylate hydrogel (MW= 750; made from 20 % in 
DMSO solution with 5% photoinitiator) was used as control. 
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5.2.7 Cytocompatibility of light cured chitosans 
In order to test the cytocompatibility of light cured chitosans, the light cured 
chitosan films were co-cultured with bovine osteoblasts. 8,000 bovine osteoblasts were 
seeded in each well of 6-well culture plate with 3 ml culture media. The films sterilized 
with 70% ethanol and neutralized with 1 X PBS were then put into the wells. At day 1, 3, 
5 and 7, Alamar Blue assay (Serotec Ltd., UK) was taken to measure the 
cytocompatibility of light cured chitosans. The wells cultured with osteoblasts and 
without films were used as positive control. 
 
5.2.8 Study of cell morphology on the surface of cured chitosans film 
In order to examine osteoblasts behavior and spreading on the surface of light 
curable chitosans, the morphology of bovine osteoblasts cultured onto photocured 
chitosans films was studied. The solution of light curable chitosans were dropped onto 
the bottom of 6-well culture plates, and after UV exposure, these chitosans were coated 
onto the 6-well culture plate. Before cells culture, these coated culture plates were 
washed with DI water, sterilized with 70% ethanol for 30 minutes and washed with 1 X 
PBS for 5 times. 8,000 bovine osteoblasts were seeded into each well and cultured for 7 
days. The media was changed every 3 days. At day 7, the cells were fixed with 4% 
paraformaldehyde and stained with phalloidin-488 for actin and drag-5 (Biostatus Ltd., 
UK) for nuclei. Confocal pictures were taken for the morphological study. 
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5.2.9 In vitro 3-D cell culture 
In order to further test the biocompatibility of photocured chitosan and examine 
the cell behavior in 3-D porous scaffold, in vitro 3-D cell culture was taken. The 3-D 
porous scaffolds were sterilized with 70% ethanol for 30 minutes, washed with 1 X PBS 
for 5 times and stored in 1X PBS. Before seeded with bovine osteoblasts, the porous 
scaffolds were blot dried with filter paper (absorbing PBS in the pores). And then, 80,000 
bovine osteoblasts in 20 µl media were seeded onto the top of the 3-D scaffolds. The 
osteoblasts with media were absorbed into the scaffold due to capillaceous force. 2 hours 
later, after osteoblasts attached onto the wall of 3-D scaffold, 3 ml media was added into 
each culture well. After two-day culture, the osteoblasts in 3-D scaffolds were fixed and 
stained with phalloidin-488 for actin and drag-5 for nuclei. Confocal microscopy was 
used to study the morphology of osteoblasts in vitro 3-D culture. 
 
5.2.10 In vivo osteoconductivity test 
The porous disc scaffolds were prepared as that in vitro 3-D cell culture. Porous 
PCL (MW=42,500) scaffolds were used as negative controls. Primary fetal bovine 
osteoblasts were propagated in monolayer culture until confluence. The harvested cells 
were then loaded onto porous disc scaffolds at a concentration of at least 80,000 
cells/scaffold. Under general anesthesia and sterile conditions, the porous discs were 
subcutaneously implanted into the backs of 4-6 week old male, athymic (nu/nu) mice. Six 
mice were used for each sample type. After 4 weeks, the mice were sacrificed and the 
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implants were harvested. Each explant was processed for paraffin histology and stained 
with H&E. 
 
5.3 Results 
5.3.1 Synthesis and characterizations 
The goal of this synthesis is to introduce benzoic and methacrylate groups onto 
the backbone of chitosan, thus increasing its solubility and imparting light curability. The 
feeding amount of benzoyl and methacryloyl chloride was adjusted during the synthesis 
to obtain three light curable chitosans with different benzoic and methacrylate content. 
FTIR confirmed the existence of benzoic groups (950 cm-1) and methacrylate groups (710 
cm-1) in the chain of chitosan. At the same time, the intensity of these groups are different 
in these three photocurable chitosans. Higher feeding amount leads to higher intensity. 
For instance, for benzoic groups, A<B≅C, while for methacrylate groups, B<A≅C (Figure 
5.1).  
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Figure 5.1: FTIR of light curable chitosans 
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This is also supported by 1H NMR. From 1H NMR, the degree of graft and degree 
of deacetylation can be quantitatively calculated (Table 5.2). C has both higher benzoic 
and methacrylate groups due to higher feeding amount. In addition, degree of graft also 
affects the solubility of these light curable chitosans. For example, C can be dissolved 
into DMSO very quickly, however, it takes longer to dissolve A and B in DMSO as 20% 
(w/w) solution. And 20% (w/w) solution of A or B is not completely clear. 
Table 5.2: The chemical structure determined by 1HNMR 
 
 Graft degree of benzoic group 
Graft degree of 
methacrylate groups Degree of deacetylation 
A 0.31 0.91 0.85 
B 0.38 0.60 0.85 
C 0.40 0.93 0.85 
 
5.3.2 Photocuring of light curable chitosans 
In order to photocure chitosan, Iragure 2959, a highly biocompatible 
photoinitiator, was added into solution to initiate the photocrosslinking. Then 
methacrylate groups will undergo polymerization to form crosslinked network. The 
concentration of light curable chitosans, photoinitiator, light intensity, the distance 
between light and samples and photocuring time would determine the conversion of 
methacrylate groups and crosslinking density of photocured chitosans. In this study, the 
concentration of light curable chitosans (20% w/w), distance between light and samples 
(5 cm) and the light intensity (10W/cm2) were kept constant. However, the effect of 
concentration of photoinitiator and photocuring time was evaluated. FTIR was used to 
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characterize light cured chitosans under different conditions (Figure 5.2 and 5.3). 
Specifically, the characteristic peak of methacrylate groups (H2C= at 950 cm –1) can be 
used to qualitatively evaluate the conversion of methacrylate groups. Obviously, higher 
photoinitiator concentration and longer photocuring time results in higher conversion of 
methacrylate groups (Figure 5.2 and 5.3). After 180s UV exposure with 0.5 % (w/w) 
photoinitiator, the peaks at 950 cm-1 almost disappeared. This result also guided to 
optimize the condition in fabricating samples. In the following fabrication, in order to 
make higher conversion rate of methacrylate groups, 0.5% (w/w) photoinitiator and at 
least 180 s photocuring time were applied. 
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Figure 5.2: The effect of concentration of photoinitiator determined by FTIR 
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Figure 5.3: The effect of curing time determined by FTIR 
 
5.3.3 Morphology of 3-D porous scaffolds 
During fabrication, salt crystals with size ranging from 300 to 325 um were used 
as porogen. SEM pictures (Figure 5.4) showed that the pore size is a little bit smaller than 
porogen size, which means that the scaffolds slightly thrink after salts were washed off. 
This might be due to the crosslinking of chitosan chain and elimination of solvent 
DMSO. 
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Figure 5.4: SEM of 3-D porous scaffold made from light curable chitosan C (A) X150 
(B) X300 
 
5.3.4 Swelling ratio test 
Although hydrophobic groups, benzoic groups and methacrylate groups, were 
bound to the backbone of chitosan, modified chitosans still remained swelling ability, 
which might be due to the hydrophilicity of chitosans chain. These photocured chitosans 
films can absorb more than two times their tried-weight water (Figure 5.5). It is very 
interesting to note that C has higher swelling ratio compared to A and B, even though C 
has higher degree of graft (or more hydrophobic groups). The reason might be due to the 
larger spaces among the modified chitosan chains resulted from the higher degree of 
graft. In addition, higher benzoic groups content and lower methacrylate groups content 
made B has the lowest swelling ratio. The swelling ratio of 3-D porous scaffolds was also 
evaluated. These 3-D scaffolds can absorb more than 6 times their dried-weight water. 
 134
swelling ratio
0
1
2
3
4
5
6
7
8
A B C
membrane porous scaffold
 
Figure 5.5: Swelling ratio of light cured chitosans 
 
5.3.5 Rheology study of light cured chitosans 
Since the light cured chitosans absorb water, it possesses some properties of 
hydrogel. Rheological study with frequency sweep was carried out to measure the 
viscoelasticity of light cured chitosans using PEG-DA as a control (Figure 5.6). From the 
result, light cured chitosans were much stronger than light cured PEG. The storage 
modulus of light cured chitosans were almost 1 MPa, however, light cured PEG was 
around 100 times weaker. In addition, the light cured chitosans have much higher loss 
modulus (0.1-0.8 MPa) compared to light cured PEG (less than 1000 Pa). As for different 
light cured chitosans, C is strongest (greatest G’ and G”) and B is stiffer than A. The 
degree of graft and crosslinking obviously are the determinants for the strength. Higher 
degree of benzoic graft and higher crosslinking density leads to higher strength. And the 
effect factor of benzoic graft is mush greater than crosslinking (B>A), since the benzoic 
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groups has more stable chemical structure than methacrylate groups, at the same time, 
benzoic groups provide higher force resistance which results in higher loss modulus. 
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Figure 5.6: Rheology study of light cured chitosans (Frequency sweep) 
 
5.3.6 Cytocompatibility and cell attachment onto different light cured chitosans 
In this in vitro test, photocured chitosan was co-cultured with fetal bovine 
osteoblasts to determine whether photocured chitosans release toxic particles which 
influence cell growth. Alamar blue was used to test cytocompatibility of photocured 
chitosans. Specifically, alamar blue incorporates an oxidation-reduction (REDOX) 
indicator that both fluoresces and changes color in response to chemical reduction of 
growth medium resulting from cell growth. The percent difference in reduction between 
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treated and control cells (cells grow in 6-well culture plate without photocured chitosan 
films) was calculated and plotted in Figure 5.7.  
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Figure 5.7: Cytocompatibility of light cured chitosans 
From the plot, it can be seen that photocured chitosans showed no toxicity during 
the 7-day culture period, because there is no marked difference among cells cultured with 
and without photocured films. This test indicated that photocured chitosans are highly 
cytocompatible. The fetal bovine osteoblasts were also cultured on the photocured films 
to examine cell behavior on the surface. It is very interesting to note that osteoblasts 
cultured on the surface of cured A and B had a narrow shape and did not spread on the 
surface (Figure 5.8). In addition, the number of osteoblasts is much less than that on C 
and control. However, Osteoblasts spread and grew very well on the surface of cured C 
compared to A and B. 
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Figure 5.8: Morphology study of osteoblasts cultured onto the surface of light cured 
chitosans (Bars are 300 µm) (A) made from light curable chitosan A; (B) made from light 
curable chitosan B; (C) made from light curable chitosan C; (D) PCL 42,500 
 
5.3.7 In vitro 3-D cells culture 
Upon the result from 7-day osteoblasts culture on the surface of light cured 
chitosan films, light curable chitosan, C, was screened for further study. In order to 
further certify the biocompatibility of light cured C and the cell seeding process for 
further in vivo osteoconductive test, fetal bovine osteoblasts were seeded in the 3-D 
porous scaffolds made from C and cultured in vitro for 48 hrs.  The confocal picture is a 
merged view of 14 layers on the 3-D scaffold of 150 μm in thickness. Figure 5.9 showed 
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that osteoblasts grew very well in the 3-D porous scaffolds during 2 days culture. At the 
same time, pores can clearly observed in Figure 5.9 and osteoblasts attached on the wall 
of pores. However, pores were not shown everywhere in Figure 5.9-A, because the pores 
in the scaffold are not in the same level. Some pores have a parallel wall with lens in this 
150 um scanning range and cells attached on these walls of pores were shown in the 
picture with larger spreading area. The results further confirmed that the light cured 
chitosan, C, is highly biocompatible and osteoblasts spread and grew very well in this 
porous scaffold. In addition, since one concern of the seeding process is whether cells can 
be seeded into 3-D scaffolds and stay inside the scaffolds when the suspension was only 
dropped on the top of the scaffolds, this result proved that the cell seeding process is 
suitable for in vivo osteoconductivity test. 
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Figure 5.9: Confocal pictures of in vitro cultured osteoblasts in porous scaffold (Bars are 
100 µm). (B) and (C) are the magnified pictures of the frames in (A) 
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5.3.8 In vivo osteoconductivity test 
The osteoconductivity of chitosan has been confirmed by many studies. Survival 
of osteoconducitivity of chitosan from chemical modification and UV crosslinking is a 
goal in this study. So ectopic bone formation evaluation on rats’ back were taken. The 
implants were harvested 4 weeks post-surgery. And X-ray was applied on these explants. 
From X-ray pictures, many white dots appeared in the light cured chitosan scaffolds were 
observed (Figure 5.10), indicating that the mineralization has already been taken place 
during 4 weeks implantation. 
 
 
Figure 5.10: X-ray picture of the explants after 4 weeks implantation (the first row are 
light cured chitosans and second row are PCL control) 
 
However, there is no mineralization observed in the negative controls, PCL 
porous scaffolds. Histological study further certified that bone formation was occurring in 
the chitosan porous scaffolds (Figure 5.11). In some pores of light cured chitosan, 
cartilaginous cells were observed, and the ECM of these cells is connected with new 
formed bone matrix, which indicated that the new bone might formed from endochondral 
ossification (Figure 5.11-D). 
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Figure 5.11: H&E staining of 4-weeks explants (A) PCL, X10; (B) PCL, X20 of frame in 
(A); (C) light curable chitosan C, X10; (D) light curable chitosan C, X20 of frame in (C) 
[‘*’ in (C) represent the new bone matrix] 
 
5.4 Discussion 
Chitosan is a partially de-acetylated derivative of chitin, the second most 
abundant natural polymer found in shells of marine crustaceans and cell walls of fungi 2-4. 
It is a linear polysaccharide composed of α-(1→4)-linked 2-amino-2-deoxy-β-D-
glucopyranose with hydroxyl and amino side groups. Due to its chemical structure, 
chitosan shows high biocompatibility leading to its being extensively applied in 
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biomedical areas, for such uses as surgical sutures, dental implants, artificial skin, etc 5. 
In recent research, chitosan has been widely used as a scaffolding material for tissue 
engineering 1, 6-12.  Many studies indicate that chitosan is very suitable for orthopaedic 
applications 4, 13-17. Specifically, in bone tissue engineering, chitosan has also been proven 
to facilitate osteoblasts growth and mineral rich matrix deposition by osteoblasts in 
culture 16.   Chitosan’s amino side groups endow it with a cationic environment that 
makes it electrostatically interact with anionic molecules, such as glycosaminoglycans 
(GAGs), proteoglycans and other negatively charged molecules. Since a large number of 
cytokines/ growth factors could be linked to GAGs, the interaction between chitosan and 
GAGs may retain and concentrate both the endogenous peptides secreted by colonizing 
cells, as well as the exogenous peptides loaded inside the scaffold. 18. This might be one 
reason that chitosan shows favorable results in cartilage tissue engineering. Another 
reason maybe due to its structural similarity to various GAGs 19.  
However, chitosan has poor solubility because of the intramolecular or 
intermolecular hydrogen bond formed between amino and acyl groups, which makes it 
soluble only in aqueous acid solution with pH value up to 6.3 and some specific solvent, 
such as DMAC-LiCl, thus greatly limiting its application. Although various efforts have 
been made to prepare functional chitosan derivatives via chemical modification, few 
increased the solubility of chitosan in organic solvents 20-24. In our previous study, we 
developed a series of light curable chitosans 1. Those chitosans have good solubility, light 
curability and also possess osteoconductivity. However, those light cured chitosans have 
weak mechanical properties. Once dried, they become fragile. The synthesis process is a 
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main reason in decreasing mechanical strength. In the synthesis, methanesulfonic acid 
was used as solvent. It is a strong acid and would cleave the polysaccharide chain and 
decrease the mechanical strength of final products. So the reaction time is undoubtedly an 
important factor influencing the properties of final products. In this study, we reduced the 
dissolving time to 25 minutes (1-2 hrs before) and reaction time to 30 minutes (15 hours 
before). At the same time, we also decreased the feeding amount of acyl chlorides. The 
purpose of this synthesis is just to introduce benzoic and methacrylate groups to improve 
solubility and incorporate light curability. So partial graft should be enough for the 
application. We even tried lower feeding amount of acyl chloride in the synthesis than 
those listed in Table 5-1 (data not shown), however, the products hardly precipitated from 
the ammonium hydroxide aqueous solution. The results showed that the modified 
synthesis process is successful. From the rheological study, we found the cured chitosans 
showed much stronger mechanical properties. And these films can also be bended for 
several times without being broken (Figure 5.12).  
 
A B
 
Figure 5.12: Bending of light curable chitosan film (A) without bending; (B) after 
bending 
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In cytocompatibility test, all of these three light cured chitosans showed good 
cytocompatibility. However, in cell morphological study, it is very interesting to note that 
osteoblasts have different spreading and proliferation on the surface of these three light 
cured chitosans. Osteoblasts grew very well on the surface of light cured chitosan with 
comparatively higher graft degree (photocurable chitosan C) and had poor spreading on 
those with lower graft degree (A and B). The reason is not clear. The structure of light 
cured chitosans and the surface tension from different graft degree might be an 
explanation.  
The main purpose of this study is to develop a functional scaffold material for 
bone tissue engineering. From the bone tissue engineering point of view, a good 
scaffolding material should have osteocompatibility and osteoconductivity. For example, 
it can induce bone repair in the wound that cannot heal if left untreated and facilitate the 
cells growth in the scaffold to form bone. And it will be perfect if the materials have 
osteoinductivity 25. To some extent, these bioactivities are determined by the chemical 
structure or components. Many research works proved that either raw chitosan or many 
chitosan derivatives are osteoconductive or even osteoinductive. For instance, Borah et 
al. 26 found that N-acetyl-chitosan induced calcification better than the control. And many 
other chitosan derivatives have been verified to have good osteoconductivity, such as N-
carboxylbutyl-chitosan 27, imidazole-chitosan 27, and 6-oxylchitin 27. In addition, 
Osteoinductivity was also observed with a chitosan coated hydroxyapatite nail 27. 
Inspired by these results, we developed chemically modified chitosan derivatives and 
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confirmed that the integrated functional groups (benzoic and methacrylate group) didn’t 
change the osteoconductivity.  
In addition, since the photocurable chitosan can be dissolved into organic solvent, 
and upon UV light exposure, they can undergo macroscopic phase change (from liquid to 
solid phase) and microscopic phase change (crosslink to form network), the photocurable 
chitosan can be easily fabricated into scaffold with desired shape (films, 3-D discs, 
porous scaffolds, etc.) and topography (different pore shape, pore size, etc.).  In this 
study, we used salt leaching coupled with photocuring to fabricate porous discs with 
desired pore size. For bone tissue engineering, the pore size of the scaffold is a major 
factor affecting the regeneration of bone. Small pore size prevents cells from penetrating 
into the scaffold. However, pores with too big size cannot effectively host cells. The 
optimal pore size of scaffolds for bone tissue engineering is around 100-300 μm. The salt 
crystals we used range in size from 300-325 um.  From the SEM images, it can be seen 
that after salt leaching, the pores in the discs have the desired pore size and they are 
interconnected. The 4-week osteoconductivity test in which we implanted cell-seeded 
photocured modified chitosan discs into the backs of athymic mice indicated the 
photocured chitosans made from C had very good osteoconductivity. However, the 
negative control, PCL porous scaffolds, contains many fibroblasts and no bone formation 
was observed.  This further verified that photocurable chitosans are osteoconductive and 
suitable for use as scaffolding materials for bone tissue engineering Since the 
photocurable chitosans have the potential to be fabricated into desired shapes, fabricating 
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larger scaffolds with irregular shapes and pore topography through stereolithography is 
the future target.  
 
5.5 Conclusions 
Three light curable chitosans were synthesized with the modified synthesis 
method used in previous study. The structures of these photocurable chitosans were 
confirmed by FTIR and 1HNMR measurement. Physical properties of the photocured 
chitosans, such as swelling ratio and rheological properties were studied. Although 
hydrophobic groups were introduced onto the chitosan backbone, photocured chitosans 
can still absorbed at lease two times their dry weight water. Rheological study indicated 
that the cured chitosan had strong mechanical properties compared to photocured PEG-
DA. These three light cured chitosans showed very good cytocompatibility, however, 
morphology study indicated that osteoblasts only grew very well on the surface of cured 
chitosan with higher graft degree. This light curable chitosan was further fabricated into 
3-D porous scaffolds for in vitro 3-D culture and in vivo osteoconductivity study. The 
results showed that this light curable chitosan had very good osteoconductivity and 
ectopic bone formation in the cured chitosan was observed. This light curable chitosan 
has great potential in fabricating into scaffolds with desired shape, pore size and 
topography, thus becoming more suitable as scaffolding materials for bone tissue 
engineering. 
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CHAPTER SIX 
 
STUDY ON THE OSTEOCONDUCTIVITY OF PHOTOCURABLE CHITOSAN AND 
ITS DEVELOPMENT TO AN OSTEOINDUCTIVE BONE GRAFT 
 
 
6.1 Introduction 
As we have shown, bone grafts are needed in many clinic cases 1-4. Development 
of ideal bone grafts is obviously urgent. An ideal bone grafts should possess 
osteoconductivity, and even osteoinductivity 4. The bone grafts with osteoconductivity 
can allow cells penetration and provide osteoblasts a matrix to attach, grow, proliferate 
and differentiate to osteocytes. These osteocytes then produce bone matrix in the 
scaffold. While, the bone grafts with osteoinductivity can induce the migration of stem 
cells into the scaffold and transform them to osteoblasts, thus resulting in the bone 
regeneration. 
In our previous studies, we synthesized a series of photocurable chitosans 5. The 
photocured porous scaffolds were proved highly osteoconductive from the ectopic bone 
formation model. Histological study showed that newly formed bone matrix existed in 
the scaffold after 4 weeks implantation. However, histological study is based on the 
dissected slices of the sample, which can only visualize the partial detail on bone 
formation. Micro-CT uses x-rays to create cross-sections of a 3D-object that later can be 
used to reconstruct a virtual structure without destroying the original scaffold. And the 
resolution of the micro-CT can reach microns on the scale 6. Therefore, use of micro-CT 
help to visualize the 3-D pattern of newly formed bone in the scaffold. In this chapter, we 
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further studied the 8 weeks scaffolds and compared them with 4 weeks scaffolds by 
histological study and micro-CT. 
The other goal of this chapter is to develop osteoinductive bone grafts based on 
this photocurable chitosan. When applied in clinic, the osteoconductivity alone is 
obviously not enough for an ideal bone graft due to the lack of available cell source. 
There are already many studies focusing on the development of osteoinductive bone 
grafts 7, 8. Basically, most of these systems are based on release of growth factors, such as 
TGF-β 9, 10, BMP-2 11-13 and BMP-7 14, 15. This localized release of bioactive growth 
factors avoids high doze systemic administration, thus increasing the efficiency and 
lowering down the cost. And BMP-2 is a widely studied growth factor because of its 
important roles in the process of bone growth and repair 16-18. In order to design a carrier 
of BMP-2, the stability of BMP-2 and the interaction between BMP-2 and the scaffolds 
should be first concerned. BMP-2 actually is easy to degrade by the enzymes or 
inactivate by binding to other nonspecific bindings than the BMP-2 receptors on the cell 
membrane 19. So the manner of BMP-2 loading is crucial. Some researchers entrapped 
BMP-2 into PLGA microspheres or macrospheres using normally used oil/water 
emulsification process 13. BMP-2 was dissolved into organic solvent before loading into 
micospheres, which may result in inactivation of BMP-2. Chen et al. also entrapped 
BMP-2 into the dextran-derived microspheres 20, 21. These methods just physically 
entrapped BMP-2 into polymer matrix, either solid or hydrogel. And the release of these 
entrapped BMP-2 is depended on diffusion and the degradation of the microspheres or 
macrospheres. Some other researchers covalently bound BMP-2 onto surface of the 
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scaffolds 22. Although chemical binding can immobilize BMP-2 on the scaffolds, it may 
also change the conformation of BMP-2, thus inactivating it. And the bioactivity of 
BMP-2 is sensitive to the chemical reaction and subsequent washing process. BMP-2 was 
also loaded into collagen 23-25, gelatin sponges 26-29 and demineralized bone matrix 
(DBM) 30, 31. The interaction between BMP-2 and these sponges is mainly the 
electrostatic interaction, which is kind of weak interaction, and hardly facilitates the 
storage of BMP-2 in the matrix. One alternative method is to build up a bridge between 
scaffold and BMP-2. This spacer should not only covalently or non-covalently bind to the 
scaffolds, but form specific binding with BMP-2 without changing its conformation. So 
BMP-2 can be kept in the scaffold and its bioactivity can be almost retained. Heparin 
could be a very good option, since it can form specific binding with BMP-2 32. And its 
carboxyl groups provide chemically reactive site for grafting on scaffold surface. In this 
chapter, we covalently bound heparin to photocured chitosan to develop an 
osteoinductive bone grafts. This covalently binding can be constructed by reaction 
between amine groups on chitosan and carboxyl groups on heparin using EDC/NHS as 
catalysts. The binding with BMP-2 was confirmed by in vitro release and at the same 
time, the osteoinductivity was proved through the in vivo ectopic bone formation. 
 
6.2 Materials and methods 
6.2.1 Materials 
Chitosan with high molecular weight and 85% deacetylation, dimethyl sulfoxide 
(DMSO) and MES buffer with low moisture content were obtain from Sigma-Aldrich 
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Inc. (St. Louis, MO, USA). Methane sulfonic acid and heparin sodium was purchased 
from Acros Organics (Geel, Belgium). Benzoyl chloride, methacryloyl chloride and 
gelatin with 100 bloom were obtained from Fisher Scientific, Inc. Ammonium hydroxide 
water solution (5N) and 1-ethyl-3-(3-dimethylaminopropyl) carbodiimide hydrochloride 
(EDC) was purchased from VWR, Inc. N-hydroxysuccinimide (NHS) was obtained from 
Pierce Inc. And rhBMP-2 was purchased from PeproTech, Inc. Iragure 2959 was 
obtained from Ciba Specialty Chemicals. 
 
6.2.2 Synthesis of light curable chitosans 
In this study, we modified the synthesis method used in Chapter 4. Briefly, 1 g 
chitosan was dissolved into 15 ml methanesulfonic acid with stirring for 25 minutes, 
followed by adding dropwise a mixture of 1.1 g benzoyl chloride and 1.227 g 
methacryloyl chloride under stirring. Then, the solution was kept at room temperature 
with stirring for another 30 minutes. After that, the solution was dropped into ammonium 
hydroxide aqueous solution (100 ml 5N ammonium hydroxide solution + 600 ml DI 
water) to precipitate the light curable chitosans. This precipitate was filtered and washed 
with DI water 10 times to clean the remained reagents and solvent. Finally, the product 
was dried in vacuum over P2O5 for two days. FTIR (Nicolet Impact 410 FTIR 
spectrometer, Inspiratech 2000 Ltd., UK) was taken to qualitatively measure the chemical 
structure of the product by proving the existence of benzoic and methacrylate groups. 1H 
NMR (Varian UNITYINOVA- 400 (9.4 T), operating at 400MHz proton, d-DMSO as 
solvent) was also measured to confirm the chemical structure of the resulting light 
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curable chitosans: δ 0.95-1.2 (0.45H, -OC-CH3), 1.5-2 (2.79H, -CH3), 3-5.2 (7H, -CH- 
and –CH2- from pyranose ring), 5.5-6.2 (1.86H, =CH2), 7.2-8.2 (2H, -CH- in benzene 
ring). 
 
6.2.3 Fabrication of porous disc scaffolds 
Photocurable chitosan was dissolved into DMSO to form a 20% (w/w) solution. 
And then 0.5% (w/w) Iragure2959 was added into the solution. Salt crystals with a size 
ranging from 300-325 μm were filled into a hight-adjustable mold of 8 mm in diameter 
and 2 mm in height. The chitosan solution was then dropped onto the top, and the 
solution penetrated to the bottom very fast, filling the inter-space between salt crystals. 
After exposed upon UV for 5 minutes, the disc was immersed into DI water to wash off 
the solvent and leach out the salts. The porous scaffolds were further freeze-dried and 
SEM was taken for morphology study. 
 
6.2.4 Covalently binding of heprin onto photocured chitosan surface 
Heparin immobilization were performed using a method as described by others 33, 
34. Carboxyl groups of heparin were first activated in EDC/NHS solution. Briefly, 1 mg 
heparin was dissolved into 1mg EDC per 0.6 mg of NHS in 500 μL of 0.05 M 2-
morpholinoethanesulfonic acid (MES) buffer (pH 5.6) for 10 min at 37 oC. Then the blot 
dried porous discs were immersed into the reagent solution, and the solution was 
evacuated to remove air from the discs. After every hour reaction at 37 oC, the discs were 
taken out, blot dried and re-immersed into flesh activated heparin/EDC/NHS solution. 
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After 4 hours, the heparinized discs were washed with 0.1 M Na2HPO4 (pH 9.2) (2h), 4M 
NaCl (four times in 24 h) and deionized water (five times in 24 h). And then these 
heparinized discs were kept into DI water for further use.  
The amount of heparin immobilized on the photocured chitosan scaffold was 
determined using the toluidine blue method 35. Toluidine blue (2 mg) was dissolved into 
6 ml hydrochloric acid (0.01 N) containing NaCl (0.2 wt%). Then the heprinized 
scaffolds were immersed into toluidin blue solution (6 ml) overnight with gently shaking. 
After removing the photocured chitosan scaffolds and toluidine blue complexes from 
solution, the remained toluidine blue was determined by absorption at 631 nm with an 
UV spectrometer. The amount of the immobilized heparin was calculated from the 
difference of the initial and final concentration of toluidin blue. The scaffolds stained 
with toluidine blue were washed with DI water, cut into half and taken photos. 
 
6.2.5 In vitro degradation test 
Porous discs were freeze-dried and further dried under vacuum over P2O5 for 2 
days. The degradation solution is 1 X PBS containing 0.5 mg/ml NaN3 and 2 mg/ml 
lysozyme. Before immersing into degradation solution, the weight of these porous 
scaffolds was recorded. And then each porous disc was immersed into 1 ml degradation 
solution and incubated at 37 oC. Every other day, the degradation solution was removed 
and replaced with fresh degradation solution. And at each time points, day 7, 14, 21, and 
28, the discs were washed with DI water for 7 times, freeze-dried, further dried over P2O5 
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and weighted again. The degradation degree of the discs was calculated according to the 
following equation: 
Degradation Degree (%) = (Weight initial – Weight time point)/ Weight initial * 100% 
 
6.2.6 In vitro release of BMP-2 from heprinized photocured chitosan 
Heprinized photocured chitosan discs were sterilized by immersing into 75% 
ethanol solution for 1 hour. Then the discs were washed with DI water for 7 times to 
eliminate the ethanol. Before loading with BMP-2, the sterilized discs were blot dried. 5 
μg human recombinant BMP-2 in 30 μl sterilized DI water was then added into the 
porous discs. These BMP-2 loaded scaffolds were placed at 4 oC overnight. The discs 
were then immersed into 1 ml 1 X PBS with 0.05% BSA and incubated at 37 oC. At each 
time point, Elisa assay was taken to measure the amount of BMP-2 in the solution and the 
old solution was replaced by flesh solution for further measurement. 
 
6.2.7 In vivo Ectopic bone formation model 
For the osteoconductive scaffolds, the porous scaffolds were implanted with 
primary fetal bovine osteoblasts. Porous PCL (MW=42,500) scaffolds were used as 
negative controls. Primary fetal bovine osteoblasts were propagated in monolayer culture 
until confluence. The harvested cells were then loaded onto porous disc scaffolds at a 
concentration of at least 80,000 cells/scaffold. While for the osteoinductive scaffolds 
containing BMP-2, the scaffolds were implanted without osteoblasts. And the heparinized 
chitosan scaffolds without BMP-2 were used as negative control. Under general 
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anesthesia and sterile conditions, the porous discs were subcutaneously implanted into the 
backs of 4-6 weeks old male, athymic (nu/nu) mice. Six mice were used for each sample 
type. After 4 and 8 weeks, the mice were sacrificed and the implants were harvested and 
immersed in 10% formaldehyde. The explants were then processed for paraffin histology 
and stained with H&E. 
 
6.2.8 Micro-CT scanning 
During scanning, the binning was set at 2 and the scanning was done with high 
magnification (18.3-20 micro meter). During scanning, every 3 slices of images average 
into single slice. The delay by which the detector camera moves to acquire another x-ray 
projection was set on 10 ms, and the time by which the detector camera exposed to the x-
ray projection and the time by which the x-ray tube scan the sample was set at 6000 ms. 
 
6.3 Results  
6.3.1 Characterizations of photocurable chitosans 
The photocurable chitosan has been characterized in our previous chapter. The 
FTIR and 1H-NMR were showed in Figure 6.1 and 6.2. The characteristic peaks in FTIR 
qualitatively indicated the existence of benzoyl groups (950 cm-1) and methacrylate 
groups (710 cm-1). And from 1H-NMR, the chemical structure of the photocurable 
chitosan, such as the degree of deacetylation, degree of benzoyl substitution and degree 
of methacrylate substitution, can be determined by integration of the peaks with different 
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chemical shift. As shown in the previous chapter, the degree of deacetylation is 0.85, and 
the degree of benzoyl and methacrylate substitution are 0.40 and 0.93, respectively. 
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Figure 6.1: FTIR of photocurable chitosan 
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Figure 2: 1H-NMR of photocurable chitosan 
 
6.3.2 Fabrication of porous discs 
According to our previous photocuring test, most of the graft methacrylate groups 
can crosslink in 3 minutes when exposed to UV light with the intensity of 10 W/cm2. In 
the fabrication of porous discs, the photocurable chitosan solution was exposed under UV 
for 5 minutes, because of the increased thickness (2 mm). After photocrosslinking, the 
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solidified discs were immersed into DI water to leach out the salts, which took about 15 
minutes with gently stirring. This indicated that the fabricated discs were interconnected 
because the salt inside the discs can leach out from the pore channels. The SEM pictures 
(Figure 6.3 A and B) showed the morphology of the freeze-dried porous discs, which 
further confirmed that the pores are interconnected. And the pore size is similar with the 
size of salt crystals. 
 
6.3.3 Immobilization of heparin onto porous discs 
Figure 6.4 showed the scheme of immobilization of heparin on the photocured 
chitosan and the incorporation of BMP-2 into the heparinized porous discs. The heparin 
immobilization is obtained by the chemical reaction between carboxyl groups on heparin  
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Figure 6.3: SEM of porous scaffolds (A) non-heparinized scaffold, X150, (B)non-
heparinized scaffold, X300, (C) heparinized scaffold, X150, (D) heparinized scaffold, 
X300 
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Figure 6.4: The scheme of heparinization of photocured chitosan and the incorporation 
of BMP-2. (A) photocured chitosan scaffold, (B) heparinized scaffold, (C) BMP-2 loaded 
heparinized scaffold 
 
and amine groups on chitosan. In order to increase the efficiency of immobilization in 
aqueous solution, the catalyst system, EDC/NHS in MES buffer solution (pH=5.6), was 
used and the carboxyl groups of heparin was activated in this EDC/NHS solution at 37 oC 
for 10 minutes before immobilized on the chitosan discs. SEM was used to study the 
morphology of heparinized discs (Figure 6.3C and D). Compared to the discs without 
heparin modification, there is almost no difference resulting from heparinization. And it 
is also hard to observe the incorporated heparin from the surface of the scaffold. The 
amount of immobilized heparin and its distribution can be determined by the toluidine 
blue staining. Toluidine blue can be dissolved into aqueous solution and this solution has 
a characteristic absorption at 631 nm. It can also form a complex with heparin, which is 
insoluble in water solution. Taking advantage of this, the heparinized chitosan scaffolds 
can be stained with toluidine blue. And the amount of the immobilized heparin can be 
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determined by the difference in the concentration of toluidine blue between before and 
after forming toluidine blue-heparin complex. According to the measurement, the 
immobilized heparin is 675 ± 57 μg/scaffold. At the same time, the distribution of 
heparin on the chitosan scaffold can be observed from the microscopy (Figure 6.5). From 
the pictures, we found that the heparinized scaffolds were stained homogeneously in the 
whole disc, because both inner and surface appear dark.  
 
6.3.4 In vitro degradation test 
From the 4-weeks degradation test, there was no big difference in degree of 
degradation between chitosan and surface-heparinized chitosan. And both of them 
degraded more than 20% of original weight (Figure 6.6). But heparinized chitosan porous  
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Figure6.5: Photos of heparinized scaffold before and after toluidine blue staining. (A) 
before staining, top view, (B) before staining, cross section, (C) after staining, top view, 
(D) after staining, cross section. (Bar = 2mm) 
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Figure 6.6: Degradation profile of non-heparinized and heparinized photocured chitosan 
 
disc has slightly slower degradation rate than non-heparinized chitosan. This may be due 
to the partial concealment of the surface by immobilized heparin. 
 
6.3.5 In vitro release of BMP-2 from heparinized photocured chitosans 
The release of BMP-2 can be influenced by not only the interaction between 
BMP-2 and covalently immobilized haprin, but the degradation of the scaffolds. In this in 
vitro model, due to the low degradation rate of the photocured chitosan in non-enzyme 
environment, the release rate of BMP-2 from the scaffolds are mainly caused by the 
diffusion. During the 4-weeks period, only around 1% of the loaded BMP-2 released out 
of the heparinized chitosan (Figure 6.7). This indicated that loaded BMP-2 has high 
affinity with heparin, which facilitates BMP-2 to store in the scaffold longer.  
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Figure 6.7: In vitro release profile of BMP-2 from heparinized photocured chitosan 
 
6.3.6 Micro-CT scanning 
The patterns of bone growth in the scaffolds were scanned by micro-CT and 
reconstructed (Figure 6.8 and 6.9). The pictures showed the cross sections in three 
different dimensions (Figure 6.8-A, C and Figure 6.9-A, C) and the 3-D pictures of the 
scaffolds (Figure 6.8-B, D and Figure 6.9-B, D). Figure 6.8 showed the discs implanted 
with bovine osteoblasts for 4 weeks (A and B) and 8 weeks (C and D). While, Figure 6.9 
showed the discs incorporated with BMP-2 after 4-week implantation (A and B) and 8-
week implantation (C and D). More bone growth was observed in the scaffold after 8 
weeks implantation than that after 4 weeks, both in the osteoconductive and 
osteoinductive scaffolds. And there is much more bone matrix in the osteoconductive 
scaffolds than osteoinductive scaffolds, because the osteoinductive scaffolds need more 
time to release BMP-2 to surrounding area and it takes longer for stem cells migration, 
differentiation and bone matrix formation. And by comparing the pattern of the newly 
formed bone matrix in the scaffold, it is very interesting to note that the bone matrix in 
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osteoinductive scaffolds is mainly formed on the edge, rather than inner space. 
Conversely, the bone matrix in osteoconductive scaffolds evenly distributed in the inner 
space of the scaffold rather than the edge. 
 
6.3.7 Histological study of the explants of 4 weeks and 8 weeks implantation 
The chitosan in both non-heparinized and heparinized scaffolds was stained in red 
(Figure 6.10, 6.11 and 6.12). For the osteoconductive photocured chitosan scaffolds, 
newly formed bone matrix was found in the pores (Figure 6.10C, D and 6.11C, D). And 
some of them were surrounded by fibrinous tissue. However, only fibrinous tissue was 
observed in the negative control, porous PCL scaffolds (Figure 6.10A, B and 6.11A, B). 
C
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Figure 6.8: Micro-CT pictures of bone growth in non-heparinized chitosan after 4 and 8 
weeks implantation (A) cross section in three dimensions, 4 weeks, (B) 3-D pictures, 4 
weeks, (C) cross section in three dimensions, 8 weeks, (D) 3-D pictures, 8 weeks (Bar =2 
mm) 
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This indicated the implanted bovine osteoblasts kept their phenotype in photocured 
chitosan scaffolds and finally produced bone matrix, while in the PCL scaffolds, they 
changed their phenotype or died due to the migration of the native fibroblasts. In the 
heparinized chitosan group, no bone formation except fibroblast and some fragments of 
red blood cells were observed in the negative control after both 4-week and 8-week 
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Figure 6.9: Micro-CT pictures of bone growth in heparinized chitosan loaded with BMP-
2 after 4 and 8 weeks implantation. (A) cross section in three dimensions, 4 weeks, (B) 3-
D pictures, 4 weeks, (C) cross section in three dimensions, 8 weeks, (D) 3-D pictures, 8 
weeks (Bar = 2mm) 
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Figure 6.10: Histological study (H&E staining) on the non-heparinized photocured 
chitosan implanted for 4 weeks. (A) negative control (PCL 42,500), X10 (B) negative 
control (PCL 42,500), X20, (C) photocured chitosan, X10 (D) photocured chitosan, X20. 
(Bar = 100 μm) 
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Figure 6.11: Histological study (H&E staining) on the non-heparinized photocured 
chitosan implanted for 8 weeks. (A) negative control (PCL 42,500), X10 (B) negative 
control (PCL 42,500), X20, (C) photocured chitosan, X10 (D) photocured chitosan, X20. 
(Bar = 100 μm) 
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Figure 6.12: Histological study (H&E staining) on heparinized photocured chitosan with 
BMP-2 implanted for 4 and 8weeks. (A) negative control (without BMP-2), 4 weeks, 
X10 (B) negative control (without BMP-2), 8 weeks, X10, (C) heparinized chitosan with 
BMP-2, 4 weeks, X10 (D) heparinized chitosan with BMP-2, 4 weeks, X20, (E) 
heparinized chitosan with BMP-2, 8 weeks, X10 (F) heparinized chitosan with BMP-2, 8 
weeks, X20. (Bar = 100 μm) 
 
implantation (Figure 6.12 A and B). There is only small volume of bone matrix found in 
the BMP-2 loaded scaffold after 4 weeks implantation (Figure 6.12C and D). While a lot 
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of newly formed bone matrixes were found on the edge of the osteoinductive scaffold and 
in some pores close to the edge (Figure 6.12E and F). 
 
6.4 Discussions 
As we have discussed in previous chapters, chitosan is a very promising material 
that shows great potential in orthopaedic applications 36-38. This is not only distributed to 
its excellent biocompatibility, biodegradability and non-toxicity, but also to its similar 
polysaccharide structure as hyaluronic acid, the most abundant polysaccharide in the 
extracellur matrix (ECM). Thus the degraded products from chitosan can be used by 
migrated cells for the regeneration process 36. At the same time, chitosan was proved 
highly osteoconductive. All of these advantages of chitosan make it become the base 
material for further functional modification and scaffold fabrications in our study. 
In our study, we synthesized photocurable chitosan that is more flexible in 
fabricating scaffolds with desired shapes and the scaffold made from the photocurable 
chitosan is osteoconductive. However, photocured chitosan alone does not show 
osteoinductivity (data was not shown). Functional modification of photocured chitosan 
into osteoinductive scaffold is the main goal in this chapter. The currently used 
osteoconductive systems are mainly based on the sustained release of growth factors, 
such as BMP-2, BMP-7 and TGF-β1, among which, BMP-2 is the most widely used and 
efficient growth factor for bone repair. And most of the studies in this area focused on 
how to build up a connection between the BMP-2 and scaffolds, such as the physical 
entrapment, covalently binding and electrostatic interactions. Recently, some researchers 
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found that there is a heparin-binding motif existing in the BMP-2 molecule 32. And this 
motif may help BMP-2 bind to the ECM, thus retaining them in the matrix without being 
deactivated. Then, Takada et al. used heparin with BMP-2 as a complex to study the 
effect of this complex on the osteoblasts behavior in vitro 19. They found that after 
forming a complex with heparin, BMP-2 has longer half-life time and can remain its 
bioactivity longer. This can be due to the increased bio-stability and decreased possibility 
in binding to heparin-like and non-specific receptors on the cell membrane other than the 
specific BMP-2 receptors. This complex was also added into collagen porous matrix, 
followed by implanting on the rats’ back 39. The results confirmed the effect of heparin 
on induced bone matrix formation in the scaffolds. Most recently, heparin was covalently 
bound to the surface of some scaffolds, including PLGA40 and demineralized bone matrix 
41. It was further confirmed that these two heparinized scaffolds loaded with BMP-2 can 
induced ectopic bone growth. Both studies were based on the same hypothesis: the 
covalently bound heparin can realize the sustained release of BMP-2 from the scaffolds. 
In our study, we also covalently bound heparin on the photocured chitosan surface, 
followed by addition of BMP-2, to fabricate an osteoinductive scaffold (Figure 6.4). And 
because of the intrinsic amine groups on chitosan chain, the covalently binding is easily 
to obtain by the reaction between the carboxyl groups in heparin and the amine groups on 
chitosan using EDC/NHS as catalysts. 
In order to obtain homogeneous modification in the whole scaffold, EDC/NHS/heparin 
solution was added in multi-steps. Each time point, the scaffold was blot dried followed 
by adding flesh solution in. The reason is that the active carboxyl groups on heparin are 
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easily deactivated in aqueous solution 42. Without the multi-steps, the heparin molecules 
are mainly immobilized on the surface of the scaffold (data not shown), since the 
deactivated heparin molecules hardly diffused out of the scaffolds and activated heparin 
molecules cannot penetrate into the scaffolds. This homogeneous immobilization of 
heparin resulting from the multi-steps modification obviously decreased the release rate 
of incorporated BMP-2 because of the high affinity from the scaffold. As shown in the in 
vitro release test, only around 1% of original BMP-2 released out of the scaffold during a 
4-week period.  
It is very interesting to note that the patterns of bone growth in osteoconductive 
and osteoinductive scaffolds are different. The osteoconductive scaffolds had no bone 
growth on the edge. However, most of the bone growth in the osteoinductive scaffolds 
appears on the edge. Once the scaffolds were implanted on the rats’ back, the native cells, 
most of which are fibroblasts, began to migrate into the scaffold. For the osteoconductive 
scaffolds, the fibroblasts invaded the edge and the implanted osteoblasts still stayed in the 
inner pores of the scaffold. While for the osteoindcutive scaffolds, the release of BMP-2 
from the scaffold formed a concentration gradient surrounding the scaffold, which 
induces stem cell to migrate towards the porous scaffold. This migration of stem cells 
will compete with that of fibroblasts. In this ectopic bone formation model with this 
BMP-2 release rate, most of the bone growth induced by the BMP-2 appeared on the 
edge. This bone growth pattern may become different when the BMP-2 loaded scaffolds 
are implanted in the bone defect. And at the same time, it can also be different if the 
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BMP-2 release rate becomes faster resulting from adjustment of the amount of 
immobilized heparin on the surface. 
 
6.5 Conclusions 
In this chapter, we further studied the osteoconductivity of photocured chitosans 
by the ectopic bone formation after 4 weeks and 8 weeks implantation using micro-CT 
and histological study. The scaffolds of 8 weeks implantation have much more bone 
growth than those of 4 weeks implantation. And the newly formed bone matrix is mainly 
in the inner pores of the scaffold other than the edge. We also fabricated an 
osteoinductive photocured chitosan scaffold. In this scaffold, heparin was covalently 
bound on the surface, which can form specific binding with loaded BMP-2. The ectopic 
bone growth model indicated that the sustained release of BMP-2 induced bone growth in 
the scaffold, mainly on the edge. 
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CHAPTER SEVEN 
 
FABRICATION AND CHARACTERIZATION OF PHOTOCURABLE CHITOSAN-
GELATIN COMPLEX SCAFFOLDS AND THEIR POTENTIAL AS 
OSTEOINDUCTIVE BONE GRAFTS 
 
 
7.1 Introduction 
Scaffolds are being widely developed and studied for tissue engineering, in which 
they are expected to mimic the native extracellular matrix (ECM) to provide a temporary 
matrix for tissue regeneration with appropriate biological cues 1-4. Thus one strategy in 
scaffold design is to follow the structure and the molecular components of ECM. In 
biology, the ECM is composed of interlocking mesh of glycosaminoglycans (GAGs) and 
fibrous proteins. And GAGs are polysaccharides which are usually attached to proteins to 
form proteoglycans 5. There are already many studies focused on the modification and 
fabrication of polysaccharides, such as hyaluronic acid 6-8, chitosan 9-11 and dextran 12,13, 
into scaffolds for tissue regeneration. However, usually, use of polysaccharides alone 
hardly obtains expected outcomes. And improved biological activities are always resulted 
from tethering appropriate peptide sequences and physically or chemically entrapping 
protein into the 3-D network 14-18. 
In our previous study, we have synthesized photocurable chitosans. The 
biocompatibility, biodegradability and bioactivity of chitosan make it very suitable as a 
scaffolding material. And the chemical modification of the chitosan molecules not only 
improved their solubility in common organic solvents but also imparted into 
photocurability, which makes it more flexible in fabricating scaffolds with desired shape, 
pore size and topography. In this chapter, we were trying to fabricate photocurable 
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chitosan-gelatin complex scaffold. Gelatin is prepared by denaturing of collagen. 
Although it doesn’t possess the same 3-helix coiled structure as collagen, it still has 
functional peptide sequences in its structure, which facilitates the cells attachment and 
growth. Moreover, its wide applications in food, pharmaceutical, and medical areas 
proved its biocompatibility, biodegradability and bioactivity 19-23. There are already many 
studies focused on gelatin-chitosan composite and their applications 17,24-29. While in our 
study, the crosslinking of photocurable chitosan triggered by UV facilitates the 
incorporation of gelatin molecules into the instant forming network.  
Another goal of this chapter is to develop an osteoinductive scaffold based on this 
photocured chitosan-gelatin complex. In our previous study, covalently binding of 
heparin in the scaffold made it possible to realize the controlled release of immobilized 
BMP-2. Based on this, we also tried to covalently bind heparin into the complex scaffold 
by virtue of the existence of lots of amine groups in the scaffold that can react with the 
carboxyl groups on heparin molecules. 
In this chapter, the complex scaffolds with different ratio of photocurable chitosan 
and gelatin were fabricated. Their physical properties, including swelling ratio and 
rheological property were studied. Bovine osteoblasts were cultured on the film or 3-D 
porous complex scaffold and their morphology was observed using confocal microscopy. 
Heparin was also covalently bound in the complex scaffold in two manners, surface only 
and the whole scaffold. In vitro BMP-2 release profile was measured by Elisa assay and 
the osteoinductivity of the BMP-2 loaded and heparinized scaffold was confirmed by the 
in vivo ectopic bone growth on rats’ back via micro-CT and histological study. 
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7.2 Materials and methods 
7.2.1 Materials 
Chitosan with high molecular weight and 85% deacetylation, dimethyl sulfoxide 
(DMSO), PEG-DA with molecular weight 750 and MES buffer with low moisture 
content were obtain from Sigma-Aldrich Inc. (St. Louis, MO, USA). Methane sulfonic 
acid and heparin sodium was purchased from Acros Organics (Geel, Belgium). Benzoyl 
chloride, methacryloyl chloride and gelatin with 100 bloom were obtained from Fisher 
Scientific, Inc. Ammonium hydroxide water solution (5N) and 1-ethyl-3-(3-
dimethylaminopropyl) carbodiimide hydrochloride (EDC) was purchased from VWR, 
Inc. N-hydroxysuccinimide (NHS) was obtained from Pierce Inc. And rhBMP-2 was 
purchased from PeproTech, Inc. Iragure 2959 was obtained from Ciba Specialty 
Chemicals. 
 
7.2.2 Synthesis of photocurable chitosans 
In this study, we modified the synthesis method used in Chapter 4. Briefly, 1 g 
chitosan was dissolved into 15 ml methanesulfonic acid with stirring for 25 minutes, 
followed by adding dropwise a mixture of 1.1 g benzoyl chloride and 1.227 g 
methacryloyl chloride under stirring. Then, the solution was kept at room temperature 
with stirring for another 30 minutes. After that, the solution was dropped into ammonium 
hydroxide aqueous solution (100 ml 5N ammonium hydroxide solution + 600 ml DI 
water) to precipitate the light curable chitosans. This precipitate was filtered and washed 
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with DI water 10 times to clean the remained reagents and solvent. Finally, the product 
was dried in vacuum over P2O5 for two days. 
 
7.2.3 Fabrication of photocured chitosan-gelatin complex 
Gelatin was dissolved into DMSO (5% w/w) to form a transparent solution. 
Before photocrosslinking, appropriate amount of photocurable chitosan (5%, 7.5%, and 
10% w/w) was dissolved into this 5% gelatin-DMSO solution with 0.5% (w/w) Iragure 
2959. Once the photocurable chitosan dissolved in the gelatin-DMSO solution, it was 
fabricated into films, discs and porous discs through the methods used in previous 
chapters. 1% PEG-DA-750 (w/w) was also mixed into 5% photocurable chitosan-5% 
gelatin DMSO solution and this solution was used to fabricate discs for test of swelling 
ratio. 
 
7.2.4 Test of swelling ratio of complex scaffolds 
The photocured chitosan films were carefully blot dried with filter paper and then 
weighted. The films were dried in vacuum over P2O5 for two days and weighted again. 
The swelling ratio was calculated by equation 1.  
Swelling ratio = (Weight wet – Weight dry)/Weight dry                        (1) 
 
7.2.5 Reological study of photoured chitosan-gelatin complex scaffolds 
In order to test the viscoelasticity of light cured chitosans, the discs of 8 mm in 
diameter and 5 mm in height were made using the same mold as that used for porous 
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discs. The mold was filled with 20% chitosan-DMSO solution and then exposed to UV 
for 5 minutes. Then the disc was immersed into DI water. Before measurement, these 
discs were washed for 10 time and eliminate solvent DMSO. Dynamic oscillatory 
experiments were performed on an AR-G2 model stress controlled rheometor (T.A. 
Instuments, U.K.) with a 8 mm parallel plate geometry at 25 0C. By adjusting the upper 
plate, a 10% compressive stain was applied to all the discs. Frequency sweep experiments 
were carried out at 0.1% strain between 0.1 and 100 Hz (i.e., 0.0628 and 62.8 rad/s) on 
these discs.  
 
7.2.6 Cytocompatibility assay and morphological study 
The 5% gelatin-DMSO solutions with different concentration of photocurable 
chitosan (5%, 7.5% and 10%) were cast on the glass slides and photocured to form films. 
These films were washed off DMSO using DI water for 7 times. They were sterilized 
through immersing into 70 % ethanol for 30 minutes and washed again with sterilized DI 
water for 7 times. For cytocompatibility assay, 8,000 bovine osteoblasts were seeded into 
each well of the 6-well culture plate, and then these films were co-cultured with bovine 
osteoblasts. On day 1, 3, 5 and 7, alamar blue assay was taken to measure the 
cytocompatibility compared to the cells without co-culturing with photocured complex 
films. In order to study the morphology of the bovine osteoblasts grew on the surface of 
complex, the mixture solutions with different concentration were also photocured on the 
cell culture plates. They were washed and sterilized using the same method. 8,000 bovine 
osteoblasts were seeded on the surface of the complex films and cultured for 7 days. On 
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day 7, the cells were fixed by 4% paraformadehyde solution and stained with phaloidin-
488 for the actin and drag5 for the nuclei. Then the morphology of the osteoblasts grew 
on the complex films were observed with confocal microscopy. 
 
7.2.7 In vitro 3-D osteoblasts culture 
The porous complex scaffolds with different chitosan concentrations were 
sterilized with 70 % ethanol for 30 minutes and then washed with DI water for 7 times. 
These porous scaffolds were blot dried and 80,000 bovine osteoblasts in culture media 
were seeded into these porous scaffolds. After 3 hours when the cells attached onto the 
porous scaffolds, 3 ml cultured media was added to each scaffolds and they were cultured 
at 37 oC for 48 hours. Then the cells cultured in the scaffolds were fixed with 4% 
paraformadehyde solution and stained with phaloidin-488 for the actin and drag5 for the 
nuclei. The morphology of the osteoblasts was observed with confocal microscopy. 
 
7.2.8 Immobilization of heparin on the porous complex scaffolds 
The heparin was covalently bound on the complex scaffolds with the similar 
method we used in the previous chapter 30,31. And the porous complex scaffolds were 
made from 5% gelatin-7.5% chitosan DMSO solution.1 mg heparin was dissolved into 
1mg EDC per 0.6 mg of NHS in 500 μL of 0.05 M 2-morpholinoethanesulfonic acid 
(MES) buffer (pH 5.6) for 10 min at 37 oC. Two modification methods were applied here. 
The first one, each complex scaffold was blot dried and then immersed into 1 ml 
activated solution. And the solution was evacuated to remove air from the discs. The 
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reaction was kept at 37 oC for 4 hours. The second one has multi-steps that are same as 
the method we used in previous chapter. After every hour reaction at 37 oC, the discs 
were taken out, blot dried and re-immersed into flesh activated heparin/EDC/NHS 
solution. The heparinized discs were washed with 0.1 M Na2HPO4 (pH 9.2) (2h), 4M 
NaCl (four times in 24 h) and deionized water (five times in 24 h). And then these 
heparinized discs were kept into DI water for further use. 
The amount of heparin immobilized on the photocured chitosan scaffold was 
determined using the toluidine blue method 32. Toluidine blue (2 mg) was dissolved into 
6 ml hydrochloric acid (0.01 N) containing NaCl (0.2 wt%). Then the heprinized 
scaffolds were immersed into toluidin blue solution (6 ml) overnight with gently shaking. 
After removing the photocured chitosan scaffolds and toluidine blue complexes from 
solution, the remained toluidine blue was determined by absorption at 631 nm with an 
UV spectrometer. The amount of the immobilized heparin was calculated from the 
difference of the initial and final concentration of toluidin blue. The scaffolds stained 
with toluidine blue were washed with DI water, cut into half and taken photos. 
 
7.2.9 Test of in vitro release of BMP-2 
Heprinized photocured chitosan discs were sterilized by immersing into 75% 
ethanol solution for 1 hour. Then the discs were washed with DI water for 7 times to 
eliminate the ethanol. Before loading with BMP-2, the sterilized discs were blot dried. 5 
μg human recombinant BMP-2 in 30 μl sterilized DI water was then added into the 
porous discs. These BMP-2 loaded scaffolds were placed at 4 oC overnight. The discs 
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were then immersed into 1 ml 1 X PBS with 0.05% BSA and incubated at 37 oC. At each 
time point, Elisa assay was taken to measure the amount of BMP-2 in the solution and the 
old solution was replaced by flesh solution for further measurement. 
 
7.2.10 In vivo ectopic bone growth model 
10 μg BMP-2 in 30μl sterile DI water was added into each scaffold that was blot 
dried before. These BMP-2 loaded complex scaffolds were then placed at 4 oC overnight. 
Under general anesthesia and sterile conditions, the porous discs were subcutaneously 
implanted into the backs of 4-6 weeks old male, athymic (nu/nu) mice. Six mice were 
used for each sample type. After 4 weeks, the mice were sacrificed and the implants were 
harvested and immersed in 10% formaldehyde. The explants were then processed for 
paraffin histology and stained with H&E. 
 
7.2.11 Micro-CT scanning on the explants 
During the scanning, the binning was set at 2 and the scanning was done with 
high magnification (18.3-20 micro meter). During scanning, every 3 slices of images 
average into single slice. The delay by which the detector camera moves to acquire 
another x-ray projection was set on 10 ms, and the time by which the detector camera 
exposed to the x-ray projection and the time by which the x-ray tube scan the sample was 
set at 6000 ms. 
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7.3 Results 
7.3.1 Synthesis of photocurable chitosan 
This photocurable chitoan has a same structure as that we used in previous 
chapter. The degree of deacetylation is 0.85, the degree of benzoyl groups substitution is 
0.40 and the degree of methacrylate groups substitution is 0.93. 
 
7.3.2 Swelling ratio of the complex scaffolds 
The swelling ratio of different complex scaffolds was plot in Figure 7.1. The 
swelling ratio was influenced by the concentration of photocurable chitosans. Higher 
concentration of chitoan resulted in lower swelling ratio. The complex discs made from 
5% gelatin and 5% photocurable chitosan has a swelling ratio about 800%, which is 
almost close to that of a common hydrogel. When the concentration of chitosan reached 
10%, the swelling ratio of discs dropped to around 450%. However, when 1% PEG-DA 
was mixed into the 5% gelatin-5% photocurable chitosan solution, the disc has a higher 
swelling ratio than that fabricated from 5% gelatin-5% photocurable chitosan solution 
alone, which may be due to the high hydrophilicity of PEG molecules. 
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Figure 7.1: Swelling ratio of the complex scaffolds. (G stands for gelatin and C stands 
for photocurable chitosan) 
 
7.3.3 Rheological study 
The rheological study showed that the complex discs with higher chitosan 
concentration had higher storage modulus or were stiffer than those made from lower 
chitosan concentration (Figure 7.2). And the loss modulus also increased along with the 
chitosan concentration. There is no big difference between the discs made from 5% 
gelatin-10% chitosan and 5% gelatin-7.5% chitosan. However, when the concentration of 
chitosan dropped to 5%, the storage modulus decreased about 0.7 times. Moreover, when 
1% PEG-DA is mixed into the disc scaffold, its storage modulus or stiffness further 
decreased. 
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Figure 7.2: The rheological study on the complex scaffolds. (G stands for gelatin and C 
stands for photocurable chitosan) 
 
7.3.4 Cytocompatibility test and cells morphology on the surface 
During the 7 days culture, the alamar blue assay indicated that the photocured complexes 
are highly cytocompatible compared to the positive control (Figure 7.3). And even in day 
5 and day 7, the cells number is more than that in positive control. From the confocal 
pictures, osteoblasts grew very well on the surface of complex scaffolds after 7 days 
culture (Figure 7.4). 
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Figure 7.3: The cytocompatibility of complex scaffolds by alamar blue assay. (G stands 
for gelatin and C stands for photocurable chitosan) 
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Figure 7.4: The morphology of osteoblasts on the complex scaffold after 7 days culture 
(A) 5%G5%C (B)5%G7.5%C (C) 5%G10%C (G stands for gelatin and C stands for 
photocurable chitosan), Bar = 300 μm. 
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7.3.5 3-D Culture of Osteoblasts in the Porous Scaffolds 
Since the scaffolds have interconnected pores, the thickness of the scaffolds 
detectable by confocal microscopy can reach 500-600 μm. And from Figure 7.5, we 
found that the osteoblasts attached on the wall of pores, spread and grew very well in all 
of those scaffolds in 48 hours culture. And there is no big difference among these three 
scaffolds with different amount of chitosan. 
A B C
 
Figure 7.5: Confocal images of 3-D cultured osteoblasts (A) 5%G5%C (B) 5%G7.5%C 
(C) 5%G10%C (G stands for gelatin and C stands for photocurable chitosan), Bar = 300 
μm. 
 
7.3.6 Immobilization of Heparin on the Porous Complex Scaffolds 
The amount of immobilized heparin on porous complex scaffolds was determined 
by toluidine blue assay, which indicated that these two modification methods resulted in 
different amount in heparin immobilization. The multi-steps resulted in higher amount 
(1261 ± 50 μg/scaffold) than single step modification (823 ± 46 μg/scaffold). This was 
also certified by the pictures taken from microscopy (Figure 7.6). The single step process 
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mainly immobilized heparin on the surface of the porous scaffold, since the inner part is 
not as dark as the surface. However, both the surface and the inner part are in the same 
dark color in the scaffolds by multi-step modification process, which means the heparin 
was homogeneously immobilized in the whole scaffold. 
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Figure 7.6: Pictures of the heparinized scaffolds stained w/o toluidine blue (A) without 
toluidine blue, top view (B) without toluidine blue, cross section (C) with toluidine blue, 
multi-steps modification, top view (D) with toluidine blue, multi-steps modification, 
cross section (E) with toluidine blue, single step modification, top view (F) with toluidine 
blue, single step modification, cross section. (Bar = 2mm) 
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7.3.7 In vitro release of BMP-2 
The BMP-2 release profiles of the two different scaffolds are different (Figure 
7.7). After 4 weeks, the scaffolds from the multi-steps released only around 1.4% of 
loaded BMP-2. However, about 7% of BMP-2 released out of the scaffolds made from 
single step modification. And the profile of the BMP-2 release can be classified into two 
stages: the first one, the comparatively fast release in the first 9 days, and the second one, 
the comparatively slow release after day 9. 
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Figure 7.7: In vitro release of BMP-2 from heparinized complex scaffolds 
 
7.3.8 In vivo ectopic bone growth on rats’ back 
From the micro-CT study, there is almost no bone growth observed in the 
scaffolds made from the multi-step modification after 4 weeks implantation (Figure 7.8). 
However, some small pieces of bone were found on the scaffold made from single step. 
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They were close to the edge. And the bone growth also appeared on the edge of the 
scaffold. The histological study also confirmed the bone growth in the single-step made 
scaffold (Figure 7.9). And bone growth was hardly found in multi-steps made scaffolds. 
In both scaffolds, there are many fibroblasts. Even in the scaffolds with bone growth, the 
fibroblasts surrounded the newly formed bone matrix. 
C
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Figure 7.8: Micro-CT of heparinized complex scaffold loaded with BMP-2 after 4 weeks 
implantation. (A) multi-steps modification, cross section in 3 different dimensions (B) 
multi-steps modification, 3-D view (C) single step modification, cross section in 3 
different dimensions (D) single step modification, 3-D view (Bar = 2mm) 
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7.4 Discussions 
ECM is a complex gel consisting of polysaccharides, proteoglycans and protein 
fibers. Its components help to attract water molecules in the matrix, keeping the ECM and  
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Figure 7.9: Histological study (H&E staining) of the heparinized complex scaffold 
loaded with BMP-2 after 4 weeks implantation. (A) and (C) single step modification, 
X10, (B) and (D) single step modification, X20, (E) multi-steps modification, X10, (F) 
multi-steps modification, X20 (Bar = 100 μm) 
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resident cells hydrated. At the same time, growth factors can also be trapped and stored in 
this hydrated matrix 33. These properties come from the collaboration of polysaccharides 
and proteins. Many studies have been focused on fabrication and applications of 
polysaccharides and proteins complex 14-18. In our study, we presented a new method in 
fabricating polysaccharides and protein complex. The polysaccharide we used is the 
photocurable chitosan developed in our lab recently. Its fast crosslinking upon UV 
exposure and solidification from liquid phase makes it possible and easy to frame the 
gelatin molecules in the crosslinked network. At the same time, taking advantages of its 
good spatial and temporal control, complex scaffolds with desirable shape, pores size and 
topography can be easily fabricated. 
In our study, we fabricated a series of complex scaffolds with different chitosan 
concentrations and exploited the influence of the chitosan content on the properties. 
Higher chitosan concentration decreased the swelling ratio of the complex scaffolds, 
because of the hydrophobic side groups in modified chitosan that limits the penetration of 
water. However, when hydrophilic molecules, PEG was co-crosslinked into the network, 
the swelling ratio increased. Obviously, the hydrophilicity of the components of the 
network greatly influences the swelling ratio. At the same time, the concentration of 
chitosan also affects the rheological properties of the complex scaffolds. Higher chitosan 
concentration resulted in higher storage modulus (G’) or stiffness. Conversely, the 
addition of PEG molecules into the network decreased the storage modulus. Somehow, 
this may be related to the swelling ratio and the hydrophilicity of the components. 
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In our in vitro study, the complex scaffolds were proved highly cytocompatible 
and biocompatible. The osteoblasts can attach, spread, and grow very well either on the 
surfaces of the complex films or in the 3-D porous complex scaffolds. And the 
concentration of chitosan showed no effects. All of these results indicated the potential of 
the complex scaffold using as scaffolds for tissue engineering. 
In order to develop an osteoinductive bone graft, we used this complex as a base 
material for designing the carrier of BMP-2 that can sustainedly release this bioactive 
protein. This complex alone is not suitable for the BMP-2 release (data not shown). 
Although chitosan and gelatin have been used as carriers for many growth factors release, 
and in particular gelatin scaffold has been used for BMP-2 release 34-37, there are still 
some problems in these two systems. The attraction of BMP-2 in the scaffolds is mainly 
based on the electrostatic force with the scaffolds. And in addition, the successful 
examples using gelatin as a carrier is also determined by many factors, such as the 
isoelectric point of the gelatin, the degree of crosslinking and its swelling ratio. An 
alternative method in designing the BMP-2 carriers is to build up a bridge between the 
scaffolds and BMP-2 molecules. This bridge should have efficient bindings with both 
scaffolds and BMP-2. In two recent papers 38,39, heparin was used to surface modify the 
scaffolds and the heparinized scaffold can used as a carrier to sustainedly release BMP-2. 
This controlled release is based on the specific binding of BMP-2 with covalently bound 
heparin. They all had good outcomes of ectopic bone formation on rats’ back. In 
particular, heparin was covalently bound to demineralized bone matrix (DBM) 39. This 
binding occurred between the carboxyl groups of heparin and the amine groups in the 
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protein components of DBM. In our study, we also covalently bound heparin on the 
scaffolds by reacting the carboxyl groups of the heparin with the amine groups on the 
chitosan and gelatin. While, we used two different approaches to obtain two different 
modification patterns of heparin on the scaffold: surface and the whole scaffold. Surface 
modification is approached by single step process, since the activated carboxyl groups on 
heparin are easily deactivated and the deactivated heparin molecules in the inner part 
hardly diffused out of the scaffold, thus hampering the penetration of the activated 
heparin. And the multi-steps modification was applied to facilitate the penetration of 
activated heparin. The patterns of the two modifications influenced not only the in vitro 
release of BMP-2 but also the in vivo ectopic bone growth. The surface modification 
resulted in much faster release rate, and newly formed bone matrix was found in it at 4 
weeks implantation. The release rate of BMP-2 from the scaffolds made by multi-steps is 
much slower in vitro and after 4 weeks implantation, there is only little bone growth 
observed from micro-CT. However, many fibroblasts were observed from histological 
study. From the results, the release of BMP-2 does reduce ectopic bone growth, while the 
amount of the newly formed bone matrix is not as much as expected. This is may be due 
to the BMP-2 release rate, gelatin and the site of implantation. As we know, gelatin is 
highly biocompatible, and its existence in the scaffolds will facilitate the penetration of 
fibroblasts. The stem cells migration towards and inwards the scaffolds is determined by 
the growth factor gradients around the scaffold. Too low release rate obviously resulted 
in low gradients of BMP-2, which is not suitable for the migration of stem cells. At the 
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same time, in the subcutaneous condition, the number of stem cells is limited, which may 
be different if the scaffolds were implanted into the bone defect. 
 
7.5 Conclusions 
With the photocurable chitosans and gelatin, we fabricated a series of complex scaffolds. 
The photocrosslinking of chitosan facilitates the incorporation of chitosan with gelatin. 
The properties of complex scaffolds, such as swelling ratio and rheological properties, are 
influenced by the concentration of photocurable chitosan. The biocompatibility of the 
complex scaffolds was confirmed by the osteoblasts culture on the 2-D films and in 3-D 
porous scaffolds no matter what concentration of photocurable chitosan was used. The 
immobilization of heparin on the complex scaffold realized the sustained release of BMP-
2 from the scaffold. The incorporation of the BMP-2 into the heparinized complex 
scaffold results in an osteoinductive scaffolds for bone repair. And the bone growth is 
determined by pattern of heparin modification on the scaffold. 
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CHAPTER EIGHT 
 
CONTROLLING THE MICROSTRUCTURE OF HYBID SCAFFOLDS BY 
GOVERNING TRANSIENT PHASE SEPARATION IN A POLYSACCHARIDE-
PROTEIN-ORGANIC SOLVENT SYSTEM 
 
 
8.1 Introduction 
Polysaccharides and proteins may interact through a variety of mechanisms 
involving Van de Waals force, hydrophobic interactions, electrostatic interactions, 
hydrogen bonding, as well as covalent bindings 1. These interactions have made it 
possible to create polysaccharide-protein complexes with unique physical and 
morphological properties for biomedical applications 1. In solution, polysaccharide-
protein-solvent interactions may lead to phase separation 2. Depending upon the affinity 
between the polysaccharide, the protein, and the solvent, segregative phase separation or 
complex coacervation results 3. Complex coacervation (also termed associative phase 
separation) occurs when the interactions between the polysaccharide and the protein are 
weak attractive and non-specific, giving rise to soluble or insoluble polysaccharide-
protein complexes 4. During a coacervation process, a homogenous solution of charged 
polysaccharide and protein molecules undergoes liquid-liquid phase separation, with the 
polysaccharide and the protein concentrated in one phase (the biopolymer-rich, solvent-
poor phase, or the coacervate), and the solvent enriched in the other phase (the solvent-
rich, biopolymer-poor phase). These two liquid phases are not directly miscible, but are 
strongly interacting. The phase separation in coacervation is driven by the electrostatic 
and solute-solvent interactions. Due to the smaller sizes and better motility of the solvent 
molecules when compared to those of the polysaccharide and the protein, the solvent 
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molecules tend to infiltrate into the biopolymer-rich (polysaccharide-protein) phase over 
time, a process associated with an overall entropy gain of the system. As a result, the 
polysaccharide-protein complex coacervation is transient and reversible. Evolution takes 
place in the system with the eventual disappearance of the phase separation, forming one 
homogeneous phase. 
Chitosan is a naturally-abundant biodegradable linear-cationic polysaccharide that 
can be produced by partial deacetylation of chitin derived from naturally occurring 
crustacean shells. Previously, we have chemically modified chitosan through 
substitutions of the hydroxyl groups in the side chains with benzoic groups and 
methacrylate groups, in an attempt to expand its biomedical utility with increased 
solubility in common organic solvents 5. The incorporation of benzoic groups in the side 
chains of the modified chitosan have greatly improved its solubility in organic solvents 
(e.g., dimethyl sulfoxide (DMSO)), while the presence of methacrylate groups has 
imparted light curability. The modified chitosan retains its cationic property and is 
readily soluble in DMSO. Upon light exposure, the modified chitosan undergoes curing 
with microscopic changes through chain crosslinking, as well as macroscopic changes by 
converting from a liquid form into a solid phase. Gelatin is a polyampholyte naturally 
derived from denatured collagen. Like many other proteins, it has a heterogeneous charge 
distribution on the surface with the presences of both negatively charged and positively 
charged patches 6. It carries specific peptide sequence that facilitates cell attachment and 
proliferation 7. Gelatin has been widely used in food, pharmaceutical, and medical areas 
given its biocompatibility, biodegradability, and bioactivity 8. The aqueous solution 
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property of gelatin has been extensively studied in the past 9. Since both chitosan and 
gelatin find utilities in a wide range of biomedical applications, generating novel 
scaffolds of these two natural biopolymers may have the potential to meet the increasing 
demands for scaffolds with unique microstructures and properties for tissue repair. 
Microstructures are characterized by pore size, pore morphology, and porosity 10. For 
tissue repair purposes, it would be desirable for the scaffolds to contain interconnected 
pores for cell attachment, spreading, infiltration, and 3-D organization to form new tissue 
11, and allow easy loading and incorporation of bioactive molecules, growth factors, and 
nutrients for sustained release to the tissue site in need of repair 12, 13.  
There are a few studies on chitosan-gelatin interactions and the fabrication of 
chitosan-gelatin composite scaffolds 6, 14-16. These studies in general have concluded that 
the interactions between chitosan and gelatin are electrostatic in nature (ionic strength-
dependent) 6. Strong attractive interactions may occur between negatively charged 
patches on gelatin and positively charged chitosan. In comparison, interactions between 
biopolymers (gelatin or chitosan) and organic solvents are usually weak and non-specific. 
For example, gelatin may interact with DMSO via hydrogen bonding, while chemically 
modified chitosan with DMSO through hydrophobic interactions. The solubility of both 
chitosan and gelatin in organic solvents such as DMSO and the differential interactions 
between biopolymers and biopolymers with solvents may make it possible to create an 
ideal system where hybrid scaffolds of chitosan and gelatin with tunable microstructures 
and properties for tissue regeneration may be produced by governing the chitosan-gelatin 
interactions/complexation in an organic solvent system. In the present work, the light-
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curable chemically modified chitosan was used to form 3-D hybrid porous scaffolds with 
gelatin in a DMSO system. By governing a transient phase separation process in the 
chitosan-gelatin-DMSO system, we have demonstrated the fabrication of 3-D porous 
polymeric scaffolds with tunable microstructures across the nano, micro, and macro 
length scales, mechanical properties superior to most existing natural biopolymers, and 
excellent cytocompatibility from chitosan-gelatin complexes formed in the organic 
solvent. Our study has proved the utility of a transient phase separation principle in 
producing 3-D porous scaffolds with tunable microstructures from natural occurring 
biopolymers, and has established simple protocols to achieve polymeric scaffolds of 
unique microstructures, superior mechanical properties, and bioactivities suitable for 
tissue engineering purposes.   
 
8.2 Results and discussion 
Based upon the literature findings on chitosan-gelatin interactions, and the 
structures and properties of the molecular chains of gelatin and chitosan, we 
hypothesized that chitosan-gelatin interactions in an organic solvent system might 
be mediated, at least in part, through a transient, reversible phase separation 
mechanism in the coacervate, and that different pore sizes and pore morphologies 
might be achieved at microscopic length scales in the chitosan-gelatin coacervate by 
varying the interaction parameters such as the gelatin to chitosan ratio, the length of 
the setting time, and the crosslinking of gelatin. Our hypothesized scheme of 
interactions between chitosan and gelatin in DMSO is shown in Fig.8.1. In this scheme, 
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the setting time is the time prior to the crosslinking of either one of the two components. 
Setting allows free chain motility/configuration changes, and the interactions of 
individual molecules of chitosan and gelatin. Within the setting time, transient phase 
separation occurs where gelatin interacts strongly with chitosan via electrostatic 
interactions to form a biopolymer-rich phase (soluble and insoluble complex coacervate), 
while gelatin interacts weakly with DMSO molecules via hydrogen-bonding, which 
forms a solvent-rich phase. Meanwhile, DMSO molecules are able to infiltrate into the 
biopolymer-rich phase over time via diffusion (entropy-gaining) and non-specific 
interactions (e.g., hydrogen bonding, hydrophobic interactions). As a result, the solvent-
rich phase co-exists with the biopolymer-rich phase either as interstitial bulk or as bound 
to the strongly interacting biopolymer chains. Setting of the chitosan-gelatin-DMSO 
system is terminated by crosslinking one of the two components, in our case, chitosan, 
upon UV exposure. Crosslinking of chitosan transforms its structure into an 
interconnected network, thus, inhibits the chain motility and interactions of individual 
chitosan molecules with gelatin, and fixes in place the conformation of chitosan in 
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Figure 8.1: Schematic diagrams showing the hypothesized structural/phase changes in a 
chitosan-gelatin-dimethyl sulfoxide (DMSO) system as a function of setting time (t) 
before and after UV exposure. UV exposure is used to crosslink photocurable chitosan in 
the system. EDC solution is used to crosslink gelatin, and gelatin with chitosan in the 
system. (A)-(C): The system before UV exposure as a function of the setting time; (D)-
(F): The system after UV exposure as a function of the setting time; (G)-(I): The system 
after EDC crosslinking of gelatin, and gelatin with chitosan as a function of the setting 
time. The dotted line circles the DMSO(solvent)-rich phase in the gelatin-chitosan 
complex coacervate. Legend: Coils represent gelatin molecules; Green rods represent 
chitosan molecules; and small yellow circles represent DMSO molecules. 
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the coacervate (Fig. 8.1 D, E, and F). Macroscopically, the system undergoes phase 
transition from liquid to solid after crosslinking of chitosans through photo-curing. 
Further crosslinking of gelatin in 1-ethyl-(3-3-dimethylaminopropyl carbodiimide 
hydrochloride) (EDC or EDAC) solution preserves the overall morphology of the gelatin-
rich phase through stabilizing the conformation of gelatin in the coacervate (Fig. 8.1 G, 
H, and I). EDC can catalyze the reaction between amine and carboxyl groups, thus 
crosslink gelatin molecules or gelatin molecules with chitosan chains 17. Under each 
condition, extension of the setting time allows better infiltration and dispersion of DMSO 
molecules within the biopolymer-rich phase, therefore, reduces phase separation in the 
system (Fig. 8.1 A, B, and C). Beyond a certain point of the setting time, complete 
dispersion of solvent in the biopolymers occurs, resulting in phase homogeneity in the 
system, and the complete disappearance of the solvent-rich phase in the gelatin-chitosan 
coacervate (Fig. 8.1 C, F, and I). According to our proposed scheme, freeze drying of the 
system after curing would produce a 3-D chitosan-gelatin scaffold containing 
microporous structures that are left by the solvent-rich phase in the coacervate (the dotted 
circles in Fig. 8.1). 
To harness the chitosan-gelatin interactions in a DMSO solution for the creation 
of hybrid porous scaffolds with unique physical and morphological properties, we 
examined the pore formation dynamics in the chitosan-gelatin coacervate as a function of 
the interaction parameters, such as the setting time, the ratio of gelatin to chitosan, and 
with or without the crosslinking of gelatin with EDC. We performed two sets of 
experiments using different ratios of gelatin (Gtn) to chitosan (Cht): 5%Gtn-5%Cht-
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DMSO, and 5%Gtn-7.5%Cht-DMSO, respectively. All the concentrations refer to weight 
percentages in the solution. In each set of the experiment, we freeze-dried the systems 
that underwent different treatments and at different setting time for scaffold production 
and SEM examination (Fig. 8.2 and 8.3).  
 
Figure 8.2: Representative SEM images of the hybrid scaffolds (5% gelatin-5% chitosan) 
made with different setting time and with or without crosslinking of gelatin (Х 1000). 
(A)-(C): no boiling water treatment and no crosslinking of gelatin; (D)-(F): with boiling 
water treatment and no crosslinking of gelatin; (G)-(I): no boiling water treatment and 
with crosslinking of gelatin; (A), (D) and (G): no setting time; (B), (E) and (H): 8 hours 
setting time; (C), (F) and (I): 12 hours setting time. 
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The boiling water immersion/washing of the freeze-dried scaffolds was performed 
to remove the uncrosslinked gelatin by dissolving it, leaving the crosslinked chitosan 
skeleton intact in the coacervate (Fig. 8.2 D, E, and F). Comparison the scaffolds 
obtained in the beginning of the setting, but with different treatments, indicates 
differences in the pore sizes and morphologies. With 5%Gtn-5%Cht-DMSO system, 
large pores of an average of 30-40 μm in diameters (Fig. 8.2 A and D) were seen in the 
scaffolds, implying the separation of the solvent-rich phase, which creates the pores, and 
the biopolymer-rich phase, which forms the scaffold skeleton, in the system. In fact, upon 
the addition of chitosan into the gelatin-DMSO solution, the system turned to be a little 
cloudy, perhaps due to the formation of microscopic coacervate droplets of chitosan and 
gelatin. Strong electrostatic interactions between chitosan and gelatin in DMSO may have 
initiated intermolecular insoluble aggregate formation comprising of charge neutralized 
chitosan-gelatin complexes 6. However, the insoluble aggregates of chitosan-gelatin 
complexes did not undergo precipitation, instead, they disappeared and the solution 
became clear over time (10 hours for 5%Gtn-5%Cht-DMSO system, and 36 hours for 
5%Gtn-7.5%Cht-DMSO system). The differences in pore sizes and morphologies of the 
scaffolds before (Fig. 8.2A) and after the boiling water removal of gelatin (Fig. 8.2D) 
suggest a biphasic distribution of gelatin in both the biopolymer-rich phase and the 
solvent-rich phase. Gelatin and chitosan were not completely associated and co-localized 
in the coacervate. While chitosan primarily existed in the biopolymer-rich phase and 
served as the structural skeleton of the scaffolds (Fig. 8.2 D), gelatin was present in both 
phases as masking and filling materials in the scaffolds (biopolymer-rich phase) and the 
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pores (solvent-rich phase) (Fig. 8.2 G). Following the boiling water treatment, the pores 
exhibited more clear morphologies with discernible edges, along with the disappearances 
of the filling structures inside the pores, again suggesting the biphasic presence of gelatin 
in both the biopolymer-rich phase and the solvent-rich phase (Fig. 8.2 A, D, G). 
Comparisons of the scaffold pore morphologies under the same set of treatments (boiling 
water, vs. EDC crosslinking), but with prolonged setting time (8 hours), indicate the same 
trend (Fig. 8.2 B, E, H). Extension of the setting time may have allowed better 
infiltration, integration, and dispersion of DMSO molecules (the solvent-rich phase) into 
the intramolecular and intermolecular space within the chitosan-gelatin complex 
coacervate. Therefore, incremental reduction in the pore sizes was documented over the 
setting time (8 and 12 hours), indicating reduction in the sizes of the solvent-rich phase in 
the biopolymer complex. Beyond a critical point of setting time (12 hours), DMSO 
molecules completely dispersed into the complex, leading to phase homogeneity of the 
system, and the disappearance of macropores (solvent-rich phase) in the scaffolds.  
A parallel set of experiments using a different ratio of gelatin to chitosan (5%Gtn-
7.5%Cht-DMSO system) indicated similar trend of changes in the scaffold pore sizes and 
morphologies as a function of setting time (Fig. 8.3). Compared to the 5%Gtn-5%Cht-
DMSO system, more chitosan molecules were available to interact with gelatin, forming 
a complex coacervate containing chitosan skeleton with denser structures (Fig. 8.3 A,E,I 
vs. Fig. 8.2 A,D,G). Pores of smaller sizes were embedded in the complex, oftentimes 
were surrounded and filled by gelatin (Fig. 8.3 I). Due to the increased density of the 
complex coacervate, it took longer for DMSO molecules to penetrate and disperse into 
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the coacervate. Therefore, there were not many differences in the pore sizes and 
morphologies of the scaffolds at 0 and 8 hours setting time points (Fig. 8.3 A,E,I vs. 
B,F,J), even though the differences in the scaffolds were pronounced at these two setting 
time points with the 5%Gtn-5%Cht-DMSO system (Fig. 8.2A,D,G vs. B,E,H). Instead of 
12 hours as with the 5%Gtn-5%Cht-DMSO system, it took 48 hours for DMSO to 
 
Figure 8.3: Representative SEM images of the hybrid scaffolds (5% gelatin-7.5% 
chitosan) made with different setting time and with or without crosslinking of gelatin (Х 
1000). (A)-(D): no boiling water treatment and no crosslinking of gelatin; (E)-(H): with 
boiling water treatment and no crosslinking of gelatin; (I)-(L): no boiling water treatment 
and with crosslinking of gelatin; (A), (E) and (I): no setting time; (B), (F) and (J): 8 hours 
setting time; (C), (G) and (K): 24 hours setting time; (D), (H) and (L): 48 hours setting 
time. 
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 completely disperse into the biopolymer complex, and the macropores (solvent-rich 
phase) in the scaffolds to disappear (Fig. 8.3 D, H, L). For the 5%Gtn-7.5%Cht-DMSO 
system, the temporal dynamics of pore size reduction was also different from that of the 
5%Gtn-5%Cht-DMSO system (Fig. 8.3 vs. Fig. 8.2). Again, morphological comparison 
of the scaffolds before and after boiling water removal of gelatin indicates a biphasic 
distribution of gelatin both in the biopolymer-rich complex and solvent-rich phase, 
preferably as masking and filling materials (Fig. 8.3 A,B,C vs. E,F,G). The results of the 
average pore size and porosity measurements of the scaffolds produced under different 
conditions are listed in Table 8.1 and 8.2. Our observations of the changes in the pore 
sizes and morphologies in the hybrid scaffolds as a function of interaction parameters 
(e.g., the setting time, the ratio of gelatin to chitosan, and the crosslinking of gelatin) are 
consistent with our hypothesized scheme of interactions between gelatin and chitosan in 
an organic solvent (DMSO) solution. The phase separation initially observed in 
coacervation between a biopolymer-rich phase and a solvent-rich phase is possibly driven 
by the electrostatic and biopolymer-solvent interactions. Prolonged setting time allowed 
the infiltration and better dispersion of the solvent-rich phase in the biopolymer-rich 
phase, a process mediated by solvent-biopolymer interactions and also associated with 
net entropy gain.  
 
 
 
 
 209
Table 8.1: The average pore sizes of the scaffolds made under different conditions (μm). 
 
 5%G 
5%C 
0hr 
5%G 
5%C 
8hrs 
5%G 
5%C 
12hrs 
5%G 
7.5%C 
0hrs 
5%G 
7.5%C 
8hrs 
5%G 
7.5%C 
24hrs 
5%G 
7.5%C 
48hrs 
UV 
Exposure 
31.87 
± 0.24 
9.40 
± 0.13 
1.78 
± 0.05 
22.33 
± 0.15 
18.58 
± 0.14 
12.19 
± 0.09 0 
Boiled 35.62 ± 0.26 
13.24 
± 0.12 
3.78 
± 0.06 
11.27 
± 0.11 
16.06 
± 0.15 
11.01 
± 0.04 0 
EDC 
solution 
27.55 
± 0.19 
8.23 
± 0.11 
1.43 
± 0.07 
29.53 
± 0.14 
23.375 
± 0.17 
14.37 
± 0.10 0 
 
Close examinations of the surfaces and inner-structures of the hybrid chitosan-
gelatin scaffolds by SEM at high magnifications reveal the presences of nanoscale 
structures (e.g., pores, beads) on the inside and surface of scaffold skeleton (Fig. 8.4). 
Since the surfaces of the scaffold skeleton are the interfaces between the two phases 
(biopolymer-rich phase, and solvent-rich phase) during the coacervation process, these 
observations again suggest biphasic distribution of gelatin and the ability of gelatin to 
form nanoscale structures at the interfaces 
Table 8.2: The porosity of the scaffolds made under different conditions. 
 
 5%G 
5%C 
0hr 
5%G 
5%C 
8hrs 
5%G 
5%C 
12hrs 
5%G 
7.5%C 
0hrs 
5%G 
7.5%C 
8hrs 
5%G 
7.5%C 
24hrs 
5%G 
7.5%C 
48hrs 
UV 
Exposure 
80% 
± 1% 
74%  
± 5% 
47%  
± 7% 
77%  
± 4% 
79%  
 ± 5% 
69%  
± 3% 0 
Boiled 85% ± 1% 
77% 
± 4% 
60%  
± 6% 
79%  
± 1% 
80% 
± 2% 
72% 
± 4% 0 
EDC 
solution 
67%  
± 2% 
72 
± 3% 
40% 
± 3% 
60% 
± 2% 
63% 
± 5% 
54% 
± 3% 0 
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during the transient phase separation. Previously, Ma and colleagues have produced 3-D 
porous nano-fibrous scaffolds with the walls of the macro-pores covered with nanoscale 
polymeric fibers 18. Cell culture experiments with osteoblasts using these scaffolds in 
comparison to solid-walled 3-D porous scaffolds indicated that nanoscale structures at the 
surfaces were critical to mediate cell attachment, differentiation, and biomineralization 
potentially through selectively enhancing the adsorption of specific types of proteins that 
are favorable for cell-cell interactions, matrix productions, cell-matrix interactions, and 
bioactivity. In a similar manner, the nanoscale architectures that we have created on the 
skeleton of the hybrid chitosan-gelatin scaffolds may serve as adhesive domains to 
promote cell attachment, spreading, ECM production, and functioning. When compared 
to the existing reports of producing nano-architectured materials 19-21, our creation of 
different forms of nanoscale architectures on the walls of 3-D porous scaffolds through 
governing a transient phase separation process in a polysaccharide-protein-organic 
solvent system represents the simplest, easy-controllable method that allows the design of 
the wall structures of the pores. 
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A B
C D
 
Figure 8.4: Representative SEM images of the surfaces (A and B) and inner-structures 
(C and D) of the gelatin-chitosan scaffolds (5% gelatin- 5% chitosans with no setting 
time) with nanostructures, such as gelatin beads (B) and nanopores (D). 
 
To determine whether different types of interactions, as characterized by different 
binding strength and energy levels, are involved in the association of gelatin with other 
molecules (chitosan, DMSO) in the system, we performed an extra set of experiments by 
subjecting the scaffolds of crosslinked chitosan but uncrosslinked gelatin to a series of 
treatments with hot water of incrementally increasing temperatures. Since gelatin is 
readily soluble in hot water, increases in the water temperature will break up the 
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interactions/bonding of gelatin with other molecules in the system. As a result, increasing 
amount of uncrosslinked gelatin tend to elute from the scaffolds as a function of 
increasing water temperature. By measuring the amount of gelatin eluted from the 
scaffolds in comparison to the total amount of gelatin in the starting material, we found a 
positive correlation between the water temperature and the amount of eluted gelatin (data 
not shown). However, even with boiling water, only a percentage of the gelatin was 
eluted from the scaffolds, indicating that the energy provided by boiling water was not 
sufficient to liberate the gelatin molecules that were involved in interactions at high 
energy levels. These results strongly suggest the presences of different types of 
interactions between gelatin and chitosans at multitude energy levels.  
We further evaluated the rheological characteristics/viscoelastic properties of the 
chitosan-gelatin hybrid scaffolds by measuring the storage modulus (G') and the loss 
modulus (G''). Storage modulus has been used as an index of the elastic component of the 
material, while loss modulus as a measure of the viscous component. The mechanical 
properties of natural polymers, such as chitosan, are usually weak. Interactions of natural 
polymers with proteins or other polymers in solution, whether hydrophobic, electrostatic, 
or hydrogen bonding in nature, may reinforce the mechanical properties of the scaffolds 
or complexes obtained from such mixtures 6. All the scaffolds exhibited elastic-dominant 
characteristics (G'>>G''), and frequency dependence of G' across the range (Fig. 8.5). 
When compared to the data for pure chitosan scaffolds, gelatin complexation with 
chitosan increased G', therefore, reinforced the gelatin-chitosan hybrid scaffolds. The 
range of the elasticity of the hybrid scaffolds has exceeded what has been achieved in any 
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other natural biopolymers except elastin, demonstrating the ability of the hybrid scaffolds 
to expand the mechanical properties of natural biopolymers. Regardless of the gelatin-
chitosan ratio in the scaffolds, G' shows a decreasing trend over the setting time (Fig. 
8.5). Since the pore sizes reduced in the scaffolds as a function of setting time, these 
observations suggest the roles of the pores formed by the solvent-rich phase in the 
coacervate in energy-dissipating and buffering to improve the resistance of the scaffolds 
to deformation. The dynamics of G' reduction over the setting time in the scaffolds of 
different gelatin-chitosan ratios was also consistent with the respective temporal 
dynamics of the changes in the pore sizes in these scaffolds. For example, the 5%Gtn-
7.5%Cht scaffolds, which have denser structures and smaller pores, display much higher 
mechanical strength, and a retarded reduction in G' over the setting time, when compared 
to that of the 5%Gtn-5%Cht scaffolds, which exhibit sharp drops in G' over the setting 
time. This is perhaps due to fact that higher chitosan content in the coacervate results in 
denser structures of the 5%Gtn-7.5%Cht scaffolds, which retard the reduction of pore 
sizes caused by the infiltration of solvent molecules into the coacervate. In addition, for 
the 5%Gtn-7.5%Cht scaffolds, no difference in G' was observed at 0 and 8-hour setting 
time, in agreement with the lack of difference in the scaffold pore sizes and morphologies 
at these two time points. 
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Figure 8.5: Measurements of storage modulus of the hybrid scaffolds containing 
different ratios of gelatin to chitosan and with different lengths of setting time. 
 
Natural bone tissue in the body resides in a complicated biomechanical 
environment that is constantly subjected to static as well as cyclic mechanical loadings. 
As candidate scaffolds for bone tissue engineering applications, the biomechanical 
functions in response to static and cyclic mechanical loadings are very important. To this 
end, we have evaluated the biomechanical behaviors of the scaffolds under static vs. 
cyclic compressive conditions. Three groups of scaffolds were tested, i.e., the photocured 
chitosan-only scaffolds, the photocured hybrid scaffolds, and the EDC post-cured hybrid 
scaffolds. Salt crystals of an average 300-325 µm in diameters were added into the 
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biopolymer-DMSO solution during the scaffold fabrication to achieve macro-pores in all 
the three groups of scaffolds. Again, post-cure of the hybrid scaffolds using EDC solution 
crossslinked gelatin, and gelatin with chitosan, leading to the formation of 
interpenetrating network (IPN) in the scaffolds. Static compression was applied to the 
scaffolds up to 90% strain. When compared to the photocured chitosan-only scaffolds, 
the hybrid scaffolds (the photocured, and the EDC post-cured) exhibited much higher 
compressive strength, as evidenced by greater compressive elastic modulus (Table 8.3). 
This is perhaps related to the presence of IPN in the EDC post-cured hybrid scaffolds, 
which is able to buffer the energy of crushing compressive loading and enhance the 
resistance of the scaffolds to deformation. Grossly, given sufficient time (48 hours) post-
compression, the EDC post-cured hybrid scaffolds were fully recovered to their original 
dimensions after static compression test up to 90% strain (Fig. 8.6), whereas the other 
two groups of scaffolds failed to recover under the same conditions (data not shown).  
The stress-strain curve of the EDC post-cured hybrid scaffolds at a constant strain 
rate of 1mm/min assumes a “J” shape, which is characteristic of foam materials (Fig. 8.7 
A) 22. Amplification of the curve at low strains (0-50%) (Fig. 8.7 B) indicates that the 
scaffolds undergo three phases of deformation as a function of strain: linear elasticity 
(bending) within 10% of strain (region a); a plateau (elastic bucking) over medium strains 
(10% to 35%) (region b), and densification at high strains (beyond 35%) (region c). 
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A B
C D
 
Figure 8.6: Compression test on the EDC post-cured chitosan-gelatin hybrid scaffolds 
using DMAQ800. (A) The initial stage of the compression test; (B) the late stage of the 
compression test with strain close to 90%; (C) the scaffold before the test; and (D) fully 
recovered scaffold at 48 hours after the test. 
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Figure 8.7: Strain-stress curve of the EDC post-cured chitosan-gelatin hybrid scaffolds 
during the static compression test. (A) Full range of compression up to 90% strain; (B) 
amplification of the curve at low strains ranging from 0 to 50%. The region a indicates 
the linear elasticity (bending), region b indicates the plateau (elastic bucking), and region 
c indicates the densification of the scaffold. 
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The compressive stress-strain behavior of the EDC post-cured hybrid scaffolds 
conforms to that of an elastic foam 22. At low relative strains (region a), the macro-pores 
in the scaffold absorbed the majority of the compressive energy and converted it into a 
linear elastic deformation of the material primarily by bending of the walls of the macro-
pores. At medium strains (region b), the wall structure of the macro-pores collapsed and 
filled into the inner-porous space, giving rise to a plateau (elastic bucking) in the stress-
strain curve where the strain continued to increase at a relatively constant level of stress. 
Eventually, at high strains (region c), the inner-porous space was fully filled by the 
collapsed wall structures, and the scaffold started to exhibit a dense solid-like 
(densification) stress-strain behavior, as evidenced by rapid increase in the stress 
necessary to generate small increase in the strain. In comparison, the other two groups of 
the scaffolds collapsed at the plateau region of the stress-strain curve, suggesting the 
insufficiency in their elastic properties and stiffness to buffer the energy or resist the 
impact by compressive loadings.  
Due to the failure of the other two groups of scaffolds during the static 
compressive test, cyclic compression test was only performed on the EDC post-cured 
hybrid scaffolds to assess the dynamic load-bearing capacity of the scaffolds at a constant 
strain rate of 1mm/min and at strains ranging from 30% to 60% (Fig. 8.8). At a medium-
range strain rate of 1mm/min, the repeated static force-time or stress-time cycles indicate 
full recovery of the scaffold in gross dimensions after each cycle within the range of the 
strain (30% to 60%) (Fig. 8.8 A,C). The stress-strain curve (Fig. 8.8 D) indicates that the 
scaffold recovers to 30% strain instead of the initial no strain condition after the first 
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cycle and reproducibly deforms and recovers along the same stress-strain loop in the 
following cycles, suggesting a temporal retardation during the recovery process possibly 
due to the creeping behavior of the scaffold. The difference in the compression and the 
recovery stress-strain curves also indicates an energy loss during the cyclic compression 
process: the compressive loading energy absorbed by the scaffold during the compression 
process was stored in the material and was only partially released during the recovery 
potentially due to the internalization/dissipation of energy by the material. The area under 
the stress-strain curve is usually defined as toughness, an index of the material’s ability to 
absorb energy during deformation. Taken together, the static and cyclic compression tests 
demonstrate that the EDC post-cured hybrid scaffolds are primarily elastic in nature and 
possess the appropriate strength and toughness to withstand both static and cyclic 
compressive loadings that simulate physiological conditions. 
Finally, we have evaluated the potential of the gelatin-chitosan hybrid scaffolds in 
supporting osteoblast attachment and 3-D organization. Osteoblasts that were seeded to 
the hybrid scaffolds in culture were seen rapidly attach, spread, and infiltrate into the bulk 
of the hybrid scaffolds through the interconnected pores (Fig. 8.9). The cells exhibited 
high viability, and were actively proliferating on the scaffolds, suggesting a high cell 
affinity of the gelatin-chitosan hybrid scaffolds that are fabricated by governing the 
transient phase separation in a polysaccharide-protein-organic solvent system, and the 
potential of the hybrid scaffolds for tissue engineering applications. 
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Figure 8.8: Cyclic compression test on the EDC post-cured chitosan-gelatin hybrid 
scaffolds at a constant strain rate of 1mm/min and a strain range of 30% to 60%. (A) 
Static force vs. time; (B) strain vs. time; (C) stress vs. time; and (D) stress-strain curve. 
 
 
Figure 8.9: Confocal image of the osteoblasts cultured on the scaffold of a 5%gelatin-
7.5%chitosan hybrid scaffold (no setting time, and no crosslinking of gelatin) at 48 hours. 
Osteoblasts were stained in green using Alexa-488 conjugated phalloidin, nuclei were 
stained in blue using Draq-5. Scale bar is 100 μm. It is clearly seen that osteoblasts 
attached, spread, and infiltrated into the scaffold. 
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8.3 Conclusions 
In summary, we have reported a novel approach in creating 3-D porous scaffolds 
of polysaccharide and protein with tunable microstructures across the nano, micro, and 
macro length scales, superior elastic properties, and excellent cytocompatibility by 
governing a transient phase separation process in a polysaccharide-protein-organic 
solvent system through the control of interaction parameters. We have shown that the 
microstructures (pore size, pore morphology, and porosity) of the hybrid scaffolds of 
chemically modified photocurable chitosan and gelatin can be varied as a function of 
interaction parameters, including the setting time, the ratio of gelatin to chitosan, and the 
crosslinking of gelatin. These observations are possibly mediated through a transient 
phase separation mechanism dominated by gelatin-chitosan interactions in an organic 
solvent (DMSO). The hybrid scaffolds exhibit superior elastic properties and 
compressive strength and toughness when compared to pure chitosan scaffolds and 
existing biopolymer scaffolds in the literature. They also promote osteoblast attachment, 
spreading, proliferation, and 3-D organization in vitro. These findings form the basis to 
manipulate microstructures of 3-D polysaccharide-protein hybrid scaffolds by governing 
transient phase separation in a polysaccharide-protein-organic solvent mixture, and 
suggest the utility of a transient phase separation mechanism in producing hybrid 
scaffolds with controllable pore sizes, pore morphologies, superior elasticity and 
compressive strength, and enhanced bioactivities for biomedical applications. Additional 
experiments are underway to better understand the mechanisms of transient phase 
separation in the chitosan-gelatin-DMSO solution, the utility of this principle to generate 
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unique microstructures or scaffolds with controllable physical and morphological 
properties, and the optimal combinations of these scaffolds with schemes of sustained 
release of a wide array of bioactive agents for the repair/regeneration of specific tissues. 
 
8.4 Methods 
8.4.1 Scaffold preparation 
Chemically modified photocurable chitosan was synthesized according to the 
method we described previously 23. Briefly, 1 g chitosan was dissolved into 
methanesulfonic acid while constantly stirring for 25 minutes, followed by dropwise 
addition of a mixture of 1.1 g benzoyl chloride and 1.227 g methacryloyl chloride. The 
solution was kept at room temperature with stirring for another 30 minutes before it was 
dropwise added into an aqueous solution of ammonium hydroxide (100 ml 5N 
ammonium hydroxide solution + 600 ml DI water). The precipitate was filtered and 
washed with DI water for 10 times to remove the reagent and solvent residues. Finally, 
the product was dried in vacuum over P2O5 for 2 days. The obtained chitosan has a 0.85 
degree of deacetylation, a 0.4 graft degree of benzoic groups, and a 0.93 graft degree of 
methacrylate groups, as determined by 1H NMR spectroscopy 23. 
 For hybrid scaffold fabrication, 2 g gelatin was dissolved into 40 g DMSO to 
reach 5% (w/w) solution in 3 days under constant stirring. Appropriate amount of 
chemically modified photocurable chitosan containing 0.5% (wt% based on chitosan) 
Iragure 2959 was added into 5% gelatin solution under stirring to obtain 5% gelatin-5% 
photocurable chitosan-DMSO mixture, and 5% gelatin-7.5% photocurable chitosan-
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DMSO mixture, respectively. The mixture was then slowly filled into molds of circular 
disc morphology with 2 mm in depth and 8 mm in diameter, and set for different lengths 
of time (0, 8, 12, and 16 hours for 5% gelatin-5% chitosan-DMSO mixture, and 0, 8, 24, 
48, and 56 hours for 5% gelatin-7.5% chitosan-DMSO mixture, respectively) before 
exposure to UV light for 2 minutes to crosslink chitosan. The photocured discs were 
immersed into DI water for 24 hours and washed several times to remove solvent 
residues. A set of the discs underwent boiling water treatment to remove uncrosslinked 
gelatin. Prior to immersion into DI water, another set of the photocured discs were further 
crosslinked by immersing into 4:1 acetone-water (v/v) solution containing 1% (w/v) 1-
ethyl-(3-3-dimethylaminopropyl carbodiimide hydrochloride) (EDC) at 4oC overnight, 
which crosslinked gelatin, and gelatin with chitosan, followed by washing and hydration 
with DI water for 2 days. The hydrated discs were cut into slices, frozen at –20oC, and 
lyophilized. The morphologies of the discs were examined by SEM. 
The scaffold samples for the compression test were fabricated through a similar 
process, except that salt crystals of an average 300-325 µm in diameters were filled into 
the mold before filling the biopolymer-DMSO solution dropwise into the mold and 
evacuating air bubbles under vacuum. Then the whole mold was exposed to UV for 4 
minutes. The solidified disc was released from the mold and immersed into DI water. 
Photocured macro-porous scaffolds were obtained after the salt particles were leached out 
of the discs in DI water. A group of the scaffolds were continued to be processed for 
further crosslinking by EDC. Due to the presence of abundant water in the scaffolds, the 
EDC post-cure protocol was different from the one that was described above. Briefly, 80 
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mg EDC and 20 mg N-hydroxysuccinimide (NHS) were dissolved into 10 ml 0.05 M 
buffer of 2-morpholinoethane sulfonic acid (MES buffer, pH 5.40). The addition of NHS 
into the EDC solution enhances the stability and catalytic efficiency of EDC in aqueous 
solution 24. The photocured porous scaffolds were first equilibrated in MES buffer 
solution for at least 30 minutes, followed by immersion into the EDC/NHS solution under 
gentle stirring for 4 hours to allow the completion of the crosslinking reaction. The EDC 
post-cured porous scaffolds were then washed with 0.1 M Na2HPO4 solution (2h) and 
demineralized water (4 times with a 30 min interval).   
 
8.4.2 Scaffold characterizations 
Rheological measurements were performed on the hydrated discs using an AR-G2 
model stress controlled rheometer (T.A. Instruments, U.K.) with 8 mm parallel plate 
geometry at 25 oC. By adjusting the upper plate, a 10% compressive strain was applied to 
all the discs. Frequency sweep experiments were carried out at 0.1% shear strain between 
0.01 and 100 Hz (i.e., 0.0628 and 62.8 rad/s) on these discs. The discs made from 5% and 
7.5% chitosan without gelatin were also measured as controls. 
The compressive properties of the scaffolds were investigated using the Dynamic 
Mechanical Analyzer Q800 (DMAQ800). All of the scaffolds were trimmed to discs with 
5 mm in diameter. And the compression test was carried out with a constant strain rate at 
1mm/min and the trigger force is 18 N. The initial elastic modulus was calculated based 
upon the slope of the stress-strain curve at low strains (< 3%). For the cyclic compression 
test, under a constant strain rate of 1 mm/min, the scaffolds were first compressed to 60% 
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strain and then recovered to 30% strain by retreating the force. After that, the scaffolds 
were repeatedly compressed and recovered between 30% and 60% strain at 1 mm/min 
strain rate for 4 more cycles. Each measurement was performed three times and averaged.  
For in vitro cell culture, primary bovine osteoblasts were cultured in a 75 mm2 
flask until confluence. The cells were harvested and counted. Cell suspension containing 
80,000 bovine osteoblasts was seeded per re-hydrated disc that was sterilized by ETO 
gas. 2 hours after the cell seeding, culture media was added into the culture plate. The 
cell-disc compound was fixed with 4% paraformaldehyde for 30 minutes after 48 hours 
of culture in incubator (37 oC, 5% CO2). Actin was stained in green using phalloidin-488 
conjugated antibody and the nuclei were stained in blue using Draq-5. The stained 
samples were observed and imaged using a Leica laser confocal microscope. 
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